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II 
This thesis provides an overview of my research over the past three 
years into microarray gene expression data analysis in clinical 
research. This work involves using bioinformatics techniques to study 
disease-related microarray gene expression data. These 
bioinformatics methods contain novel features which are of 
considerable biological interest. Fundamental to this thesis is that the 
mass of numbers produced by DNA microarrays amounting to 
hundreds of data points for thousands or tens of thousands of genes 
are primarily driven by their genetic roots in the human genome. It 
enables the genome to become a unifying explanation for all of human 
biology and medicine. 
This thesis is composed of three parts. In the first part, I describe the 
fundamental research strategies in which DNA microarrays have 
started to affect clinical research. In the second part of the work, I 
provide a choice of bioinformatics techniques to support the use of 
genome-based expression profiling as a commonplace microarray 
platform for minimally invasive diagnostic tests and therapeutic 
interventions in the study of diseases. In the third part, I employ the 
bioinformatics techniques presented in the second part to identify the 
molecular biological mechanisms as well as to pinpoint potential 
targets for drug discovery and diagnostics. 
This work, as described in the three parts, leads to the facility of 
genome-based expression profiling as a commonplace platform for 
diagnosis and therapeutic interventions of almost any kind of disease 
in clinical practice in a straightforward manner. 
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Chapter 1 
DNA Microarray Technology and 
Clinical Research 
1.1 Introduction 
Generally speaking, one may take either a genome-scale 
experimental or a conventional observational approach to the study of 
disease at the transcriptional level. A conventional observational 
study often observes the activities of one gene at any one time, 
whereas a genome-scale experiment involved planned intervention 
on all genes suspected of causing the disease under investigation. 
Nonetheless, the objective of both conventional observational and 
genome-scale experimental studies is the elucidation of 
cause-and-effect relationships. 
DNA microarrays or gene chips are prominent among the 
genome-scale experimental technologies [Aitman, 2001]. During the 
past decade, there has been a dramatic rise in the use of DNA 
microarrays for clinical research. For almost any disease, clinical 
investigators can, in principal, start by searching for its genetic roots 
in the human genome [Wade 2001]. Such progress is a far cry from 
the conventional observational method of medical discovery with its 
heavy dependence on luck and inspiration [Wade, 2001]. In the era of 
post-genomics, clinical investigators should be less dependent on 
happy accidents of the type that accompanied Alexander Fleming's 
discovery of penicillin [Fleming, 1944; Wade, 2001]. But instead of 
waiting for another Fleming, clinical investigators can scan the 
genome of a pathogen with the aid of DNA microarrays, searching for 
weak points in their resistance where a drug or vaccine might be 
brought to bear [Wade, 2001]. For any human disease the DNA 
microarray technology provides a powerful new starting point and a 
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means of accelerating clinical research leads from elsewhere. 
One of the principal features of DNA microarrays it the mass of 
numbers, which amount to hundreds of data points from thousands or 
tens of thousands of genes they produce. As a consequence, the 
major challenge in the discipline is to analyse and make sense of this 
immense amount of biological information. The discipline of 
bioinformatics has come to mean the applications of mathematics, 
statistics, and information technology in the biological science, and 
the bioinformatics of microarray is the answer to that challenge 
[Skeletal, 2001]. As a rule, it is not possible to accomplish a profound 
microarray experiment without bioinformatics taking part. 
Even though there are many proposed techniques in bioinformatics 
for the analysis of microarray gene expression data, none of these 
techniques can lead to the discovery of the biology underlying cell 
function [Fielden and Zacharewski, 2001; Khatri and Draghici, 2005; 
Hanai et al., 2006; Werner, 2007]. Particularly, changes in 
transcriptional levels are assessed by some parametric or 
non-parametric tests on an individual basis, essentially resulting in 
long lists of genes that are thought to have significantly changed 
transcriptional levels [Werner, 2007]. On the other hand, in biology 
these changes do not occur as independent events as the lists suggest, 
but in a complex and interdependent manner [Werner, 2007]. To 
address this problem, this thesis provides better fundamental 
bioinformatics techniques to account for the biological complexities 
and interdependencies in the analysis of disease-related microarray 
gene expression data. 
This chapter sets out the fundamentals of DNA microarray technology 
and research strategies in clinical research. The rest of the chapter is 
arranged as follows: Section 1.2 described what DNA microarrays are. 
The methods by which DNA microarrays are produced as described in 
Section 1.3, whose expression profiling enables us to study the cause 
of disease (Section 1.4 ). The concept of clinical research designs and 
choosing among research strategies are discussed in Sections 1.5, 1.6 
and 1.7. 
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1.2 DNA Microarrays Technologies 
DNA microarrays are solid supports onto which the DNA or RNA 
sequences from thousands or tens of thousands of distinct genes are 
attached at fixed locations. The supports themselves are glass 
microscope slides, the size of two side-by-side pinky fingers but can 
also silicon chips or nylon membranes [Skeletal, 2003]. The DNA is 
printed, spotted or actually synthesised directly on the glass slide 
[Skeletal, 2003]. 
For the past three decades, the standard techniques used to detect 
specific sequences of DNA or RNA has depended on the use of a DNA 
probe [Aitman, 2001]. A single-stranded DNA molecule with a known 
sequence is labeled with a radioactive isotope or a fluorescent tag and 
then used as a "probe" to detect a fragment of DNA or messenger RNA 
(mRNA) with the complementary sequence [Aitman, 2001]. For 
example, if a scientist wanted to know whether gene X is differentially 
expressed in a particular tissue, he or she would make a radio-labeled 
DNA probe by using a small piece of gene X, isolate mRNA from the 
tissue, bind the mRNA to a solid medium and then hybridise the probe 
to the filter. If gene X is differentially expressed in the tissue, this 
scientist will see a radioactive signal on the filter. 
This procedure is known as northern blot analysis [Alwine et al., 1977]. 
DNA microarrays have enabled us to do thousands or tens of 
thousands of northern blot analysis at the same time. DNA 
microarrays use the same DNA probe detection method but on a much 
larger scale. Instead of studying one gene at a time, microarrays 
allow thousands of specific DNA or RNA sequences to be detected at 
the same time on a small glass or silica slide [Aitman, 2001]. While 
the principals of specific DNA or RNA detection have remained 
unchanged, the notably increased scale on which this can be achieved 
with DNA microarrays has made it possible to examine quantitatively 
different statistical hypotheses at the same time. 
1.3 Making Microarray Platforms 
·I 
Microarray platforms come in various types. Whether they are created 
by scientists or manufactured commercially by one of several 
companies, arrays depend on the same principal: Complementary 
sequences of nucleotides stick to, or "hybridise" to one another. For 
instance, a DNA molecule with the sequence -A-T-T-G-C- will 
hybridise to another with the sequence - T -A-A-C-G- to form a 
double-stranded DNA. 
Presently, two main technologies are used for making microarrays. In 
the first, DNA is spotted onto a glass slide (Figure 1.1); and in the 
second, RNA/in situ oligonucleotides of 15-30 nucleic acid base pairs 
are synthesized onto a silica slide by a process known as 
photolithography (Figure 1.2) [Aitman, 2001]. 
--.... 
• 
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DNA microarray 
Figure 1.1 Gene expression analysis of two tissue samples using a spotted DNA 
microarray. RNA extracted from samples 1 and 2 is labeled w1th red or green 
fluorescent dyes [Brown and Botstein, 1999; Aitman, 2001]. The dye labeled RNA 
populations are mixed and hybrid1sed to the microarray, on which has been spotted 
eDNA from thousands of genes, each spot representing one gene [Brown and Botstein, 
1999; Aitman, 2001]. The RNA from each sample hybridises to each spot m proportion 
to the level of expression of that gene in the sample [Brown and Botstein, 1999; 
Aitman, 2001]. After hybridisation, the red and green fluorescent signal from each 
spot is determined, and the ratio of red to green reflects the relative expression of 
each gene in the two samples [Brown and Botstein, 1999; Aitman, 2001]. 
~ 
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Figure 1.2 Gene expression analysis using an oligonucleotide microarray. Up to half 
a million distinct oligonucleotides are synthesised on the mtcroarray by 
photolithography and act as probes tn ind1v1dual "features" on the microarray surface 
[Brown and Botstein, 1999; Aitman, 2001]. About 30 dtstinct oligonucleotides, printed 
as individual features, represent the partial sequence of one gene [Brown and 
Botstein, 1999; Aitman, 2001]. Fluorescent labelled eDNA derived from a single test 
sample is hybridised to the microarray, allowing the expression level of up to 15,000 
genes to be measured in the test sample [Brown and Botstein, 1999; Aitman, 2001]. 
In spotted microarrays, eDNA, oligonucleotides, or small fragments of 
the polymerase chain reaction (PCR) products at the level of particular 
genes are spotted on the gene chip [Aitman, 2001]. A robot typically 
carries out the procedure and one or more probes can be used for 
each gene [Aitman, 2001]. Unlike RNA sin situ oligonucleotide arrays, 
spotted arrays are "customizable". The user can choose the probes to 
be spotted consistent with specific experimental needs [Aitman, 
2001]. While the technology for manufacturing spotted microarray 
platforms is now widely accessible, a major disadvantage of this 
technique is that consistency of spotted and reliable annotation of the 
DNA on the microarray platforms is hard to achieve [Aitman, 2001]. 
The photolithography technique, originally borrowed from the 
semiconductor industry, is limited to a small number of 
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manufacturers, of whom the best known is Affymetrix, a California 
Silicon Valley-based biotechnology company that has cornered a large 
share of the microarray market [Aitman, 2001]. The very high spotted 
density possible with photolithography (Figure 1.2) means that the 
expression of up to 15,000 genes can be measured on a single slide 
(the signal for each being derived from about 30 spots) [Aitman, 
2001]. While these commercial arrays have high unit cost, the 
consistency between arrays is assured by the production process, and 
microarrays representing most of the genes in the human genome 
and a range of other genomes can be bought ready for use without the 
need for development by the user [Aitman, 2001]. 
1.4 Microarray Gene Expression Profiling 
One of the principal applications of DNA microarrays is gene 
expression profiling, in which RNA is isolated from a tissue or cell. The 
result reveals the expression levels of mRNA from thousands or tens 
of thousands of genes, in a tissue or cell. It enables the investigation 
of a complete cell at work at any one time. Through global analysis of 
gene expression profiling, the function of genes previously identified 
only by their DNA or RNA sequence is being discovered almost as a 
matter of routine [Aitman, 2001]. Furthermore, clinical investigators 
hope to understand and explain the pathogenic mechanisms of almost 
any kind of diseases at the genetic level and, in time, to develop 
genome-based treatments or cures. 
For individual patients, more precise diagnosis and risk assessment 
based on gene expression profiling are achievable for almost any kind 
of diseases, leading to more precise determination of prognosis and 
more individualised medicine [Aitman, 2001]. In individualised 
medicine, as it has been called, more and more drugs will be 
packaged with diagnostic tests designed to identify the patients who 
will respond best and to screen out those likely to suffer unwanted 
adverse effects [Wade, 2001]. And as the genetic basis for more 
diseases is understood, it will be easy to devise tests for susceptibility 
to each, although treatments or cures will take longer to develop 
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[Wade, 2001]. Many diagnostic tests could be useful even without an 
accompanying treatment, if they point to some preventive change in 
lifestyle [Wade, 2001]. Knowledge of a genetic susceptibility to type 2 
diabetes, for example, might help an obese person pay particular 
attention to health, devise a diet and exercise program. 
In a minor way, genome-based diagnostic testing has already begun, 
although for only a handful of diseases [Wade, 2001]. When a 
newborn in the United States and Japan is a tender twenty-four hours 
old, it gets a first taste of medical procedures [Wade, 2001]. A nurse 
jabs the baby and a drop of blood falls onto a piece of filter paper 
[Wade, 2001]. The blood is then tested, principally for 
phenylketonuria, a metabolic disorder caused by a deficiency of the 
enzyme phenylalanine hydroxylase, which affects 1 in 10,000 live 
births and leads to mental retardation unless prevented by a special 
diet [Wade, 2001]. 
On the other hand, though gene expression profiling has already been 
proven to be clinically useful in the diagnosis of cancer, most 
genome-based diagnostic tests are still in the development stages 
[Aitman, 2001]. Presently, for instance, the procedure used to classify 
pediatric acute lymphoblastic leukaemia (ALL) subtypes using DNA 
microarrays is to select a number of diagnostic discriminating genes 
of the various leukaemia subgroups using Chi-square statistics, and 
there are marked differences in the number of diagnostic diagnostic 
discriminating genes for the various leukemia subtypes [Ross et al, 
2003; Ross et al, 2004]. This simple technique does not allow the use 
of genome-based expression profiling as a single standardised 
microarray platform for diagnosis of the known prognostic subgroups 
of pediatric acute lymphoblastic leukaemia in clinical practice, since it 
can be extremely laborious, time consuming and expensive. In 
addition, such procedures do not address the full potential of 
genome-scale experiments to alter our understanding of cellular 
biology by giving, through an inclusive analysis of the entire 
repertoire of transcripts, a continuing comprehensive window into the 
biology responsible for the clinical differences among these leukemia 
subgroups. To direct support to the use of genome-based diagnostic 
testing as a single standardised microarray platform for the diagnosis 
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of pediatric acute lymphoblastic leukaemia in clinical practice, we 
have put forward a better fundamental analysis for transcriptional 
responses of bone marrow samples from pediatric patients with ALL 
(Chapter 5, Section 5.1). 
1.5 Study Designs 
In microarray data analysis of gene expression the expressed genes 
are referred to as variables, and the values of the measurement 
recorded for them are referred to as microarray gene expression data. 
Generally speaking, disease-related data from microarray-based 
studies may come from different sources, with the two fundamental 
designs being retrospective and prospective. 
1.5.1 Retrospective Studies 
Retrospective studies, also called case-control 
aetiological investigations in which comparisons are 
studies, are 
made between 
individuals who have a particular disease or physiological condition, 
known as cases, and individuals who do not have the disease or 
physiological condition, known as controls [Collett, 1991]. At time a 
distinction is made between the sources from which cases and 
controls are chosen. In a population based case-control study, all 
cases of the disease under investigation taking place within a defined 
geographic area during a specific period of time are ascertained, often 
through a disease registry or hospital network [Schlesselman, 1982]. 
The entire case series or a random sample of it is chosen for study, 
whereas controls are chosen by taking a probability sample of 
individuals free of the disease being studied in the geographic area 
from which the case arose [Schlesselman, 1982]. In a hospital-based 
case-control study, all cases of the disease admitted to a single 
hospital or network of hospitals are ascertained during a specified 
period of time [Schlesselman, 1982]. The entire case series of a 
random sample is selected for study. In the hospitals from which the 
case arose, controls are selected from persons admitted for conditions 
other than the disease. 
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In microarray-based clinical studies, gene expression profiles from 
selected cases and controls are compared to determine differences, if 
any, in relation to the occurrence of disease. The advantages of a 
case-control study are that it is relatively inexpensive and it is 
possible to obtain answers to research questions relatively quickly 
because the cases are already available. 
1.5.2 Prospective Studies 
Prospective studies, also called cohort studies, a group of persons of 
comparable health are enrolled and followed over a certain period to 
observe the time at which a disease or physiological condition 
develops. Given the time-to-event data, the scientist then seeks to 
determine whether there is a statistical relation between exposure 
and the disease [Le, 1997]. Another form of the prospective study 
consists of clinical trials [Le, 1997]. A clinical trial is a controlled 
experiment that often seeks to determine the safety and efficacy of a 
new drug or device. A controlled clinical trial (Figure 1.3) consists of 
two periods: 
1. During the enrollment period, the time interval (0.1,), volunteer 
enter the study sequentially and are randomized to receive either a 
potentially therapeutic agent or a placebo (or the standard 
therapeutic treatment) [Le, 1997]. 
2. Recruited volunteers are then followed to the time of the primary 
ending event, or to time c, where I, 21,; the time interval (t,.l,) 
is called the follow-up period [Le, 1997]. As an example, a clinical 
trial may consist of 2 year of enrolment and 2 years of follow-up; 
no patients are enrolled during the last 2 years. 
No new volunteer recruited after 
this time point 
[ Enrollment period 
j 
I [
-··--, 
__ Follow-up period 1 
,. 
Study initiation ,, Study termination 
Figure 1.3 A clinical trial: 
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1. During the enrollment period, the time interval (O.t;}, volunteer enter the 
study sequentially and are randomized to receive either a potentially therapeutic 
agent or a placebo (or the standard therapeutic treatment) [Le, 1997]. 
2. Recruited volunteers are then followed to the time of the primary ending 
event, or to 
time 1., where 1, 2: 11 ; the time interval (1,.1 2 } is called the follow-up period [Le, 
1997]. As an example, a clinical trial may consist of 2 year of enrolment and 2 
years of follow-up; no patients are enrolled during the last 2 years. 
1.6 Exploratory Study 
In microarray-based studies of global gene expression, the 
case-control method of investigation is nonetheless often the 
research strategy of choice, particularly when initiating an 
explanatory study of disease etiology. So far, since we have very little 
a priori knowledge the exact mechanisms of the disease under 
investigation at the transcriptional level, exploratory study, 
colloquially called a "fishing expedition", is the one in which multiple 
hypotheses are proposed for scientific investigation with the help of 
microarray gene expression profiles from selected cases and controls. 
The purpose of such studies is to learn enough about possible causes 
of the disease in question so that one or more specific hypotheses 
may be proposed and be sufficiently supported to justify a detailed 
investigation [Schlesselman, 1982]. 
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An example of an exploratory case-control study was one conducted 
by Dr. Ling-Hong Tseng and his coauthors (including me), as to the 
etiology of pelvic organ prolapse (POP) taking place in a certain 
population of women corresponding to non-prolapse controls [Tseng, 
2009]. At the start of this investigation, we did not know the cause of 
POP since basic science research into its pathogenesis had been very 
limited [Alperin and Moalli, 2006]. In this research, global gene 
expression profiles were studied in pelvic connective tissue from 
women with POP corresponding to non-prolapse controls. The round 
and uterosacral ligaments were removed from each women, both 
cases and controls, at the time of a laparoscopic hysterosctomy. Total 
RNA was then extracted and all labeled samples were hybridised to 
Human Genome Survey Microarray Version 2.0 (Applied Biosystem, 
CA, USA). A specific hypothesis which emerged from the finding was 
that defective mitochondrial translation caused by ribosomal proteins 
was the molecular etiology of POP [Tseng, 2009]. 
Irrespective of the terminology employed, the characteristics of 
exploratory case-control studies are similar to: (1) data concerning 
the distribution of potentially important characteristics among cases 
and controls are unavailable, and knowledge of the natural history of 
the disease is insufficient to justify study of a specific hypothesis; (2) 
an attempt is made to gather data concerning possible differences on 
a variety of factors among the cases as compared to the controls in 
the hope that etiologic clues leading to further study will emerge 
[Schlesselman, 1982]. 
While some clinical investigators have disparaged explanatory studied, 
they are usually the logical first step to understand disease etiology 
and are to be favoured over a study restricted to a specific hypothesis 
that is speculative or weakly supported [Schlesselman, 1982]. For 
example, Dr. Bertha Chen and his coauthors in 2005 reported that 
elastin metabolism was the etiology of POP resulting in urinary stress 
incontinence [Chen et al., 2004; Wen et al., 2006; Wen et al., 2007]. 
But their attempts remained undetermined for two reasons: First, 
they examined global gene expression profiling of vaginal tissues 
from women with POP, without examining their connective tissue 
samples collecting from supportive ligaments (e.g. utero-sacral, 
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round and uterosacral ligaments). Next, they hypothesised that 
elastic metabolism is the cause of POP, and chose to examine genes 
involved in extracellular matrix remodeling only. However, another 
explanatory study of global gene expression profiles in the round and 
uterosacral ligaments from women with POP suggests that defective 
mitochondrial translation caused by ribosomal proteins was the 
molecular etiology of POP [Tseng, 2009]. Such a study would have 
been premature and would have diverted energies and research funds 
from the completion of a comprehensive descriptive investigation. 
Unlike an explanatory studies, an analytical study is an investigation 
designs to test a specific hypothesis concerning the cause of the 
disease under investigation [Schlesselman, 1982]. The hypothesis 
must be stated in an explicit way that permits definitive and unbiased 
assessment. "Obesity causes type 2 diabetes", for example, is a 
hypothesis of a different degree of clarity than a hypothesis stated as 
follows: "Obesity is associated with type 2 diabetes". Compared with 
obese persons who are free of type 2 diabetes, patients with type 2 
diabetes will be obese with the progress of hyperglycemia. 
1.7 Choosing Among Research Strategies 
With the help of the DNA microarrays that monitor the simultaneous 
activity of thousands or tens of thousands of genes in a cell, it 
becomes achievable to examine a complete cell at work. A 
microarray-based experimental method is universally believed to be 
the most powerful explanatory method, and it is available to most 
clinical researchers. A patient's past and current biochemical status 
can be assessed using a single gene chip. In microarray-based clinical 
research, the choice of research strategies is limited to the cohort or 
the case-control approach, whereas the case-control method of 
investigation is usually the research strategy of choice. Furthermore, 
the exploitation of disease-related global gene expression profiling 
strengths a case-control study's capability of detecting the underlying 
etiology. 
!3 
The case-control method is especially useful for the study of rare 
diseases [Schlesselman, 1982]. In this situation, a cohort study is 
extremely inefficient since virtually all of the effort is devoted to the 
follow-up of individuals who remain free of the disease under 
investigation [Schlesselman, 1982]. The case-control method is also 
most appropriate for studying diseases with long latency 
[Schlesselman, 1982]. A clinical investigator adopting the 
case-control method studies patients who have already developed the 
disease under investigation has no need to wait for time to elapse 
between the possible cause and the appearance of disease symptoms. 
One can start to search for cases without delay. In other words, a 
case-control study will almost be less costly and less difficult to mount 
and complete than a current cohort study. The speed with which the 
case-control study can be accomplished and its smaller required 
sample size enables a reduction in costs for gene chips and microarray 
data processing. 
Nonetheless, the case-control method is not suited to the assessment 
of therapy of prophylaxis of disease. Compared with non-diseased 
individuals, cases of the study disease would necessarily be expect to 
have the higher rate of exposure to drugs or other factors than are 
used for treatment (See Section 1.5.2). 
Chapter 2 
Analysis of Variant Genes 
2.1 Introduction 
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The main objective of microarray-based clinical studies is intervention 
on variant genes which contribute to the biological mechanisms of the 
disease under investigation. Furthermore, if an alternation in a 
biological process is followed a change in the character of a disease, 
one may regard this biological process to be a cause. An exposure to 
a biological process may increase, decrease or have no effect on the 
onset of disease, and a case-control study is equally well suited to 
assess any one of these possibilities. 
This chapter presents some methods for determining the effect of 
exposure to variant genes with the disease under investigation, and 
points out the manner in which an assessment can be made on the 
basis of a case-control study. The problem of interpreting an apparent 
effect of exposure to variant genes, in consideration of potential bias 
from extraneous genetic or environmental factors is addressed in a 
discussion of confounding. To further characterise the biological 
process for variant genes associated with the disease under 
investigation, Entrez Gene [Maglott et al., 2007] is used for the 
retrieval of gene-specific information and structuring of biological 
knowledge [Maglott et al., 2007]. 
2.2 Measure of Association 
The concept of association refers to a dependence, which may or may 
not be casual, between two or more variables [Schlesselman, 1982]. 
A statistical explication is made in terms of various measures of 
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association, the correlation coefficient being a typical example. The 
odds ratio is one other. 
Consider two groups of subjects comparable in all respects relevant to 
the onset of disease, apart from presence or absence of exposure to 
some variant genes at a specific point or time 1,. Suppose that during 
a given period of time, from 1, to 11 , one observes the number of 
individuals who develop disease and who remain disease free. In 
biostatistics, if a disease occurs with probability p, then the ratio 
I 
'/(1 -p) is called the odds [Schlesselman, 1982]. If p 1 denotes the 
rate of disease occurrence among subjects expose to certain variant 
genes, the odds of disease are 1/0 _1'
1
). Similarly, if p. denotes the 
ratio of disease occurrence among subjects unexposed to certain 
variant genes, the corresponding odds of disease are P;i -p, )· The 
ratio of the odds of disease in exposed subjects relative to unexposed 
subjects is called the odds ratio [Collett, 1991]. Using the notation 
OR, the odds ratio may be written as 
!'; 
OR= (l-p 1) 
p, 
. (1-p,} 
p,(I- p,) 
p.(I-p!) 
(2.1) 
The odds ratio, OR, can be defined in terms of the odds of disease in 
exposed subjects relative to the odds of disease in the unexposed 
subjects. In particular, if a disease is rare, p, and p, are both small 
and the odds ratio, OR, the odds ratio is approximately equal to 
pj [Collett, 1991]. To prove this, consider the odds of disease for a jp. 
subject in the exposed group, 1/0 _ p,). This can be written as 
f!;(I- P,t = P;(I + p, + P/ + ... ) (2.2) 
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When p, is small, ,,,- and higher-order powers of p, will be 
negligible and therefore pJ!- p, t' will be approximately equal to p, 
[Collett, 1991]. As a consequence, when the disease is rare, this 
approximation is likely to be valid in most studies of the association 
between disease occurrence and variant genes. Furthermore, the 
odds ratio can easily be computer after fitting a linear logistic 
regression model leading to the identification of variant genes 
associated with the disease under investigation, as we will see in 
Section 3.6. 
2.3 Confounding 
In biostatistics, the term confounding refers to the effect of an 
extraneous variable that wholly or partially accounts for the apparent 
effect of the study exposure that masks an underlying true 
association [Schlesselman, 1982]. As a result, an apparent 
association between the exposure and disease may essentially due to 
another variable [Schlesselman, 1982]. On the other hand, the 
apparent lack of an association could result from failure of control for 
the effect of some other factors [Schlesselman, 1982]. To take a 
simple example, suppose that one wanted to investigate by means of 
a case-control study the relationship between insulin resistance and 
type 2 diabetes. In a comparison of cases and controls, one might find 
that the case group contained a greater proportion of the activation of 
complement cascade than the control groups since the complement 
system is known to be a fundamental component of innate immunity 
[Schifferli, 2005]. At the same time, since the activation of 
complement cascade may be correlated with insulin resistance. Thus, 
an apparent increased risk of type 2 diabetes found to be associated 
with the activation of complement cascade in fact might be due to 
insulin resistance. As a rule, a confounder's association with the 
disease under investigation may be either case-and-effect of a 
non-casual relation resulting from the confounder's association with 
casual factors other than the study exposure [Schlesselman, 1982]. 
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In microarray-based clinical studies of gene expression, a confounder 
or confounding gene can be defined as an extraneous gene that 
satisfies both of two conditions: (1) It is a variant gene for the study 
disease, and (2) it is associated with another variant gene that is not 
a direct consequence of that variant gene. For example, if gene A is 
contributed to disease D, the confounding gene B may not be solely 
caused by gene A, and gene B shall not always lead to disease D. 
Figure 2.1 shows path diagram that illustrates in which a gene B is or 
is not a confounder for an association between gene A and disease D. 
I 
A I D 8/ 
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Figure 2.1 (a} Situations in which gene B is a confounder for an association 
between gene A and disease D. 
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Figure 2.1 (b) Situations in which gene B is not a confounder for an association 
between gene A and disease D. 
In planning a case-control study, one should regard any known 
variant genes for the study disease as a potential confounder. The 
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study design and analysis should be planned to either assess or 
eliminate the effects of confounder [Schlesselman, 1982]. Genes that 
are not differentially expressed for the study disease may nonetheless 
be confounders as the result of unwitting selection biased introduced 
by the procedures used to obtain cases and controls [Schlesselman, 
1982]. A variant gene that is a confounder in the sample may be dealt 
with by adjusting procedures that rely upon matching (Section 2.5), 
linear logistic regression model (Section 2.6), conditional or fixed 
effect logistic regression model (Section 2. 7), and cluster analysis 
with the Mahalanobis distance as a distance measure (Chapter 3), 
which gives straightforward ways to account for the confounding. 
Generally speaking, the confounding effects is a major threat to the 
validity of inferences made about cause and effect, i.e. internal 
validity, are the observed effects should be attributed to the 
confounder. The consequence of ignoring confounders in the analysis 
of microarray gene expression data is that incorrect molecular 
signatures underlying the study disease can be obtained. 
2.4 Source of Bias 
Microarray based case-control studies are vulnerable to misleading 
association arising from the circumstances in which cases and 
controls are ascertained and selected for study. Specifically, 
characteristics or exposures associated with differential diagnosis or 
selection of subjects can lead to biased estimates of odds ratio 
[Schlesselman, 1982]. 
The validity of diagnosis is a major source in which bias may occur. For 
example, the diagnosis of cervical dysplasia and carcinoma is based 
on both the objective assessment of well-defined microscopic features 
and on the more subjective analysis of often subtle parameters to 
result in a final diagnosis [Jarcoe et al., 2002]. The routine practice of 
cervical cytology is therefore limited by problems of false negative 
diagnoses as well as by poor specificity for clinically significant lesions 
in patients with low-grade cytological abnormalities [Jarcoe et al., 
2002]. 
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Differential selection is a further source of potential bias. For example, 
in a case-control study of complications of tension-free vaginal tape 
(TVT), some interviews were found to be "keying" on cases who were 
exposed to the study factor. One nurse in particular was searching out 
all cases of TVT patients. If all TVT patients are ultimately selected, 
this causes no problem. If only a fraction of TVT patients are selected, 
however, the sample is biased toward overexposure among the cases. 
To avoid such a problem, one must establish precisely and in advance 
the method by which cases and controls are identified and selected 
[Mantel & Haenszel, 1959]. One must also carefully train staff to do 
the field work properly and establish a system of quality control to 
maintain standards throughout the investigation [Schlesselman, 
1982]. 
2.5 Matching 
Matching refers to the pairing of one or more controls to each case on 
the basis of their "similarity" with respect to selected criteria 
[[Schlesselman, 1982]. Any characteristics or attribute of an 
individual, such as age, gender, race, disease stage, personal or 
family history of disease, may serve as a foundation for pairing. 
Furthermore, if the cases and controls differ in relation to some 
variant genes, suggesting an association with the study disease, then 
the association cannot be explained in terms of case-control 
differences on the matching variables. 
A design with M controls per N cases is known as a N : M 
matched study, and the subjects that constitute the N cases and the 
M controls to which the case has been matched as referred to as a 
matched set [Collett, 1991]. Although the objective of matching is the 
elimination of biased comparisons between cases and controls, this 
objective can only be accompanied by an analysis that corresponds to 
the matched design [Schlesselman, 1982]. Unless the analysis 
properly account for the matching used in the selection phases of a 
case-control, the estimated statistic associated with the study disease 
can be biased as a result of matching [Schlesselman, 1982]. Thus, 
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matching is only the first of a two-step process that can be used to 
control for confounding: (1) matched design, followed by (2) matched 
analysis [Schlesselman, 1982]. 
While the ultimate objective of matching may be the elimination of 
biased comparisons, the immediate consequence of matching is the 
achievement of "balance" in the number of cases and controls that 
occur at each level of the matching variables [Collett, 1991]. For 
example, if one pairs on gender, then equal numbers of cases and 
controls will happen within any gender group. If one pairs on both 
gender and age, then cases and controls will be balanced on gender 
within each age group. Similarly, within any specified gender group, 
cases and controls will be balanced on age. 
In microarray-based clinical studies, matching may be used in special 
circumstance to rule out some particular factor in a postulate casual 
pathway between exposure and distance. For example, suppose that 
effect of leptin on type 2 diabetes is mediated by an elevation of 
serum glucose levels. Then, one might deliberately match on glucose 
to see if the association of leptin with type 2 diabetes is eliminated or 
diminished. 
2.6 Linear Logistic Regression Model 
The first applications of linear logistic regression model to data from 
clinical research appeared during the early 1960s and were the result 
of work by Cornfield and his colleagues on the analysis from a study 
about coronary heart disease [Collett, 1991]. For a number of reasons, 
this method can be used in the analysis of disease-related microarray 
gene expression data. First, it gives a methodical way to exploring the 
relationship between the probability of disease occurrence and some 
variant genes. Next, it is straightforward to ascertain whether or not 
there are interactions between variant genes and confounders and 
estimates of the odds ratio of disease occurrence can be easily 
obtained from the fitted model. 
In a case-control study, the cases are selected from a population or 
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hospital-network of individuals who have the disease that is being 
examined, whereas the controls are selected from a corresponding 
population or hospital-network of individuals without that disease. 
Information on their exposure to particular variant genes is then 
sought retrospectively. If the variable that represents whether or not 
a particular individual is a case in the study is regarded as a binary 
response variable, and then variant genes are treated as explanatory 
variables, linear logistic regression model can be used to identify 
variant genes associated with the study disease. Such model can be 
used to extent of any association between variant genes and a disease 
of interest. 
In a microarray based case-control study of gene expression, let o, 
represent the proportion of cases that have been sampled from the 
disease population, so that fl, is the sampling fraction for the cases. 
The value of o, can be thought as the probability that a disease 
individual is chosen for inclusion in the study, that is 
o, =I' (an individual is in the study I with disease) 
Similarly, let o, be the proportion of subjects is the disease-free 
population who from the controls, so that 0, is the sampling fraction 
for the controls, and 
0, =!'(an individual is in the study I without disease) 
The probability that an individual in the population develops the 
disease will depend on the values of k explanatory variables 
corresponding to levels of gene expression, x, ..... x, , of k genes. For 
this reason, the probability that a particular individual has the disease 
is denoted by rr(x), where x = [x, ..... x, J'. 
If an individual in the case-control study has the disease, this 
conditional probability is given by 
rr,(x)= II, rr(x) !'(with disease! individual ·,sin the study) 
22 
To obtain this conditional probability, we use a standard result from 
probability theory, according to which the probability of an event A, 
conditional on an event B, is given by P(A 1 B)= !'(An 11)1,(B) [Collett, 
1991]. Similarly, !'(B 1 A)= 1'(.4 n ~;(A) . Combining these two 
formulas we have I'( A 1 B)= P(B I.!)P(.){,(B), which is the standard 
form of the Bayes Theorem [Collett, 1991]. Using the result 
rr(x) =of rr,(x)/ ['(individual is diseased) 
Subsequently, an individual is included in the study if that individual is 
diseased and has been selected as a case, or if that person is 
disease-free and has been selected as a control. As a result, 
I' (individual is in the study) is the sum of !'(individual is diseased 
and is a case) and P (individual is disease-free and is a control). Using 
the result P(A n B)= P(A 1 B)f'(B), P (individual is diseased and is in the 
study) is equal to 
P (individual is in the study I diseased) x P (individual is diseased) 
which is 111 rr0 (x) as before . The probability that an individual does not 
have the disease is I- rr,(x) and therefore !' (individual is 
disease-free and is in the study) is 11.(1- rr 11 (x)). Therefore, 
!'(individual is in the study)= 01 rr,(x)+ 0,(1- rr,(x)) 
and so 
rr(x)= 01rr,(x) 
01rr0 (x)+ fl.(!- rr,Jx)) 
(2.3) 
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From this result, 
rr(x) (!1 rr,(x) 
I -rr(x) = tJ, I- rr,(x) (2.4) 
and it then follows that 
I . [ ( )] rr(x) (1 1 rr,(x) og1t rr x = log ( ) = log- + log ( ) 1-rrx 0, 1-rr, x (2.5) 
If a linear logistic regression model is adopted for the probability that 
a subject in the population with the levels of gene expression, 
x = [x1 ••••• xJ, of k genes has the disease, then 
logit[rr,(x)]= a+ /1 1X 1 + ... {J;X, (2.6) 
where " and {J, 's are regression coefficients. So the probability that 
a subject with explanatory variables x is a case in the case-control 
study is given by 
logit[rr(x )] = log ~: r!.+ {11x 1 + ... fi,x, ( 2. 7) 
which, since 11, and li. do not depend on x, can be written as 
logit[rr(x )] =a' + {i1X 1 + .. . {!, x, 
where 
• (i I 
o. =a+log-
0. 
(2.8) 
(2.9) 
This model is a linear logistic regression model for the probability that 
t 
! 
r· 
! 
t 
2~ 
an individual is a case in the case-control study. To fit this model, a 
binary response variable is defined that takes the values on when an 
individual is case, and zero when an individual is a control. On fitting 
this mode, one could estimate n,Jx), the probability that an individual 
with altered expression of genes x has the disease. From equation 
(2.6), this probability depends upon an estimate of " , which from 
equation (2.9) depends on estimates of "., 11, and 11,. Though ,· 
can be estimated, the two sampling fractions, 111 and II,, cannot be 
estimated unless information is available on the number of diseased 
and diseased-free persons in the population being sampled. Such 
information is usually unavailable, and so in general it will not be 
possible to estimate ((. 
Similarly, the odds of disease for a subject with exposure to 
differentially expressed genes x, relative to someone whose values 
are x11 is given by 
n,(x,} 
OR= (1-n,(x,)) 
n,(x
11
} •· 
(1- n, (x11 )) 
(2.10) 
From equation (2.7), 
n,(xJ II, n(x;) 
I-n, (x J = f! 1 I- n(x :1 
(2.11) 
for j = 0,1, and so 
n(x,) 
OR= (!- n(xJ) 
n(x0 ) (1- n(x 11 )) 
(2.12) 
:.:. 
~ 
:: 
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The odds ratio is independent of a , and so it can be estimated from 
microarray gene expression profiles from a case-control study. In 
practice, we can find the maximum likelihood estimators for " and 
the estimated odds ratio using a standard statistical package, such as 
SPSS, SAS, STATA, Splus orR. As we will see in Section 4.2, we have 
used this method to examine microarray gene expression profiling of 
skeletal muscle response to endurance exercise training. 
2. 7 Conditional or Fixed Effect Logistic Regression 
Model 
In section 2.4, we explained how a matched case-control study can be 
used for the purpose of controlling the effects of confounding 
variables. As in modeling microarray gene expression data from an 
unmatched case-control study, the probability that an individual is 
diseased will be assumed to depend on the expression levels of p 
genes that have been measured on that individual with the help of 
gene chips. The expression levels of p genes may represent risk 
genes and those potential confounders that have not been used in the 
matching process. In addition, the probability that a particular 
individual is diseased may also depend on the values of the matching 
variables that define the matching set in which an individual occurs 
[Collett, 1991]. To take the matching into consideration in the 
analysis of variant genes from a matched case-control study, a 
conditional likelihood or fixed effect likelihood is constructed. The 
augmentation used to construct the relevant likelihood is: 
Assume a 1: M matched case-control study, where the t-th matched 
set contains one case and AI controls. Let D and D denote the 
presence and absence of the disease under investigation, respectively. 
Assume that the presence of the disease under investigation when 
comparing with controls depend on the expression levels, x,,. .... ,x
1
,_,, 
of p genes. Let Y be the vector of joint levels of gene expression, 
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i.e. Y =[x,, ..... x,, 11J. Let P(DI !J denote the probability that the i-th 
individual has the disease at the t-th matched set has the vector of 
joint levels of gene expression, 1;,. Similarly, r( D 1 r) = 1- P(D 1 l,) 
denote the probability that the i-th individual corresponds to a control 
at the t-th matched set has the vector of joint levels of gene 
expression, 1;,. We consider the linear logistic regression model as 
follows: 
P(D 11;,) = a,+ fi 1x 1, + ... + fl,,x,, log/- P(D I!:,) 
Therefore, 
P(D' y )= cxp(a, + /1 1x1, + ... + fl,,x,,,) 
1 
" I+ exp(a, + fi 1x1, + ... + fi,.x 1,,) 
(2.13) 
(2.14) 
Since an individual can be either a case, with the disease, or a control, 
without the disease, the likelihood of a,.[J, ..... fJ,, is given by 
L = r(u,. jJ, ..... fJ,. I data) 
"(AI) =I] /l, P(IJ I r;,)' [1- P(D I!:.}]"-' 
= fr("Hl exp{rx, +fi1x1,. + ... +/f,xr,.)'· 
, 1 A, ) [1 + cxp(a, + /f1x1, + ... + flrx,,, Jr (2.15) 
where l AI J denotes the combination of the i-th subject has the 
A,l, 
disease at the t-th matched set has the vector of joint levels of gene 
expression, 1;,. The conditional log-likelihood is therefore 
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log L = L f(DIYJa, + fi,X,, + ... + fJ,,x,J 
,.\/ 
- M log[l + cxp(a + jJ, X,, + ... + prxrJl+ log( ~~J} 
(2.16) 
We can estimate fJ,, ... , /f,, using a standard statistical package, such 
as SPSS, SAS, STATA, Splus or R. FORTRAN code for analysis data 
from matched case-control studies is also given by Smith et al. [ 1981). 
And the process of estimating jf,, ... , ji
1
, is termed as conditional or 
fixed effect logistic regression modeling. 
The proof of the model is given to show that the effects on levels of 
gene expression are considered within and among various 
experimental criteria, respectively. To do this, let us consider the 
conditional probability given by equation (2.15). Let x;, ..... x;,, and 
x;;, ..... x;:;, denote the levels of the gene expression when the i-th 
individual with and without the disease, respectively. When the i-th 
individual at the t-th matched set has the disease, we have 
P( o 1 r;,) 
P( D I 1;,) r<, +fl,x;, + ... +firx;., 
When the i-th individual at the t-th matched set does not have the 
disease, we have 
P(D It:,) , !') ·" 
( ) 
!!., + /)1,\ 1, + ... + Jf',\ 1,, 
P D I>;, 
Then, the conditional likelihood in equation (2.15) becomes 
[/+ ~exp(fiJ<, -X:,,)+ ... +fiJ,;,, -x;:,)f (2.17) 
In particular, the values X!tt''"'Xf,ll I ..• , ·~ h xtrl''···xro correspond to the 
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effects of gene expression measured within each experimental 
criterion. As a consequence, this conditional likelihood considers the 
effects of gene expression within each experimental criterion 
primarily; then, it judges the effects of gene expression measured 
among various experimental criteria. As we will see in Section 6.2.1, 
we have used this method to examine microarray gene expression 
profiling of bladder epithelial cells from patients with interstitial 
cystitis corresponding to their age- and gender- matched controls. 
2.8 Entrez Gene Database 
In sections 2.5 and 2. 7, the linear and conditional logistic regression 
models are given to identify variant genes associated with the disease 
under investigation on an individual basis, essentially resulting in lists 
of genes that are found to have significantly changed transcriptional 
levels. On the other hand, in biology these changes do not occur as 
individual events as the lists suggest, but in a complex and 
interdependent manner [Werner, 2007]. In order to characterise the 
biological processes for variant genes associated with the disease 
under investigation, Entrez Gene [Maglott et al., 2007] is used for the 
retrieval of gene-specific information and structuring of biological 
knowledge. 
What is Entrez Gene? Entrez Gene 
( htto: //www. pubmedcentral. nih .gov /red irect3. cg i?&&auth- ODkKd Ls 
ftR -n Rij I EdyHj b W p RkGcH u 6a pdX -9 Bkb T&refty pe-ext! in k&a rtid- 5 39 
985&iid= 17832&iid=4&FROM-Article% 7CFront%20Matter& TO- Ext 
ernal% ?Clink% 7CURI&article-id- 539985&journal-id =4&renderinq-t 
ype-normal&&www.ncbi.nlm.nih.gov/entrez/query.fcqi?db-gene) is 
the gene-specific database at the National Centre for Biotechnology 
Information (NCBI), a division of the National Library of Medicine, 
located on the campus of the United States National Institute of 
Health (NIH) in Bethesda, MD, USA [Maglott, 2005]. It provides 
unique integer identifier for genes and other loci for a subset of model 
organisms [Maglott, 2005]. It includes up-to-date gene-specific 
information for genes in sequenced genomes, that have an active 
research community to contribute gene-specific information, or that 
L 
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are scheduled for intense sequence analysis [Maglott, 2005]. 
Table 2.1 recapitulates the gene specific information that can be 
retrieved through the Entrez Gene database, how the data are 
revealed, and some aspects of how those data are processed [Maglott, 
2005]. For example, Gene Ontology (GO) terms provide links of the 
functions, processes and components for all completely sequenced 
genes in model organisms [Maglott, 2005]. These connections are 
designed to provide keywords and linked to make Entrez Gene an 
effective starting place to retrieve information of interest [Maglott, 
2005]. 
Table 2.1 Gene specific information that can be retrieved through Entrez Gene, 
how the data are revealed, and some aspects of how those data are processed 
[Maglott, 2005]. 
Subcategory 
Nomenclature 
Gene symbols 
and full 
descriptions 
Protein names 
Gene structure 
and sequence 
Gene structure 
Reference 
sequences 
Related 
sequences 
Revealed 
Report, 
Table 
Report, 
Table 
Report, 
Remarks 
Sources: External authorities, 
GenBank, Publications. 
'LOC'+GeneiD designation assigned 
if none of the above officially 
accepted nomenclature has 
precedence 
Often same as the gene name, but 
may be edited to make orthologs' 
names uniform 
Based on annotation of the Reference 
Table sequence 
Report, The accessions are shown in the 
Table, Links report page; the sequences are 
Report, 
Links 
retrieved from Nucleotide or Protein 
Based on eDNA or protein 
comparison, best genomic placement 
and curation. Accessions are shown 
in the report page; sequences are 
retrieved from Nucleotide or Protein 
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Genomic 
position 
By sequence Report, Genomic annotation 
Links 
By independent Links Shared markers or reports of 
maps cytogenetic position 
Citations 
Not annotated Links Sources: external authorities, RefSeq 
curation 
Annotated Report, Sources: external databases, 
Links GeneRIFs 
Functional 
annotation 
Domain content Report, Conserved Domain Database (CDD) 
Links 
GO terms Report GO Consortium 
Pathways and Report, Kyoto Encyclopedia of Genes and 
interactions Links Genomes (KEGG) 
Disease and Report, External authorities such as OMIM, 
other Links RefSeq curation 
phenotypes 
Homology 
By Gene Links HomoloGene 
By Protein Links COG 
Conserved Links Map Viewer 
segments 
Expression 
ESTs Links UniGene 
External Links External resource is named and used 
resources to anchor a Link. The expression data 
are available at that source 
Arrays Links GEO 
Related 
information 
Integrated by Links May be displayed on report as well as 
Gene staff from Links menu 
External sources Links LinkOut choice in Links menu 
'I 
In addition, Entrez Gene can serve as a directory to gene-specific 
information for database outside of NCBI [Maglott, 2005] For instance, 
Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway is a 
collection of acknowledged biochemical pathway representing our 
knowledge of the molecular interactions and reaction networks for 
metabolisms, genetic information processing, environmental 
information processing, cellular processes, human diseases and drug 
development [Kanehisa et al, 2002; Kanehisa et al, 2004; Kanehisa et 
al 2006; Aoki-Kinoshita and Kanehisa, 2007; Kanehisa 2008]. 
In Chapters 3, 4, and 5, Entrez Gene and KEGG pathway are used to 
characterise biological processes for variant genes associated with the 
disease or physiological condition under investigation. 
Chapter 3 
Clustering of Gene Expression 
Profiles 
3.1 Introduction 
1:2 
Cluster analysis is a genetic term that attempts to determine whether 
or not a given dataset contains distinct groups, and, if so, to 
determine the groups [Chen et al., 2007; Chen et al., 2007; Chen et 
al., 2008]. Two general references on the subjects of cluster analysis 
are given by Hartigan [1975] and Gordon [1981]. 
In microarray based clinical studies of gene expression, beyond 
identification of variant genes associated with the disease under 
investigation, another general problem facing clinical investigators is 
how to arrange measured gene expression profiles into biological 
meaningful groups, if any, according to similarity of their expression 
patterns. Cluster analysis is an explanatory data analysis tool for 
resolving this problem. 
There are many possible methods of performing cluster analysis, and 
the relative merits of the alternative approaches have been discussed 
extensively [Shannon, 2003; Armstrong and van de Wiel, 2004; Wu 
and Dewey, 2006]. Recommendations for clustering methods have 
focused on the selection between supervised and unsupervised 
algorithms, between hierarchical and non-hierarchical methods, and 
among various linkage options, but inadequate consideration has 
been given to the substance of the method of computing the distance 
matrix. Given that all clustering procedures are based on some form 
of distance measures, the method of computing this matrix can have 
an important effect on the clustering results. In this chapter, the 
:_n 
applicability of the Mahalanobis distance as a distance measure IS 
discussed in the context of grouping disease-related microarray gene 
expression profiles, whose application enables us to study the 
etiology of cancers and other diseases are discussed in Chapters 5 and 
6. 
3.2 Distance Measures 
Cluster analysis was one of the first methods used to impose order on 
microarray gene expression data [Eisen et al., 1998]. Its purpose is to 
arrange genes into groups in order that the degree of association is 
strong between genes of the same cluster and weak between genes of 
different clusters. This method always starts from the assignment of a 
set of n genes to groups on the basis of the measurements of 
distance between the genes, as measured on a set of p samples. Let 
d(A. B) denote the distance between data points A and H in the 
p -dimensional space, all distance measures have the following three 
properties: 
1. symmetric, i.e.d(A.B)=d(B.A); 
2. non-negative, i.e. d(A.B):>o; 
3. identificatin, i.d. d(A. A)= o 
It is generally considered desirable for the distance measure to be a 
metric: 
d(A.C)<; d(A.B)+d(B.C), which is called the triangular inequality, 
or an ultrametric: 
d(A.C)<; max(d(A. B).d(B.C)) 
but need not be either [Venables and Ripley, 1995]. 
At present, cluster analysis with the corelation coefficient (e.g. 
Pearson correlation coefficient, Spearman correlation coefficient, and 
standard correlatin coefficient) as a distance measure has been 
commonly used in the analysis of microarray gene expression data. 
Although the correlation coefficient is scale invariant, it does not take 
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the covariance between genes into consideration. However, changes 
in expression levels of genes do not occur as individual events, but 
participate in a complex and interdependent manner due to gene 
co-expression and co-regulation, giving rise to the working of lively 
organisms and their parts. Unless the distance measure properly 
takes the covariance between genes into account, the organised 
profiling can be disturbed as a result of ignoring interdependencies. 
To account for the correlation between genes, a proper distance 
measure can be used is the Mahalanobis distance defined as follows: 
d 2n = (x,- x,)' s-1(xi- x,) 
(3.1) 
where xi and x1 are two data points, 5 is the p x p covariance matrix 
of X, and X is assumed to be of full rank so that s-1 exists [Mimmack, 
2001]. The Mahalanobis distance incorporates covariance between 
gene expression levels as well as differences in variances [Mimmack 
et al., 2001]. It gives less weight to genes with high variance and to 
high correlated genes, so that all characteristics are treated as equally 
important [Mimmack et al., 2001]. Thus far, the Mahalanobis distance 
has not explicitly been commonly used in the organisation of 
microarray gene expression data. 
3.3 Hierarchical Clustering 
This section discusses the most frequently used explanatory data 
analysis tool for gene expression data: hierarchical clustering. This is 
a methodology that arranges the expression profiles into a tree-like 
diagram, known as a dendrogram, so that similar profiles appear 
close together in the dendrogram and dissimilar profiles are farther 
apart [Stekel, 2003]. 
This technique has become popular for four reasons: 
1. It simplifies the mass of numbers generated by DNA microarrays. 
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2. The analysis exhibits clusters of genes sharing similar expression 
patterns. 
3. The results can be viewed graphically in a hierarchical way using a 
tree-like dendrogram. 
4. The technique is familiar to most biologists through its application 
in sequence and phylogenetic analysis [Stekel, 2003]. 
Hierarchical clustering begins from a distance matrix computed 
between the genes to be clustered, on the basis of their expression 
patterns. Furthermore, differences between the methods arise from 
the variety of ways in which distance between a cluster and a single 
gene, or between two clusters, can be defined [Everitt, 1994]. The 
distance between two clusters could, for example, be defined as the 
distance between their closest genes, leading to single linkage 
clustering. Another possibility is to define inter-group distance as that 
which is between the most remote pairs of genes, one from each 
cluster. This leads to complete linkage clustering. A measure that 
uses more than a single inter-gene distance is average linkage, where 
the distance between two clusters is defined as the average of the 
distance between all pairs of genes where members of a pair are in 
different clusters. Ward's linkage is distinct from all other linkage 
options since it uses an analysis of variance approach to calculate the 
distances between clusters [Tseng et al., 2009]. Briefly, this method 
attempts to minimize the sum of squares of any two clusters that can 
be formed at each step. 
As we will see in Chapters 5 and 6, the Mahalanobis distance in the 
Ward's linkage hierarchical clustering is used to investigate the 
aetiology of various types of cancer and other diseases with the help 
of DNA microarrays. 
3.4 K-means clustering 
K-means clustering is described in Sneath and Sokol [1973] and 
differs from hierarchical clustering. Concisely, this algorithm has six 
steps: 
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1. Choose the number of clusters, denoted as k. 
2. Randomly assign each gene expression profile to one of the k 
clusters. 
3. Calculate the centroid of each of the k clusters. 
4. For each profile in turn, calculate the distance between it and the 
centroid of each of the k clusters. 
5. If that profile is closest to a cluster different from the one in which 
it currently belongs, move the profile to the new cluster and update 
the centroids of both clusters. 
6. Go to step 4 and repeat until no profiles change cluster 
membership [Stekel, 2003]. 
As we will see in Chapters 5 and 6, the Mahalanobis distance in the 
K-means clustering algorithm is used to examine the aetiology of 
various types of cancer and other diseases with the help of DNA 
microarrays. 
Chapter 4 
DNA Microarrays and Endurance 
Training -induced Physiological 
Responses 
4-1 Introduction 
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Endurance training was initially developed by Dr. Alios Mader in the 
1980s, and it has had considerable influence on the training of 
athletes in all endurance sports, including competitive swimming 
[Hollman et al, 1986]. Coaches design training programs around the 
idea of pushing athletes to the limit of their pain tolerance and then 
motivating them to go beyond it [Maglischo, 2002; Chen et al,2009]. 
Programs had athletes swimming faster, farther, or with less rest in 
training than they or their competitors had ever swum before 
[Maglischo, 2002; Chen et al, 2009]. These training programs involve 
targeting each of the major phases of the energy system and other 
aspects of physical conditioning, such as muscle strength, flexibility 
and power, with specific training procedures designed to develop each 
to their optimum potential [Maglischo, 2002; Chen et al,2009]. 
The Australian Institute of Sport (AIS) is one of the major institutes 
for swimming in Australia and trains approximately one-third of 
swimmers for the Australian national swimming team [Colwin, 2002]. 
The AIS uses several testing protocols to assess various components 
of training loads in international-level swimmers, including the 
measurements of heart rate, oxygen consumption and blood lactate 
concentration [Colwin, 2002; Maglischo, 2002]. To do this, for 
instance, a sample of blood is collected from the ear or fingertip from 
each elite swimmer after each swim in order to measure the amount 
of lactate acid [Maglischo, 2002; Chen et al, 2009]. Such blood testing 
involves swimming a series of repeated at progressively faster speeds 
during the training of high-rate swimmers (Maglischo, 2002]. 
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However, athletes may not like such blood testing since it can increase 
the possibility of carrying the AIDS, hepatitis B, hepatitis B and many 
other viruses from one person to another [Maglischo, 2002]. 
Furthermore, it would be unnecessary to do so since the quantities 
that are dealt with are merely the amount of lactate acid; 
consequently, an integrated knowledge of the athletes' physiological 
conditions being studied would be quite superficial. We need to 
develop some better fundamental tools to examine athletes' 
physiological conditions for endurance training. 
During the past six decades, research in the sport and exercise 
sciences has developed at an ever-increasing rate. In the period from 
1950 to the early 1970s the motivate for most scientific work was 
primarily at the organ and whole-body level [Colwin, 2002]. Many 
studies revealed the substance of body size, muscle strength, 
flexibility, power, cardiac and respiratory fitness, demonstrating how 
these attributes could be improved through athletic training [Colwin, 
2002]. In the 1980s and 1990s, advancements in medical 
instrumentation and technology shifted focus on examining the 
effects of exercise and training at the cellular level [Baldwin, 2002]. 
This period saw a great deal of interest in using emerging medical 
technologies to study muscle and blood [Colwin, 2002]. 
The next few decades of the 21st century will see application of DNA 
microarray technology to sport and exercise science [Baldwin, 2002]. 
At present, most attention is directed toward addressing the biological 
complexities of cancer, asthma, diabetes, obesity, aging and other 
diseases. In this chapter, we target such issues as identification of 
genetically gifted athletes, and improved diagnosis of training loads. 
The primary theme of this chapter is to show how DNA microarrays 
can usefully assess athletes' physiological conditions for endurance 
training at the transcriptional levels. As we will see in Section 4.2, 
linear logistic regression model is used to examine gene expression 
profiling of vastus lateralis muscle biopsies from subjects following a 
50-minute endurance training course at 20-week before and after 
undergoing the endurance training course, respectively. 
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The main theme of this chapter is to show how DNA microarrays can 
usefully assess athletes' physiological conditions for endurance 
training at the transcriptional levels. As we will see in Section 4.2, 
linear logistic regression model is used to examine global gene 
expression profiling of vastus lateralis muscle biopsies from subjects 
following a 50-minute endurance training course at 20-week before 
and after undergoing the endurance training course, respectively. 
4-2 Microarray Data Analysis 
In this section, we examined microarray gene expression profiling of 
vastus lateralis muscle biopsies from subjects following a 50-minute 
endurance training course at 20-week before and after undergoing 
the endurance training course. The data used here was collected from 
Gene Expression Omnibus under platform accession no GSE1718, and 
this microarray experiment was performed by Teran-Garcia et al 
[2005]. Here we use linear logistic regression model to identify 
variant genes following a 50-minute endurance training course at 
20-week before and after undergoing the endurance training course. 
This enables us to characterise 109 distinct genes that were 
differentially expressed in vastus lateralis biopsies from subjects 
following a 50-minute endurance training course at 20-week before 
and after undergoing the endurance training course (Table 4.1). 
The results were very interesting. First, complex metabolic reactions, 
including carbohydrate, lipid and energy metabolisms, were found to 
have a strong relationship with endurance training -induced vastus 
lateralis muscle contraction. This muscle contraction requires the 
release of energy, which is made available from ribosomes. The 
ribosomes have sites that adapt transfer-RNA (tRNA), which identify 
molecular components that occur between macromolecular entities in 
vastus lateralis muscle cells. Next, based on the mapping of the 
resultant variant genes associated with endurance training -induced 
vastus lateral is muscle contraction onto the KEGG reference pathways 
of axon guidance such as regulation of actin cytoskeleton, 
mitogen-activated protein kinase (MAPK) signaling transduction and 
peroxisome-activated receptor (PPAR) signaling transduction, we are 
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able to identify the transcriptional regulation of endurance 
training -induced vastus lateralis muscle contraction status, including 
the level of contractile force, tissue strength, plasticity and energy 
homeostasis. Thus, the mapping of a gene onto the KEGG pathway 
mimics its actual transcriptional. A more insightful explanation is 
provided as follows. 
Table 4.1 Variant genes in vastus lateralis muscle biopsies from subjects 
following a 50-minute endurance training course at 20-week after undergoing the 
endurance training course. Variant genes are prioritized relating to the following 
criteria: the estimated odds ratio, OR, greater than or equal to unity. 
Gene Symbol Gene Ontology 
ELAVLl mRNA stabilisation 
CPTlB lipid metabolism 
CPT2 lipid metabolism 
ACADM lipid metabolism 
ACADVL lipid metabolism 
ACATl lipid metabolism 
ACE metabolism 
EFNBl axon guidance 
EFNB2 axon guidance 
EPHB2 axon guidance 
EPOR small GTPases mediated signaling transduction 
FABP3 transport 
FABP4 cytokine production 
ACADM lipid metabolism 
ACADVL lipid metabolism 
ACATl lipid metabolism 
ACE metabolism 
ACTB cell motility 
ACTN 1 focal adhesion formation 
ACTN2 focal adhesion formation 
ADAMS (CD156) cell-cell adhesion 
ADORAl nervous system development 
ADORA2A central nervous system development; 
ADRAlB G protein coupled receptor signaling pathway 
AGTR2 G protein coupled receptor signaling pathway 
ALDOB 
ALDOC 
CD34 
CD36 
CDHS (CD144) 
COL4Al 
COX411 
COXSB 
CPTlB 
CPT2 
CSK 
CYCS 
DC! 
DES 
DMD 
ECHl 
ECHSl 
EDN3 
EFNBl 
EFNB2 
ELAVLl 
EPOR 
FABP3 
FABP4 
FASN 
FGFR2 
FGFR4 
FLTl 
FLT4 
FNl 
FST 
GHR 
H!FlA 
HKl 
HPRTl 
IGFl 
IGF2 
IGF2R (CD222) 
carbohydrate metabolism 
carbohydrate metabolism 
cell adhesion 
lipid metabolism 
cell adhesion 
phosphate transport 
electron transport 
electron transport; 
lipid metabolism 
lipid metabolism 
T cell activation 
caspase activation 
lipid metabolism 
cytoskeleton biosynthesis and organization 
cytoskeleton anchoring 
lipid metabolism 
lipid metabolism 
neural crest cell migration 
axon guidance 
axon guidance 
mRNA stabilization 
small GTPases mediated signaling transduction 
regulation of cell proliferation 
cytokine production 
lipid metabolism 
amino acid phosphorylation; cell growth 
amino acid phosphorylation 
TGF-beta receptor signaling pathway 
TGF-beta receptor signaling pathway 
acute phase response 
TGF-beta receptor signaling pathway 
skeletal development 
neural crest cell migration 
glycolysis 
nucleotide metabolism 
Ras protein signal transduction 
skeletal development 
receptor-mediated endocytosis 
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IGFBPl 
IGFBP3 
IL6 
IL6ST 
INSR 
ITGA8 
ITGAV (CDSl) 
ITGBl 
JUN 
K-ALPHA-1 
LAMA4 
LAMBl 
LDHA 
LDHB 
LPL 
MB 
MDH2 
MEF2A 
MGST3 
MYFS 
MYHl 
MYH3 
MYH4 
MYH6 
MYH7 
MYODl 
MT-COl 
PDGFA 
PDGFB 
PDHA2 
PDKl 
PLAU 
PPARA 
PPARG (NR1C3) 
RBl 
RPL13A 
RPS29 
SCP2 
regulation of cell growth 
regulation of signal transduction 
cell surface receptor linked signal transduction 
cell surface receptor linked signal transduction 
carbohydrate metabolism 
cell-cell adhesion 
cell adhesion 
cell adhesion 
leading edge cell differentiation 
microtubule based movement 
metabolism 
neurite development 
carbohydrate metabolism 
carbohydrate metabolism 
lipid metabolism 
oxygen transport 
carbohydrate metabolism 
muscle development 
lipid metabolism 
striated muscle contraction 
striated muscle contraction 
striated muscle contraction 
striated muscle contraction on 
striated muscle contraction 
striated muscle contraction 
striated muscle contraction 
electron transport 
actin cytoskeleton organization and biogenesis 
actin cytoskeleton organization and biogenesis 
glycolysis 
carbohydrate metabolism 
blood coagulation 
lipid metabolism 
lipid metabolism 
striated muscle differentiation 
protein biosynthesis 
ribosome biosynthesis 
lipid metabolism 
~2 
-Li 
SLC27A4 lipid metabolism 
SOD2 superoxide metabolism 
THBS3 cell motility 
TNNCl regulation of muscle contraction 
TTN carbohydrate metabolism 
VCAMl (CD106) cell-cell adhesion; 
VCL metabolism 
VIM cell motility 
Regulation of the level of contraction force. The contraction of 
vastus lateralis muscle is supported by the nervous systems. 
Examining the mapping onto the pathways representing the 
regulation of axon guidance (Figure 4.1) and actin cytoskeleton 
regulation (Figure 4.2), respectively, indicates that developing neuron 
extend axons were found to be guided by Ephrin-B (EPHBl and EPHB2) 
along specific pathways to regulate cytoskeleton dynamics in axonal 
growth cones in response to contraction stimulated by the assembly 
of focal adhesions and actin stress fibers in vastus lateralis muscle 
cells. 
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Figure 4 . 1 Reference KEGG pathway representing the regulation of axon 
Kanehisa et al, 2004; Kanel1isa et al 2006; guidance [Kanehisa et al, 2002; 
Aoki-Kinoshita and Kanehisa, 2007; Kanehisa 2008]. 
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Figure 4.2 Reference KEGG pathway representing the regulation of actin 
cytoskeleton [Kanehisa et al, 2002; Kanehisa et al, 2004; Kanehisa et al 2006; 
4) 
I Aoki-Kinoshit~and Kanehisa, 2007; Kanehisa 20os]: 
Ras proteins of small GTPases domains are strong candidates to 
transmit guidance signals in the growth cone in response to stress. 
They regulate muscular cellular processes where filaments actin plays 
a central role. Both Ras and ATP proteins are identified as responsible 
for the generation of mechanical forces upon the hydrolysis, 
consisting with their structural similarity of the catalytic region of 
GTPases and ATPases domains [Kosztin et al., 2002]. The force 
transmission mechanisms is based on an irreversible structural 
change, produced by the hydrolysis, which trigger thermal switching 
between force-generating substates through change in the 
configurational space of the proteins [Kosztin et al., 2002]. Studies of 
vertebrate growth cone suggest common mechanisms that regulate 
growth cone behaviours and axon branching [Dickson, 2002]. These 
include reformation of actin and microtubules, affect of axon guidance 
factors, actions of actin regulatory proteins and dynamic changes in 
intracellular Ca2+ signaling. These guidance systems are contrived to 
encourage as astonishing varied set of neuronal circuits underlying 
axon guidance in response to the contraction stimulated by the 
assembly of focal adhesions and actin stress fibers. 
Regulation of tissue strength and plasticity. The mitogen 
receptors are known to regulate synaptic strength and plasticity in 
adult nervous system via a cell-dependent manner [Dent et al., 2003]. 
Inspecting the mapping on the MAPK signaling pathway indicates that 
neutrophins signal through Trk receptor domains of platelet derived 
growth factor receptors and fibroblast growth factor receptors to 
regulate cell survival and proliferation. The whole process involved 
the fate of neural precursors, axon and dendrite growth and 
patterning, the expression and activity of functionally important 
proteins through vastus lateralis muscle contraction process [Dent et 
al., 2003]. Thus, the classical MAPK signaling transduction system 
regulates the strength and plasticity of vastus lateral is muscle tissues. 
Regulation of energy homeostasis. PPAR is a member of the 
nuclear receptor superfamily, which is activated by various 
hydrophobic compounds [Takada and Koto, 2005]. PPAR has three 
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isoforms, PPARalpha, PPARgamma and PPARdelta, which regulate 
homeostasis, cell proliferation, cell differentiation and associated 
hypolipidemia, atherosclerosis, diabetes and obesity [Takahashi et al., 
2005]. According to the mapping on the PPAR signaling pathway 
(Figure 4.3), PPARalpha and PPARgamma are activated in response to 
the stimulus of vastus lateral is muscle contraction. PPARalpha plays a 
role in the clearance of circulating in lipid metabolism in liver and 
skeletal muscle [Takahashi et al., 2005]. PPARgamma promotes 
adipocyte differentiation to enhance blood glucose uptake [Takahashi 
et al., 2005]. Thus, PPARalpha and PPARgamma act at crucial nodes of 
the regulatory network, which regulate energy homeostasis in 
response to the contraction stimulated by the assembly of focal 
adhesions and actin stress fibers. 
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Figure 4.3 The KEGG reference pathway representing the regulation of PPAR 
signaling transduction [Kanehisa et al, 2002; Kanehisa et al, 2004; Kanehisa et al 
2006; Aoki-Kinoshita and Kanehisa, 2007; Kanehisa 2008]. 
Reactive oxygen species excess. There is an indication of the 
presence of reactive oxygen species (ROS) excess (oxidative stress) 
during endurance training -induced vastus lateralis muscle 
contraction status. To date, it is well known that ROS are a family of 
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molecules and its derivatives produced in all aerobic cells, which are 
yielded from the metabolisms of molecular oxygen [Waris and Ahsah, 
2006]. On the basis of our present observations this endurance 
training course has led to the deleterious effects of oxygen from the 
metabolic reduction of the highly reactive and toxic species, 
promoting endothelial damage or dysfunction and atherosclerosis 
[Waris and Ahsah, 2006]. 
4-3 Conclusion 
We very often need to examine athletes' physiological conditions for 
endurance training from an initial state to a final state through a 
succession of many intermediate states. Unfortunately, none of the 
physiological assessment tools in current use, including the 
measurements of heart rate, oxygen consumption and blood lactate 
concentration, can precisely assess the changes in athletes' 
physiological conditions for endurance training. Nonetheless, if the 
state of athletes' physiological conditions can be assessed with the 
help of DNA microarrays, our approach described here will make 
available the recognition of athletes' physiological conditions. To do 
this, a natural way is to first scan and inspect variant genes with 
endurance training -induced skeletal muscle response and then to 
analyse the details of interest. In this chapter, we first identify variant 
genes with endurance training -induced vastus lateralis muscle 
response using the linear logistic regression model. Next, we map 
variant genes onto the KEGG pathway to attain a linkage between key 
molecules and biochemical pathways with endurance 
training -induced skeletal muscle response in a cause-effect format. A 
study of the gene expression model relating to endurance 
t training -induced skeletal muscle response exhibits the presence of 
"' 
~~ 
carbohydrate, lipid and energy metabolisms, the transcriptional 
regulations of endurance training -induced skeletal muscle response, 
and the presence of oxidative stress causing endothelial damage or 
dysfunction and atherosclerosis. 
Finally, we have seen that the approach described here can supply 
genera/ tools to assess athletes' physiological conditions for 
~: 
endurance training, and this has made possible a revolution in the 
outlook of athletic training. 
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Chapter 5 
DNA Microarrays for the Study of 
Cancer 
5.1 Introduction 
In 1970 President Richard Nixon declared the "war on cancer" in the 
United States [Barnes, 2005]. The war continues to this day, costing 
billions of dollars each year in clinical research and treatment, 
whereas overall cancer rates have not shown any change in their 
continuous climb for the past hundred and fifty years [Barnes, 2005]. 
Actually, rates of some types of cancer have decreased in the last fifty 
years, but other types of cancer have increased significantly, pushing 
the overall cancer rates upward [Barnes, 2005]. Part of this growth 
correlates with the increased in the aging population over the past 
fifty years, since the majority of cancers show up in the old ago groups 
[Tomatis, 1990]. However, the climbing rates, along with changing 
patterns of cancer, can also be attributed to changes within our 
environmental and life types that began with industrialisation [Barnes, 
2005]. 
The term cancer refers to a class of disease in which a group of cells 
lose control of replication at the cellular level and therefore lose their 
ability to specialise because of the loss of the normal replication of the 
nucleic acids in the DNA. Almost every tissue on the body can spawn 
malignancies and some can yield several types [Waris and Ahsan, 
2006]. Cancer cells possess a very insidious properly enabling them 
to migrate from the site where they originate and form masses at 
distinct sites in the body [Waris and Ahsan, 2006]. Cancer 
progression is a stepwise process where the initiated cells, nodules, 
polyp or the papilloma evolve further and become progressively more 
malignant [Waris and Ahsan, 2006]. The genes implicated in 
malignancy are often modified forms of human genes [Waris and 
Ahsan, 2006]. All result from cells that have accumulated a set of 
genetic changes that allow them to invade the body's usual strict 
constraints on growth and proliferation [Wade, 2001]. 
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The treatment of patients with cancer depends on establishing precise 
diagnoses with a combination of clinical and pathological information 
[Ramaswamy et al., 2001]. However, clinical information can be 
incomplete or misleading [Ramaswamy et al., 2001]. Furthermore, 
there is a broad spectrum in cancer morphology and many tumours 
are atypical or lack morphologic features that are useful for 
differential diagnosis [Ramaswamy et al., 2001]. These problems 
have caused diagnostic confusion, promoting calls for mandatory 
second opinions in all surginal pathology cases [Tomaszewski, 1999]. 
In the aggregate, there are limitations that may hinder patient care 
and confound the results of clinical trials [Golub et al., 1999]. 
Among genome's first applications in cancer may be the use of DNA 
microarrays to monitor the simultaneous activity of variant genes in 
tumour cells. Although substantial progress toward commercialisation 
has occurred in some cases, most microarray-based diagnostic tests 
of cancer are still at the development stages [Aitman, 2001]. 
Presently, for instance, the procedure used to classify childhood ALL 
subtypes with the help of gene chips is the selection of a number of 
discriminating genes for the various ALL subtypes using chi-square 
statistics, and there are marked differences in the number of 
diagnostic discriminating genes for the various ALL subtypes [Ross et 
al., 2003; Ross et al., 2004]. This simple technique, however, does 
not support the use of genome-based expression profiling as a 
commonplace microarray platform for the diagnosis of the known 
prognostic subgroups of pediatric ALL in clinical practice, since it can 
be extremely laborious, time-consuming and expensive. In addition, 
such procedures do not address the full potential of genome-based 
experiments to alter our understanding of cellular biology by offering, 
through an inclusive analysis of the entire repertoire of transcripts, a 
continuing comprehensive window into the biology underlying the 
clinical differences among these leukaemia subtypes. 
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To address these challenge, the Mahalanobis distance in K-means or 
hierarchical clustering algorithms have been used to examine 
transcriptional responses in several types of cancer, including 
childhood ALL Waldenstri:im's macroglobulinemia, bladder cancer, 
prostate cancer, serous ovarian cancer and breast cancer. The variant 
genes can be exhibited for further interpretation of toxic mechanisms 
responsible for the progression of tumour cells. 
5.2 Microarray Data Analysis 
In this section, the Mahalanobis distance in K-means or hierarchical 
clustering algorithms is used to classify microarray gene expression 
profiles in childhood acute lymphoblastic leukaemia, Waldenstri:im's 
macroglobulinemia, bladder cancer, prostate cancer, serous ovarian 
cancer and breast cancer. Heat maps are used to represent the 
measured fluorescence intensities on the 2-dimensional grids. Cells 
with intensities of zero are coloured black, increasing positive 
intensities with reds of increasing intensity, and increasing negative 
intensities with greens of increasing intensities. This visual 
representation preserves all the quantitative information, but 
transmits to our brain by ways of a much higher-bandwidth channel 
than the "number-reading" channel [Eisen et al., 1998]. 
5.2.1 Childhood ALL 
Childhood ALL is a heterogeneous disease with prognostic subtypes 
that differ markedly in their cellular and molecular characteristics as 
well as their response to therapy and subsequent risk of relapse [Ross 
et al., 2003]. Current risk assignment includes clinical characteristics 
(e.g. age, sex), basic laboratory studies (presenting white blood cell 
count and presence or absence of leukaemia in cerebral spinal fluid), 
as well as characteristics of the leukaemic blasts (immunophenotype, 
cytogenetics, molecular diagnostics for the presence of 
translocation-encoded fusion transcripts, and response to therapy) 
[Pui and Evans, 1998; Pui et al, 2001].The early risk features are 
identified from epidemiologic studies correlating clinical 
characteristics with outcome data. For example, infants are found to 
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have poorer overall survival rate than kids between the ages of 2 and 
10 years old [Ross et al., 2003]. Immunophenotypic characterization 
of leukemic blasts subsequently revealed that patients with T-cell 
lineage ALL (T-ALL) had a higher risk for relapse than B-precursor ALL 
(B-ALL) [Ross et al., 2003]. These include t(9;22)(BCRABL), 
t(1;19)(E2A-PBX1), t(12;21)(TEL-AML1), rearrangement in the MLL 
gene on chromosome llq23, and hyperdiploid karyotype with more 
than 50 chromosomes [Ross et al., 2003]. 
Contemporary treatment of childhood acute lymphoblastic leukaemia 
requires the assignment of patients to specific risk groups [Ross et al., 
2003; Ross et al., 2004]. To find the molecular markers that naturally 
discriminate childhood acute lymphoblastic leukaemia subtypes, the 
Mahalanobis distance in K-means clustering is used to organise 
microarray gene expression profiling of bone marrow samples from 
pediatric patients with acute lymphoblastic leukaemia. The data used 
here was available from Gene Expression Omnibus under platform 
accession no GSE2605, and this microarray experiment was 
performed previously by De Pitta et al [2007]. 
We consider fifteen group arrangements corresponding to the 
measured fluorescence intensities of bone marrow samples from 
pediatric patients with acute lymphoblastic leukemia (Figure 5.1). At 
the finest level, we find that there is a cluster of 70 features that 
naturally discriminate pediatric patients with B-ALL, T-ALL and B-ALL 
through MLL/AF4 chromosomal rearrangement in agreement with 
clinical classification (Figure 5.2). 
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Figure 5.1 K-means clustering results of microarray gene expression profiling of I 
bone marrow samples from pediatric patients with B-ALL, T-ALL and B-ALL j 
l_!hrough MLL/AF4 chromosomal rearrangement (K= 15). _ __ _ _ 
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Figure 5.2 A cluster with 70 features that are up-regulated in bone marrow 
samples from pediatric patients with B-ALL, moderately expressed for those with 
B-ALL through MLL-Af4 chromosomal rearrangement, and down-regulated for 
~ose with T-ALL. _ _ ~ _ J 
Table 5.1 Diagnostic discriminating genes in bone marrow samples from pediatric 
patients with B-ALL, T-ALL and B-ALL through MLL/AF4 rearrangement. 
Gene symbol 
RBM38 
TOP2B 
REXl 
MDH2 
USP33 
LAPTMS 
FAM65A 
MST150 
MRPL37 
HHEX 
NR4Al 
KLF2 
TSC22D3 
AFFl 
MEF2C 
PDL!Ml 
HLA-DQBl 
HLA-DPAl 
CD74 
HLA-DRBl 
HLA-G 
HLA-B 
HLA-DRA 
EMCN 
ENG 
MY LIP 
OSGIN2 
DIRASl 
RHOB 
Gene ontology 
DNA damage response 
DNA topological change 
oxygen free radical metabolism 
carbohydrate metabolism 
protein deubiquitinylation 
transport 
unknown 
unknown 
translation 
mRNA export out of nucleus 
transcription 
transcription 
transcription 
transcription 
transcription 
transcription 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
cell adhesion 
cell adhesion 
cell motility 
meiosis 
small GTPases mediated signal transduction 
Rho GTPases mediated signal transduction 
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To characterise their biological processes we use Entrez Gene to 
identify gene-specific information on all features within this cluster 
[Maglott et al., 2007]. This enables us to identify 31 distinct genes 
that are up-regulated in bone marrow samples from pediatric patients 
with B-ALL, moderately expressed for those with B-ALL through 
MLL/AF4 chromosomal rearrangement, and down-regulated for those 
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with T-ALL (Table 5.1). In particular, we find the expressions of the 
major histocompatibility complex (MHC) class II molecules 
(HLA-DQBl, HLA-DPAl, CD74 ~ HLA-DRBl, HLA-G, HLA-B, and 
HLA-DRA) are up-regulate din bone marrow samples from pediatric 
patients with B-ALL, moderately expressed for those with B-ALL 
through MLL/AF4 chromosomal rearrangement, and down-regulated 
for those with T-ALL. 
Therefore, a unique gene set in classifying childhood ALL takes into 
account the expressions of MHC class II molecules. In addition, since 
it is well known that pediatric patients with T-ALL have a higher risk of 
relapse than those with B-ALL, the application of DNA dementhylating 
agent to induce MHC class II expressions will be beneficial in the 
prevention of pediatric ALL relapse [Holling et al., 2004]. 
5.2.2 Waldenstrom's Macroglobulinemia 
Waldenstri:im's macroglobulinemia is a pathological distinct B-cell 
malignancy characterised by intramedullary monoclonal expansion of 
predominantly small B lymphocytes with variable plasmacytoid 
differentiation in the bone marrow, associated with serum IgM 
paraprotein [Ghng et al., 2005]. Histologically, this represents bone 
marrow involvement by lymphoplasmacytic lymphoma [Owen et al., 
2003]. Though the clinical disease spectrum has been well established, 
little is known about its biology [Chng et al., 2006]. Unlike other B cell 
malignancies, anslocations involving the IgH locus on chromosome 
14q32 are rare in WM [Kriangkum et al., 2006]. The most common 
genetic abnormality is deletion of the long arm of chromosome 6 
[Schop et al., 2002; Ackroyd et al., 2005]. Nonetheless, this genetic 
abnormality is not unique to Waldenstri:im's macroglobulinemia and 
its biological and clinical significance in Waldenstri:im's 
macroglobulinemia has yet to be elucidated [Chng et al., 2006]. 
At present, there is no cure for Waldenstri:im's macroglobulinemia. 
The average survival rate for patients diagnosed with Waldenstri:im's 
macroglobulinemia is approximately five to seven years. To find a 
unique gene set to Waldenstri:im's macroglobulinemia, the 
Mahalanobis distance in the K-means clustering algorithm is used to 
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arrange gene expression profiling of bone marrow samples from 
patients with Waldenstrom's macroglobulinemia corresponding to 
those of other malignant B cells, including chronic lymphocytic 
leukaemia and multiple myeloma. The data used here was available 
from Gene Expression Omnibus under platform accession no 
GSE5591, and this microarray experiment was perform previously by 
Gutierrez et al [2006]. 
We consider fourteen group arrangements corresponding to the 
measured fluorescence intensity of bone marrow samples from 
patients with Waldenstrom's macroglobulinemia, chronic 
lymphoblastic leukaemia and multiple myeloma (Figure 5.3). At the 
finest level, we have found that there is a cluster of 72 features that 
naturally discriminate patients with B-cell malignancies into 
Waldenstrom's macroglobulinemia, chronic lymphoblastic leukaemia 
and multiple myeloma (Figure 5.4), whereas there is a cluster of 92 
features that reveal considerable fold increase in B lymphocytes from 
patients with Waldenstrom's macroglobulinemia and chronic 
lymphoblastic leukaemia (Figure 5.5). 
Figure 5.3 K-means clustering results of m1croarray gene expression profilmg of 
bone marrow samples from patients with Waldenstrbm's macroglobulinemia, 
I chronic lymphoblastic leukaemia and multiple myeloma (K= 14). 
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Figure 5.4 A cluster with 72 features that are up-regulated in plasma cells from 
patients with Waldenstrbm's macroglobulinemia, down- regulated in B 
lymphocytes for those w1th chronic lymphoblastic leukaemia, and moderately 
expressed in plasma cell for those with multiple myeloma. 
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Figure 5.5 A cluster with 92 features that reveal considerable fold increase in B 
lymphocytes from patients with Waldenstrom's macroglobulinemia and chronic 
lymphoblastic leukaemia. 
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Table 5.2 Diagnostic discriminating genes whose expressions are up-regulated in 
plasma cells from patients with Waldenstrom's macroglobulinemia, down-regulated 
in B lymphocytes from those with chronic lymphoblastic leukaemia, and moderately 
expressed in plasma cells from those with multiple myeloma. 
Gene symbol Gene ontology 
IVD amino acid metabolism 
MPO 
PRTN3 
PRG2 
LTF 
FCNl 
CD302 
FGL2 
CEBPD 
MYB 
KIAA0101 
LOC643332 
LRPSL 
X79782 
MIRN650 
RNASE2 
RNASE3 
C5orf13 
C6orf142 
CKAP2 
DTNB 
CD 
VCAN 
ANXAl 
IGFBP7 
ILS 
IGHG3 
IGHGl 
IGU3 
IGL@ 
IGLV@ 
IGKC 
IGKVlD-13 
energy metabolism; amino acid metabolism 
collagen catabolism 
phosphatidic acid phosphatase activity 
transport (iron ion) 
transport (phosphate) 
sugar binding 
signal transduction 
transcription 
transcription 
unknown 
unknown 
unknown 
unknown 
micro RNA 
RNA catabolic process 
RNA catabolic process 
open reading frame 
open reading frame 
apoptosis; cell cycle 
calcium binding; protein binding; zinc ion binding 
cell adhesion; platelet activation 
cell adhesion 
cell motion; peptide cross-linking 
regulation of cell growth 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
IGKV10R2-108 immune response 
IGKVlORlS-118 immune response 
LOC91316 
CST? 
DEFAl 
DEFA4 
CEACAMS 
CCR2 
CLC 
AZUl 
SlOOAS 
S100A9 
SlOOA12 
SlOOP 
ELA2 
CPA3 
CTSG 
NTN2L 
ACTNl 
MS4A3 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response; Jak-STATE cascade 
B cell differentiation; JAK-STAT cascade 
inflammatory response 
inflammatory response 
inflammatory response 
inflammatory response 
endothelial cell migration 
leukocyte migration 
renin-angie tensin system 
renin-angie tensin system 
axon guidance 
actin filament bundle formation 
signal transduction 
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Table 5.3 Highly differentially expressed genes in B lymphocytes from patients 
with Waldenstrom's macroglobulinemia and chronic lymphoblastic leukaemia. 
Gene symbol Gene ontology 
CHST6 carbohydrate metabolism 
DCK nucleotide metabolism 
HBAl oxygen transport 
HBB oxygen transport 
HBA2 oxygen transport 
LAPTMS transport 
LYST transport (protein) 
STX7 interscellular protein transport 
SH3BP5 interscellular signaling cascade 
PRKCBl interscellular signaling cascade 
CTSH proteolysis 
IRFS myeloid cell differentiation 
BCL2 B cell proliferation 
MS4Al B cell activation 
BANKl 
PIK3CD 
SYK 
CD24 
MS4Al 
IL23A 
INPPSD 
CD83 
CD79B 
EBI2 
TRIM22 
TRAFS 
FAIM3 
LTB 
ALOXS 
IGHM 
HLA-DPBl 
HLA-DMA 
HLA-DMB 
HLA-DRBS 
HLA-DRB4 
HLA-DRA 
HLA-DRBl 
HLA-DQBl 
HLA-DPAl 
HLA-DQAl 
FNBPl 
CD 52 
ADD3 
MTSSl 
ARHGEF18 
RASGRP2 
RRAS2 
CD69 
DEK 
ZNF107 
ZNF238 
B cell activation 
B cell activation; B cell homeostasis 
B cell receptor signaling pathway 
B cell receptor translocation into membrane raft; T cell 
costimulation 
B cell activation 
immune and infiammatory response 
B cell receptor signaling pathway 
immune response 
immune response 
immune response 
immune response 
immune response 
immune and defense response 
immune response 
inflammatory response 
immune response 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
endocytosis 
cytosolic calcium ion concentration elevation 
structural constituent of cytoskeleton 
actin cytoskeleton organization and biogenesis 
Rho protein signaling transduction 
Ras protein signaling transduction 
Ras protein signaling transduction 
transmembrane receptor activity 
transcription 
transcription 
transcription 
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(Ji 
TCLlA transcription 
TCF4 transcription 
BCLllA transcription 
LBH transcription 
C3orf63 open reading frame 
C12orf35 open reading frame 
SFRSlB unknown 
BCA54 unknown 
LOC151162 hypothetical protein 
SWAP70 somatic cell DNA recombination 
A!Ml cell cycle; cell division 
FAM65B cell differentiation 
NOTCH2NL cell differentiation 
SELL cell adhesion 
CYFIP2 cell adhesion 
To characterise their biological processes, we use Entrez Gene to 
search for gene-specific information [Maglott et al., 2007]. This 
enables us to identify 53 distinct genes that are up-regulated in 
plasma cells from patients with Waldenstrom's macroglobulinemia, 
down-regulated in B lymphocytes from patients with chronic 
lymphoblastic leukaemia, and moderately expressed in plasma cells 
from patients with multiple myeloma (Table 5.2). At the same time, 
we find that there are 78 distinct genes that reveal considerable fold 
increase in B lymphocytes from patients with Waldenstrom's 
macroglobulinemia and chronic lymphoblastic leukaemia (Table 5.3). 
In particular, the expressions of IgH (IGHG1 and IGHG3), IgK (IGKC, 
IGKVlD-13, IGKV10R2-108 and IGKV10R15-118) and Igl 
(IGLJ3JIGL@ and IGLV@) genes are up-regulated in plasma cells 
from patients with Waldenstrom's macroglobulinemia, and 
moderately expressed in plasma cells from patients with multiple 
myeloma. High expressions of bone marrow rennin-angiotensin 
system are observed in plasma cells from patients with 
Waldenstrom's macroglobulinemia. Several genes involved in 
potential interactions with Netrin-2 mediated axon guidance are 
up-regulate in Waldenstrom's macroglobulinemia [Dickson, 2002], 
suggesting Netrin-2 mediated axon guidance is linked to the 
susceptibility to Waldenstrom's macroglobulinemia. In addition, it can 
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be observed that the expressions of MHC class II molecules are 
up-regulated in B lymphocytes from patients with Waldenstrom's 
macroglobulinemia and chronic lymphoblastic leukaemia, but 
down-regulated in plasma cells from patients with multiple myeloma. 
As a result, the expressions of MHC class II molecules in 
Waldenstrom's macroglobulinemia are very similar to chronic 
lymphoblastic leukaemia but distinct from multiple myeloma. 
In summary, a unique gene set to Waldenstrom's macroglobulinemia 
takes into account the high expressions of IgH, IgK and Igl genes in 
plasma cells plus high expressions of MHC class II molecules in B 
lymphocytes. 
5.3.3 Bladder cancer 
Bladder cancer represents a global public health problem. It ranks 
ninth in world cancer incidence [Murta-Nascimento et al., 2007]. 
Around 80 percent of the patients present originally with superficial 
disease, which comprise Ta tumours located in the mucosa only, 
submucosa invasive T1 tumours, and carcinoma in situ (CIS) lesions 
[Dyrskj0t et al., 2004]. The patients presenting Ta and T1 tumours 
experience frequent tumour recurrences and to a lesser extent 
disease progression to a muscle invasive stage, whereas the patients 
presenting with isolated or concomitant CIS lesions have a high risk of 
disease progression to a muscle invasive stage [Dyrskj0t et al., 2004]. 
At present, there are no clinically useful markers available for 
identifying bladder cancer patients with a high risk of disease 
progression to a muscle invasive stage [Dyrskj0t et al., 2004]. If we 
would predict which tumours are likely to progress, we can gain a 
great impact on the clinical management of patients with superficial 
disease, since it would be possible to treat high-risk patients more 
aggressively. 
In order to find clinical useful markers that naturally discriminate 
distinct classes of bladder cancer, the Mahala nobis distance in Ward's 
linkage hierarchical clustering algorithm is used to group microarray 
gene expression profiling of bladder biopsies from 15 superficial 
transitional cell carcinomas without CIS lesion, 13 superficial 
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transitional cell carcinomas with surrounding CIS lesions, and 12 
muscle invasive transitional carcinomas (Figure 5.6). The data used 
here was available from Gene Expression Omnibus under platform 
accession no GSE3167 and this microarray experiment was 
implemented by [Dyrskj0t et al., 2004]. At the finest level, we find 
that there is a cluster of 239 features that naturally discriminate 
bladder cancer patients with three classes, those with superficial 
transitional cell carcinomas with or without CIS lesions, and muscle 
invasive carcinomas (Figure 5. 7). 
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Figure 5.6 Clustering results of microarray gene expression profiles in bladder 
biopsies from patients with superficial transitional cell carcinoma with or without CIS 
lesions, and in muscle invasive carcinomas. 
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Figure 5.7 A cluster with 225 features that are up-regulated in bladder biopsies from patients with invasive muscle ca rcinomas, 
down-regulated for those with superficial transitional cell carcinomas without CIS lesion, and moderately expressed for those with 
superficial transitional cell carcinomas with surrounding CIS lesions. 
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Table 5.4 Diagnostic discriminating genes in bladder biopsies from patients with 
superficial transitional cell carcinoma with or without CIS lesions, and muscle 
invasive carcinomas. 
Gene symbol 
CD74 
HLA-DPBl 
HLA-DMA 
HLA-DRA 
HLA-DRB4 
HLA-DRBl 
HLA-DRBS 
HLA-DPAl 
HLA-DQAl 
IFI30 
FCERlG 
FCGR2A 
FCGR3B 
UBD 
PSMB9 
TYROBP 
GZMB 
NTN2L 
CD 52 
RAB31 
IFI27 
STATl 
LGALSl 
LCP2 
SRGN 
IFITM3 
IFITM2 
IFITMl 
IL7R 
Gene ontology 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
IgE binding 
IgE binding 
IgE binding 
ubiqintin-dependent protein catabolism 
ubiqintin-dependent protein catabolism 
natural killer mediated cytotoxicity 
natural killer mediated cytotoxicity 
axon guidance 
cytosolic calcium ion concentration elevation 
small GTPases mediated signaling transduction 
biological process 
NIK-I-kappaB/NF-kappaB cascade 
regulation of apoptosis; upregulation of I-kappaB 
kinase/NF-kappaB cascade 
mast cell activation; cytokine secretion; natural killer mediated 
cytotoxicity 
mast cell secretory granule organization and biogenesis; T 
lymphocyte secretory granule organization and biogenesis 
interferon induced transmembrane protein 3 (1-BU) 
immune response 
cell surface receptor mediated signal transduction; B cell 
receptor signaling pathway 
cell surface receptor mediated signal transduction 
LY96 immune response 
GZMA immune response 
!GU3 immune response 
IGLV@ immune response 
IGHGl immune response 
!GHG3 immune response 
IGHM immune response 
IGKC immune response 
!GKV1D-13 immune response 
!GKV10R2-108 immune response 
IGKV10R15-118 immune response 
GBP1 
LTB 
COR01A 
IL8 
SPP1 
IL23A 
IL32 
CXCLl 
CCLS 
CXCL6 
CXCL9 
CXCLlO 
CXCL11 
CXCL13 
CCL18 
CCL19 
NCF2 
S100A7 
S100A8 
S100A9 
ALOXSAP 
CD163 
CD14 
CD 53 
CEACAM6 
COL1A1 
immune response 
immune response 
immune response 
immune response 
cytokine activity 
cell surface receptor mediated signal transduction; immune 
response 
immune response 
immune and inflammatory response 
immune and inflammatory response 
immune and inflammatory response 
immune and inflammatory response 
immune and inflammatory response 
immune and inflammatory response 
immune and inflammatory response 
immune and inflammatory response 
immune and inflammatory response 
immune response 
inflammatory response 
inflammatory response 
inflammatory response 
inflammatory response 
inflammatory response 
inflammatory response 
signal transduction 
signal transduction 
immune response 
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COL1A2 
COL3Al 
INHBA 
GREMl 
ADAMDECl 
MSN 
COLSAl 
MUC4 
OLFM4 
POSTN 
VCAN 
ITGB2 
PTPRC 
ASPN 
FKBPll 
ISG20 
RUNX3 
RARRES3 
EMP3 
BCL2Al 
G0 52 
CKAP2 
TGFBI 
SPRRlB 
KRT6A 
COL6A2 
HCK 
W!PFl 
MMD 
ClQA 
ClQB 
CFB 
PLAUR 
SERPINAl 
SERPINB3 
SERPINB4 
TGF-beta receptor signaling pathway 
integrin-mediated signaling pathway; TGF-beta receptor 
signaling pathway 
TGF-beta receptor signaling pathway 
regulation of TGF-beta receptor signaling pathway 
integrin-mediated signaling pathway 
leukocyte adhesion 
cell adhesion 
cell adhesion 
cell adhesion 
cell adhesion 
cell adhesion 
activated T cell proliferation 
B cell receptor signaling pathway; T cell receptor signaling 
pathway 
protein binding 
protein folding 
cell proliferation 
cell proliferation; apoptosis 
regulation of cell proliferation 
cell growth 
regulation of apoptosis 
cell cycle 
cell cycle 
cell proliferation 
epidermis development; peptide cross-linking 
ectoderm development 
ectoderm development 
mesoderm development 
actin filament based movement 
cytolysis 
complement component, Cl complex 
complement activation, classical pathway 
complement activation, alternative pathway 
blood coagulation 
blood coagulation 
blood coagulation 
blood coagulation 
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MAFB 
MNDA 
POU2AF1 
MIRN650 
C6orf142 
C12orf32 
EVI2B 
MTlL 
KIAA1755 
CHI3Ll 
LOC91316 
DEGSl 
NNMT 
IVD 
WARS 
SULFl 
CD37 
ADCY? 
RARRES2 
MMPl 
MMP3 
MMP? 
MMP9 
MMPlO 
MMP12 
SOD2 
APOE 
LAPTMS 
LCN2 
TAPl 
transcription 
transcription 
transcription 
microRNA 
open reading frame 
open reading frame 
unknown 
unknown 
unknown 
carbohydrate metabolism 
carbohydrate metabolism 
lipid metabolism 
metabolisms of cofactors and vitamins 
amino acid metabolism 
amino acid metabolism 
heparan sulfate proteoglycan metabolism 
protein amino acid N-glycan biosynthesis 
nucleotide metabolism 
retinoid metabolism 
metabolism 
metabolism 
metabolism 
metabolism 
metabolism 
metabolism 
response to oxidative stress 
Cdc42 protein signal transduction; lipid metabolism 
transport 
transport 
transport (oligopeptide) 
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To characterise their biological processes, we search for gene-specific 
information on all features with the aid of Entrez Gene [Maglott et al., 
2007]. This enables us to identify 132 distinct genes that are 
up-regulated in bladder biopsies from patients with muscle invasive 
carcinomas, moderately expressed for those with superficial 
transitional cell carcinomas with CIS lesions, and down-regulated for 
those with superficial transitional cell carcinomas without CIS lesion 
6() 
(Table 5.4 ). At a result, these 132 genes naturally distinguish the 
patients into three distinct classes of bladder cancer, those with 
muscle invasive carcinomas, superficial transitional cell carcinomas 
with CIS lesions, and superficial transitional cell carcinomas without 
CIS lesion. Particularly, we observe the MHC class II expressions 
(CD74, HLA-DPB1, HLA-DMA, HLA-DRA, HLA-DRB4, HLA-DRB1, 
HLA-DRBS, HLA-DPA1, HLA-DQA1 and IFI30) are up-regulated in 
bladder biopsies from patients with muscle invasive carcinomas, 
moderately expressed for those with superficial transitional cell 
carcinomas with CIS lesions, and down-regulated for those with 
superficial transitional cell carcinomas without CIS lesion. The 
expressions of interferon -induced transmembrane proteins (IFITM1, 
IFITM2 and IFITM3), IgH (IGHG1, IGHG3 and IGHM),Igl genes 
(IGLJ3 and IGLV@) and IgK genes (IGKC, IGKVlD-13, 
IGKV10R2-108, and IGKV10R15-118) are also up-regulated in 
bladder biopsies from patients with muscle invasive carcinomas, 
moderately expressed for those with superficial transitional cell 
carcinomas with CIS lesions, and down-regulated for those with 
superficial transitional cell carcinomas without CIS lesion [Qhu and 
Burgess, 2000]. 
It can be observed that the progression of a muscle invasive stage of 
bladder cancer leads to the binding of IgE to the high-affinity Fe 
episilon RI and cytokine-cytokine receptor interactions promoting 
natural killer mediated cytotoxicity [Perussia, 2000; Vivier, 2004]. 
The progression of a muscle invasive stage of bladder cancer also 
leads to Netrin-2 mediated axon guidance [Dickson, 2002]. In 
addition, several genes involved in the regulation of TGF-beta 
receptor signaling pathway is up-regulated in bladder biopsies from 
patients with muscle invasive carcinomas, moderately expressed for 
those with superficial transitional cell carcinomas with CIS lesions, 
and down-regulated for those with superficial transitional cell 
carcinomas without CIS lesions, suggesting the activation of TGF-beta 
receptor signaling pathway is involved in the progression of a muscle 
invasive stage of bladder cancer. 
In summary, the biological mechanisms of bladder cancer progress to 
a muscle invasive stage include: (1) the MHC class II expressions, 
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interferon-induced transmembrane proteins, Igl, IgH and IgK 
molecules are up-regulated in bladder biopsies from patients with 
muscle invasive carcinomas, moderately expressed for those with 
superficial transitional cell carcinomas with CIS lesions, and 
down-regulated for those with superficial transitional cell carcinomas 
without CIS lesion, (2) Netrin-2 like mediated axon guidance has a 
strong association with the progression of a muscle invasive stage of 
bladder cancer, (3) the progression of a muscle invasive stage of 
bladder cancer leads to the binding of IgE to the high-affinity Fe 
episilon RI and cytokine-cytokine receptor interactions promoting 
natural killer mediated cytotoxicity, and ( 4) TGF-beta receptor 
signaling pathway is involved in the progression of a muscle invasive 
stage of bladder cancer. 
5.3.4 Prostate Cancer 
Prostate cancer is the second most widespread cause of cancer death 
in males, with around 3,000 men dying from the disease annually in 
Australia. The prognosis and choice of therapy for prostate cancer is 
based primarily on three parameters obtained at the time of diagnosis: 
clinical stage, serum prostate-specific antigen (PSA) and the Gleason 
score of the cancer [Partin et al., 1997]. The Gleason grade system, 
which is based on the progressive deterioration of the microscopic 
tumour architecture, consists of five histological patterns that 
annotate cancers into five categories exhibiting well differentiated 
(pattern) to poorly differentiated (pattern 5) features [Gleason and 
Mellinger, 1974]. A number from 1 to 5 is assigned to the most 
dominant patterns [True et al., 2006]. A second number, also from 1 
to 5, is assigned to the second most dominant patterns [True et al., 
2006]. The Gleason grade, which is the sum of these two numbers, 
has a value between 2 and 10 [True et al., 2006]. In current clinical 
practice, the vast majority of prostate tumours have a Gleason score 
of 26 [Epstein, 2000]. Therefore, tumours composed of Gleason 
patterns 3, 4, and/or 5 are considered clinically significant [True et al., 
2006]. The reporting of individual Gleason patterns is not a trivial 
distinction, since the amount of pattern 4 and the presence of any 
pattern 5 has been highly correlated with the probability of cancer 
dissemination, with respect to therapy, disease outcome, 
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patient-management decisions, and clinical-trial enrolment [Chan et 
al., 2000; True et al., 2006]. Several studies have suggested a direct 
correlation between the Gleason score and clinical measurements of 
disease outcome, including death due to tumour within 15 years and 
the likelihood of remaining free of biochemical evidence of the 
recurrence of the disease after either definitive, potentially curative 
radical prostatectomy or radiation therapy [True et al., 2006]. 
Although different Gleason patterns are histologically distinctive, the 
molecular features underlying these tumour phenotypes are still 
relatively unknown [True et al., 2006]. 
To know molecular alterations underlying prostate cancer grade, the 
Mahalanobis distance in Ward's linkage hierarchical clustering 
algorithm is used to group microarray gene expression profiles in 
prostate epithelial cells of Gleason grades 3, 4 and 5 (Figure 5.8). The 
data used here was available from Gene Expression Omnibus under 
platform accession no GSE5132, and this microarray experiment was 
implemented by True et al. [2006]. At the finest level, we find that 
there is a cluster of 55 features whose expressions are up-regulated in 
high-grade prostate tumours of Gleason patterns 4 and 5, and 
moderately expressed in low-grade prostate tumours of Gleason 
pattern 3 (Figure 5.9). 
-
Figure 5.8 Clustering results of microarray gene expression profiles in prostate 
epithelial cells of Gleason patterns 3, 4 and 5. _ j 
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Figure 5.9 A cluster of 55 features that are up-regulated in prostate epithelial 
cells of Gleason patterns 4 and 5, and moderately expressed from those with 
Gleason pattern 3. 
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Table 5.5 Diagnostic discriminating genes whose express1ons are up-regulated m 
prostate epithelial cells of Gleason patterns 4 and 5, and moderately expressed from 
those with Gleason pattern 3. 
Gene symbol Gene ontology 
MYCBP 
MDHl 
STX12 
HSPA5 
COX7A2L 
TXNDCl 
PSMA5 
UBE2A 
STAMBP 
CBXl 
HNRNPA2Bl 
RAB2A 
SRP9 
CNTF 
CAMKl 
spermatogenesis 
carbohydrate metabolism 
cholesterol efflux 
endoplasmic reticulum overload response 
electron transport chain 
electron transport chain 
ubiquitin-dependent protein catabolism 
ubiquitin-dependent protein catabolism 
ubiquitin-dependent protein catabolism 
chromatin remodeling 
nuclear mRNA splicing, via spliceosome 
protem transport 
protein export 
cell differentiation 
cell differentiation 
To characterise their biological processes, gene ontology within this 
cluster is perform on all features with the help of Entrez Gene [Maglott 
et al., 2007]. This enables us to identify 15 distinct genes that are 
up-regulated in high-grade prostate tumours of Gleason grades 4 and 
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5, and moderately expressed in low-grade prostate tumours of 
Gleason grade 3 (Table 5.5). In particular, we observe changes in 
spermatogenesis (MYCMP) in high-grade prostate tumours. We also 
observe changes in carbohydrate metabolism (MDH1) and cholesterol 
efflux (STX12) in high-grade prostate tumours. The occurrence of 
ubiquitin-mediated protein catabolism (PSMA5, UBE2A), electron 
transport chain (COX7A2L, TXNDC1), and endoplasmic reticulum 
overload response (HSPA5) are also observed in high-grade prostate 
tumours. In addition, several genes involved in potential interactions 
with chromatin remodeling and nuclear mRNA splicing, via 
spliceosome assembly, are up-regulated in high-grade prostate 
tumours. 
In summary, the molecular alterations underlying high-grade prostate 
tumours of Gleason patterns 4 and 5 include: (1) changes in 
MYCMP-mediated spermatogenesis, (2) changes in carbohydrate 
metabolism and cholesterol efflux, (3) the occurrence of 
ubiquitin-mediated degradation and endoplasmic reticulum overload 
response, and ( 4) ubiqintin-mediated RNA splicing and nuclear mRNA 
splicing, via the spliceosome. Specifically, RNA splicing is a process 
that removes introns and joins exons in the primary transcript; 
whereas nuclear mRNA splicing, via spliceosome, is a process that the 
joining together of exons from one or more primary transcripts of 
mRNA and the excision of intron sequences, via a spliceosomal 
mechanism, so that mRNA consisting only of the joining exons is 
produced [Patel & Steitz, 2003]. 
5.3.5 Serous Ovarian Cancer 
Ovarian cancer is the sixth most widespread cancer in women 
worldwide and a highly aggressive gynaecological malignancy causing 
around 125,000 deaths per year [Parkin et al., 2005]. Despite 
advances in detection and cytotoxic therapies, only 30 percent of 
patients with advanced stage ovarian cancer survive 5 years after 
initial diagnosis [Parkin et al., 2005]. As a result, an understanding of 
molecular features involved in ovarian cancer pathogenesis and 
progression has the potential to have a significant impact on the 
outcomes for this devastating disease [Wang et al., 2006]. 
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Most ovarian neoplasms are adenocarcinomas that occur as four 
major histological subtypes, serous, mucinous, endometrioid and 
clear cell, with serous being the most widespread [Wang et al., 2006]. 
Current epidemiological data suggests that each of these histological 
subtypes is associated with distinct morphological and molecular 
genet1c alterations [Bell, 2005]. Further investigations of biolog1cal 
mechanisms promoting ovarian cancer are necessary to determine 
how each of the subtypes emerges. Relatively little is known about the 
molecular events that lead to the progress of ovarian cancer. 
In this section, the Mahalanobis distance in Ward's linkage 
hierarchical clustering algorithm is used to group microarray gene 
expression profiling of ovarian cancer cell lines from patients with 
serous adenocarcinomas corresponding to those with clear 
adenocarcinomas (Figure 5.10). The data used here was available 
from Gene Expression Omnibus under platform accession no 
GSE3001, and this microarray experiment was implemented by 
Komatsu et al [2006]. At the finest level, we find that there is a cluster 
of 25 features that exhibit substantial fold increase in serous 
adenocarcinomas (Figure 5.11 ). Thus, genes within this cluster are 
highly differentially expressed in serous ovarian adenocarcinomas. 
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Figure 5.10 Clustering results of microarray gene expression profiling of ovanan 
cancer cell lines from patients with serous adenocarcinomas corresponding to those 
with clear adenocarcinomas. 
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Figure 5.11 A cluster of 24 features that exhibit substantia l fold increase in 
ovarian cancer cell lines from patients w1th serous adenocarcinomas versus those I 
1 with clear adenocarcinomas. __ _ 
Table 5.6 Highly differential ly expressed genes in serous ovarian 
adenocarcinomas. 
Gene Symbol 
HSD17B8 
AES 
XRCC3 
C6orf125 
CCDClS 
THOC7 
BMD3 
KLF3 
ZNF544 
KIAA1394 
RAVERl 
PIFl 
SFRS2 
RIOKl 
TRIM 54 
TFDPl 
COXSB 
USP45 
CEP72 
PFDN6 
COPS4 
Gene Ontology 
estrogen biosynthesis 
Wnt receptor signaling pathway 
DNA recombination; cell cycle 
open reading frame 
unknown 
unknown 
transcnpt1on 
transcription 
transcription 
ATP bindmg 
ribonucleoprotein, RNA/nucleotide/nucleic acid bmdmg 
regu lat1on of telomere maintenance 
RNA splicmg; nuclear mRNA splicing v1a spllceosome 
kmase activity (prematurely truncated due to Insertion of intronic 
sequence ) 
cell cycle 
cel l proliferation 
respiratory gaseous exchange 
ub1qu1t1 n-dependent proteolysis 
Identical protein binding 
protein folding 
protein folding 
BOlAl 
RWDDl 
SLC29Al 
protein folding 
protein folding 
transport (nucleoside) 
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To characterise their biological processes, gene ontology within this 
cluster is performed on all features using Entrez Gene [Maglott et al., 
2007]. This enables us to identify 24 distinct genes that are 
up-regulated in serous ovarian adenocarcinomas {Table 5.6). 
Specifically, we observe the occurrence of estrogen biosynthesis 
(HSD17B8) in serous ovarian adenocarcinomas. AES, a gene played a 
role in WNT receptor signaling pathway is up-regulated in serous 
ovarian adenocarcinomas as well. We also observe the occurrence of 
respiratory gaseous exchange (COX5B), ubiquitin-dependent 
proteolysis (USP45), cell cycle (TRIM54) and cell proliferation (TFDPl) 
respiratory gaseous exchange (COX5B), ubiquitin-dependent 
proteolysis (USP45), cell cycle (TRIM54) and cell proliferation 
(TFDPl). The expression of ribonucleoprotein (RAVERl) is also 
up-regulated in serous ovarian adenocarcinomas. In addition, it can 
be observed that several genes involved in potential interactions with 
ubiquitin-mediated RNA and nuclear mRNA splicing, via spliceosome, 
are up-regulated in serous ovarian adenocarcinomas. 
To sum up, the molecular alterations underlying serous ovarian 
adenocarcinomas include: ( 1) the presence of estrogen biosynthesis, 
(2) the involvement of WNT receptor signaling pathway, and (3) 
ubiqintin-mediated RNA splicing and nuclear mRNA splicing, via the 
spliceosome. s 
5.3.6 Breast Cancer 
Breast cancer is the most frequently diagnosed cancer and the top 
cause of cancer death among women worldwide [Parkin et al., 2005]. 
At present, breast tumours are well known to be composed of 
phenotypically diverse groups of cells [Abraham et al., 2005]. 
However, it is unclear which of these cell types contribute to tumour 
development [Abraham et al., 2005]. In contrast to the hypothesis 
that all cell populations have the capacity to become tumorigenic 
through accumulation of mutations, another hypothesis limits this 
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ability to an elite group of cells that share classic features of stem cells 
such as the ability of self-renew and to differentiate [Reya et al., 
2001]. 
To know molecular alterations underlying solid tumours heterogeneity 
in breast cancer, the Mahalanobis distance in Ward's linkage 
hierarchical clustering algorithm is used to group microarray gene 
expression profiling of tumorigenic and non-tumorigenic breast 
cancer cell lines corresponding to normal breast epithelial cells 
(Figure 5.12). The data used here was available from Gene Expression 
Omnibus under platform accession no GSE2618, and this microarray 
experiment was performed previously by Liu et al [2007]. At the finest 
level, we find that there is a cluster of 97 features that are 
up-regulated in tumorigenic breast cancer, moderately expressed in 
non-tumorigenic breast cancer, and down-regulated in normal breast 
epithelium (Figure 5.13). Thus, genes within this cluster naturally 
discriminate samples into normal breast epithelium, tumorigenic and 
non-tumorigenic breast cancer cells. 
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Figure 5.12 Clustering results of m1croarray gene expression profies in normal 
[ breast epithelium, tumorigemc and non-tumorigenic ~~e~~~ancer cells. 
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Figure 5.13 A cluster of 97 features that are up-regulated in tumorigenic breast 
cancer, moderately expressed m non-tumongenic breast cancer, and 
down-regulated 1n normal brest epithelium. 
Table 5.7 Diagnostic discriminating genes whose expressions are up-regulated in 
tumorigenic breast cancer, moderately expressed m non-tumongen1c breast cancer, 
and down-regulated 1n normal brest epithelium. 
Gene Symbol Gene Ontology 
LYCAT lipid biosynthetic process 
AGPS lipid biosynthetic process 
RP5-1022P6.2 
INTS2 
INTSlO 
ROD! 
THOC2 
TRMT6 
ElF lAD 
GFMl 
GTF2H2 
NMD3 
MCMlO 
FAM33A 
SERPINE2 
SASS6 
FAM29A 
FAM36A 
FAMlOSB 
FAM133B 
FSD2 
PCNX 
lipid metabolism 
snRNA processing 
snRNA processing 
mRNA process1ng 
mRNA processing 
tRNA processing; translation 
translational initiation 
translation elongation 
RNA elongation from Pol II promoter 
nonsense-mediated mRNA decay 
DNA replication 
cell cycle 
cell d1fferentiat1on 
cell cycle 
hypothetical protein 
hypothetical protein 
hypothetical protem 
hypothetical protein 
unknown 
unknown 
QSERl 
TMEM69 
CCDC43 
CTDSPL2 
NARG2 
SPATS2 
TMEM182 
VTAl 
ZBTB37 
ZNF280C 
C15org23 
C13orf3 
Clorf104 
C20orf7 
C200rf20 
CBX3 
KIAA1524 
WAC 
TRIM 59 
5100A16 
TMOD3 
CASCS 
CEP78 
CENPL 
CENPN 
BIRCS 
P!Fl 
PMCHL2 
kR!Tl 
RAB39B 
GPR93 
OR51E2 
GOLTlB 
SEC22C 
ERG!Cl 
SYT13 
XP04 
SLC25A40 
unknown 
unknown 
unknown 
unknown 
unknown 
unknown 
unknown 
unknown 
transcription 
transcription 
open reading frame 
open reading frame 
open reading frame 
open reading frame 
open reading frame 
chromatin remodeling 
protein binding 
protein binding 
protein binding 
calcium ion binding protein 
actin binding; tropomysin binding 
acrosome formation 
centrosomal protein 
centrosomal protein 
centrosomal protein 
establishment of chromosome localization 
regulation of telomere maintenance 
biological process 
small GTPases mediated signaling transduction 
small GTPases mediated signaling transduction 
G protein coupled receptor signaling pathway 
G protein coupled receptor signaling pathway 
vehicle-mediated transport 
vehicle-mediated transport 
vehicle-mediated transport 
vehicle-mediated transport 
protein transport 
transport 
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SLC39A10 
CSNKlGl 
TIMM23 
ASPM 
PPILS 
DTL 
DNHD2 
ASBS 
RAD18 
CDC2 
CDC23 
TBLlXRl 
UBE2R2 
XPNPEPl 
transport (ion, metal ion, zinc ion) 
WNT receptor signaling pathway 
protein targeting to mitochondrion 
maintenance of centrosome localization 
ubiquitin-mediated protein catabolism 
ubiquitin-mediated protein catabolism 
ubiquitin-mediated protein catabolism 
ubiquitin-mediated protein catabolism 
ubiquitin-mediated protein catabolism 
ubiquitin-mediated protein catabolism 
ubiquitin-mediated protein catabolism 
ubiquitin-mediated protein catabolism 
ubiquitin-mediated protein catabolism 
proteolysis 
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To characterise their biological processes, gene ontology within this 
cluster is perform on all features with the help of Entrez Gene [Maglott 
et al., 2007]. This enables us to identify 74 distinct genes that are 
up-regulated in tumorigenic breast tumours, moderately expressed in 
non-tumorigenic breast tumours, and down-regulated in normal 
breast cancer epithelium (Table 5. 7). In particular, we observe 
changes in lipid biosynthetic and metabolic processes (LYCAT, AGPS, 
and RP5-1022P6.2) in tumorigenic breast tumours. We also observe 
changes in (LYCAT, AGPS, and RP5-1022P6.2) in tumorigenic breast 
tumours. Changes in DNA replication (MCMlO), cell differentiation 
(SERPINE2), cell cycle (FMA33A and SASS6) and WNT receptor 
signaling pathway (CSNKlGl) are also found in tumorigenic breast 
tumours. 
It can be observed that several genes involved in ubiquitin-mediated 
protein catabolism (PPILS, DTL, DNHD2, ASBS, RAD18, CDC2, CDC23, 
TBLlXRl and UBE2R2) and proteolysis (XPNPEP1) are up-regulated in 
tumorigenic breast tumours, moderately expressed in 
non-tumorigenic breast tumours, and down-regulated in normal 
breast epithelium, suggesting the potential role of ubiquitin-mediated 
degradation machinery in the development of tumorigenic status. The 
occurrence of acrosome formation (CASCS), telomere maintenance 
(PIF1), centrosome (CEP78, CENPL and CENPN), chromatin 
remodeling (CBX3), and establishment of chromosome localization 
(BIRCS) are also observed in tumorigenic breast cancer cells, 
suggesting the potential role of centrosome amplification and 
chromosome instability underlying the development of tumorigenic 
status in breast tumours. 
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In conclusion, gene expression profiling identified the potential roles 
·of ubiquitin-mediated degradation machinery, centrosome 
amplification and chromosome instability underlying the development 
of tumorigenic status in breast tumours, and subsequently 
substantiated the hypothesis that all cell populations have the 
capacity to become tumorigenic through accumulation of mutations. 
5.3 Conclusion 
Microarray-based genomic surveys and other high-throughput 
approaches (ranging from genomics to combinational chemistry) are 
becoming increasingly important in clinical studies [Eisen et al., 1998]. 
As a result, we need to enable ourselves to "see" the information in 
the massive tables of quantitative measures that these techniques 
generate [Eisen et al., 1998]. Our approach to this problem can be 
generalised as follows: First, we use the Mahalanobis distance in the 
K-means or hierarchical clustering algorithm to classify cancer-related 
microarray gene expression data, which take the biological 
complexities and interdependencies into account. Next, the results as 
presented gain insight into toxic mechanisms underlying the 
progression of tumour cells, which lead to the development of 
diagnostic array platforms and promising new therapeutic strategies 
to treat or cure cancer. The success of this computational approach 
has enabled the diagnosis of toxic mechanisms of cancer, thus offering 
genome-based expression profiling as a single standardised 
microarray platform for diagnosis and therapeutic interventions in 
cancer. 
Chapter 6 
DNA Microarrays for the Study of 
Other Diseases 
6-1 Introduction 
The race to sequence and elucidate the human genome has 
culminated in an unparalleled gift to clinical investigators [Wade, 
2001]. With the genome sequence in hand, clinical investigators can 
expect to understand all human diseases at the genetic level and, in 
time, to develop treatments or cures on the basis of this 
understanding [Wade, 2001]. At least in principal the prospect of 
conquering almost all diseases can be entertained [Wade, 2001]. 
In this chapter, the bioinformatics techniques described in Chapters 2 
and 3 are used to analyse and make sense of microarray gene 
expression data in a choice of complex diseases, such as interstitial 
cystitis (IC), as asthma, type 2 diabetes, HIV/AIDS, organ transplant 
rejection, ovarian endometriosis and inflammatory papules. The 
analytical results lead to the classification of pathological samples of 
unknown, equivocal and ambiguous history, thus offering the basis of 
minimally invasive diagnostic tests and therapeutic interventions in 
the study of disease. 
6.2 Microarray Data Analysis 
In Section 6.2.1, the conditional logistic regression model is used to 
study the aetiology of interstitial cystitis (IC) in a matched 
case-control study. From Section 6.2.2 to Section 6.2.11, the 
Mahalanobis distance in the K-means or agglomerative hierarchical 
0' 
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clustering algorithms is sued to study the etiology of various complex 
diseases, such as asthma, diabetes, HIV/AIDS, organ transplant 
rejection, endometriosis and so on. Heat maps are used to represent 
the measured fluorescence intensities on the 2-dimensional grids. 
Cells with intensities of zero are coloured black, increasing positive 
intensities with reds of increasing intensity, and increasing negative 
intensities with greens of increasing intensities. This visual 
representation preserves all the quantitative information, but 
transmits to our brain by ways of a much higher-bandwidth channel 
than the "number-reading" channel [Eisen et al., 1998]. 
6.2.1 Interstitial Cystitis 
Research into interstitial cystitis (IC) has a very long history. It was 
first documented by Mercier in 1937, and characterised by Skene in 
1887, as the presence of an inflammation that destroys the urinary 
bladder mucous membrane, partly or wholly, and extends to muscular 
parietes [Rover and Esdridge, 2005]. In 1914, Hunner popularized IC 
with the description of a characteristic bladder wall ulcer [Rover and 
Esdridge, 2005]. In 1947, Hand made the first epidemiological 
description of IC as the widespread, small, submcosal, bladder 
hemorrhages and substantial shrinkage in the bladder capacity [Rover 
and Esdridge, 2005]. In 1987, Messeing and Stamey documented 
glomerulation as an indicator of IC [Rover and Esdridge, 2005]. To 
date, IC is still relatively unknown and has been acknowledged by the 
American Urological Association, as the most challenging disease. 
One of the most difficult aspects in the treatment of IC is its diagnosis. 
Presently, the requirements for diagnosis involve excluding all other 
causes, such as urinary tract infection, bladder cancer, kidney 
diseases and sexually transmitted diseases. Also, an invasive 
cystoscopy must be performed in which the bladder is distended and 
hemorrhages are identified. Although Keay et al [2003] have isolated 
several potential candidate IC markers from the urine of patients with 
IC, their attempts remained undetermined for two reasons: 
N4 
1. We all know that IC is a complex disease. An individual molecular 
marker for superior intelligence probably does not it does for IC. 
Instead, genes and gene products work together in a complex and 
interdependent way to cause symptoms of IC. 
2. Keay et al [2003] studied gene expression based RNA/spotted 
DNA/eDNA array on bladder epithelial cells from human IC subjects 
corresponding to their age- and gender- matched controls. 
However, they used ANOVA to identify IC markers, which failed to 
take the matching into consideration. As a result, the results they 
presented suffered from excessive type I error: A "false-positive" 
conclusion that the outcome are in a causal relationship with 
confounding factors. Although the primary objective of matching is 
the elimination of biased comparisons between cases and controls, 
their objective can only be accomplished in general if matching is 
accompanied by an analysis that corresponds to the matched 
design [Schlesselman, 1982]. Unless the statistical analysis 
accounts for the matching used in the selection phases of a 
case-control, the estimated statistic associated with the onset of IC 
can be biased as a consequence of matching. Therefore, matching 
is only the first of a two-step process that can be used to control for 
confounding (i) matching design, followed by (ii) matched 
analysis. 
We perform an analysis of gene expression of 4,132 genes using 
spotted DNA microarrays, and compared microarray gene expression 
profiling of bladder epithelial cells from patients with IC corresponding 
to their age- and gender- matched controls. To take the matching into 
consideration, the conditional logistic regression model is used to 
analyse gene expression profiling of bladder epithelial cells from 
patients with IC corresponding to their age- and gender- matched 
controls. To consider the tradeoff between the biological meaning and 
statistical significance, significantly differential expressed genes with 
IC are prioritised relating to combinations of the following two criteria: 
fi, > 100 and fi,- p(!i, )/ > 1. This enables us to identify 139 
/lt(/1,) 
significant differentially expressed genes in response to IC stimulus. 
The data used here was collected from Gene Expression Omnibus 
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under platform accession no GSE621, and this microarray experiment 
was performed previously by Keay et al [2003]. 
The results were very interesting. First, complex metabolic reactions, 
including carbohydrate, lipid, cofactors, vitamins, xenobiotics, 
nucleotide and amino acid metabolisms, are found to have a strong 
relationship with bladder smooth muscle contraction through IC 
status. Next, based on the mapping of the resultant differentially 
expressed genes onto the biochemical pathways of cytoskeleton 
dynamics, including the regulation of actin cytoskeleton, transforming 
growth factor-beta (TGF-beta) signaling transduction, 
mitogen-activated protein kinase (MAPK) signaling transduction, 
peroxisome proliferators-activated receptor (PPAR) signaling 
transduction and adipocytokine signaling transduction, we are able to 
find the transcriptional regulations of IC-induced bladder smooth 
muscle contraction status, including the level of contractile force, 
tissue homeostasis, energy homeostasis and the development of 
nervous system. Thus, the mapping of a gene onto these biochemical 
pathways mimics its actual transcription. A more insightful 
explanation is given as follows. 
Table 6.1 Significant differentially expressed genes in response to IC stimulus 
using fixed effect logistic regression model. 
Gene Symbol Gene Ontology 
ALDH4Al amino acid metabolism 
IVD 
PSMC4 
PSMB6 
AMPDl 
ATPSD 
TSTA3 
INDO 
VNNl 
GNLY 
INPPSD 
INPPl 
INSR 
LDHA 
amino acid metabolism 
amino acid metabolism 
amino acid metabolism 
nucleotide metabolism 
nucleotide metabolism 
nucleotide metabolism 
metabolisms of cofactors and vitamins 
metabolisms of cofactors and vitamins 
xenobiotics metabolism 
carbohydrate metabolism 
carbohydrate metabolism 
carbohydrate metabolism 
carbohydrate metabolism 
HYAL2 
MAN2Al 
PGMl 
PIPSKlC 
ACSM3 
ASAHl 
PRKAGl 
PLCG2 
BTN2Al 
MTPA 
HADHA 
ECHSl 
HSD1162 
HSD1763 
NQ02 
PRDX4 
NDRGl 
VTilB 
ASNAl 
TCN2 
STX4A 
SLC7A2 
SLC22Al8 
SLC25A46 
CYPlAl 
DLD 
PCMl 
QP-C 
ARF4 
KCNSl 
KCNN3 
COL7Al 
SLC17Al 
VDBG 
IL3 
TNF 
THYl 
carbohydrate metabolism 
carbohydrate metabolism 
carbohydrate metabolism 
carbohydrate metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism 
oxidation reduction 
oxidation reduction 
response to metal ion 
vehicle mediated transport 
transport (anion) 
transport (cobalamin) 
transport (neurotransmitter) 
transport (amino acid) 
transport (tetracycline) 
transport (phosphate) 
transport (electron) 
transport (electron) 
transport (electron) 
transport (electron) 
transport (protein) 
transport (potassium ion) 
transport (potassium ion) 
transport (phosphate) 
transport (phosphate) 
transport (vitamin D) 
R6 
immune response; promote eosinophil production and activation 
inflammatory response; stimulates cytokines and chemokines; 
activates endothelium 
mast-cell activation 
CXCL7 
CCL3 
DARC 
IGJ 
IL6 
ILlS 
IFRD2 
IFITM 1 
KIT 
PSMB9 
IGJ 
TAPBP 
TRB 
XBPl 
CLU 
TFPI 
TFPI2 
SERPINAS 
SERPINHl 
CHGA 
GPSl 
PPP2R1B 
FGFl 
MADD 
SHC 
MAP2K2 
MAP2K3 
RHOA 
RREBl 
GNAll 
ITPKB 
RGS18 
MYL3 
XRCCl 
PTHLH 
PIM2 
SNTB2 
CDC42BPA 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
blood coagulation and complement; immune response 
blood coagulation and complement; immune response 
blood coagulation and complement; immune response 
blood coagulation and complement; immune response 
blood coagulation and complement; immune response 
blood pressure regulation 
JNK cascade 
signaling by MAPK 
signaling by MAPK 
activation of MAPK 
activation of MAPK 
Ras protein signal transduction 
signal transduction 
Rho protein signal transduction 
Ras protein signal transduction 
signal transduction 
signal transduction 
GTPases activator activity 
regulation of ATPase activity 
regulation of GTPase activity 
G protein signaling 
ATP binding 
actin binding 
actin cytoskeleton organization and biogenesis 
R7 
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CAPZA2 actin cytoskeleton organization and biogenesis 
PTPN13 amino acid dephosphorylation 
ICAMl cell adhesion 
CD47 cell adhesion 
ITGBS cell adhesion 
PCDHB16 cell adhesion 
FLOT2 cell adhesion 
CASPlO apoptosis 
DADl apoptosis 
PDCDlO apoptosis 
FAS apoptosis 
IER3 apoptosis 
MCLl apoptosis 
BCAP31 apoptosis 
SIAH2 apoptosis 
KIT TGF-beta receptor signaling pathway 
ACVR2 TGF-beta receptor signaling pathway 
BMP2 TGF-beta receptor signaling pathway 
BMP6 TGF-beta receptor signaling pathway 
AGER TGF-beta receptor signaling pathway 
FNl TGF-beta receptor signaling pathway 
PTN TGF-beta receptor signaling pathway 
PTPRG TGF-beta receptor signaling pathway 
PRKCZ amino acid phosphorylation 
PSKHl amino acid phosphorylation 
PTPRM amino acid phosphorylation 
TESKl amino acid phosphorylation 
SFRSS mRNA processing 
SF3B4 mRNA processing 
SFRSlO mRNA processing 
HNRPL mRNA processing 
HNRPU mRNA processing 
BRPFl transcription 
r ETS2 transcription 
' GATA6 transcription 
GTF2B transcription 
HMGAl transcription 
HOXA4 transcription 
R9 
ID2 transcription 
LDB2 transcription 
NR3Cl transcription 
PELPl transcription 
SMCX transcription 
ZNF3 transcription 
ZNF161 transcription 
ZNF345 transcription 
C190rf56 open reading frame 
Clorf2 open reading frame 
METAP2 translation 
E!FlAY translation 
Regulation of the level of contraction force. The contraction of 
bladder smooth muscle is controlled by the nervous system. 
According to the mapping representing the regulation of actin 
cytoskeleton (Figure 6.1), Ras protein of small GTPases domains are 
strong candidates to transmit axonal guidance signals in the growth 
cone in response to stress. Both Ras and ATP proteins are identified as 
responsible for the generation of mechanical forces upon the 
hydrolysis, consisting with their structural similarity for the catalytic 
regions of GTPases and ATPases domains [Kosztin et al., 2002]. The 
force transmission mechanism is based on an irreversible structural 
change, produced by the hydrolysis, which trigger a thermal switch 
between force-generating substates through change in the 
configurational space of the proteins [Kosztin et al., 2002]. 
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Figure 6.1 Reference KEGG pathway representing the regulation of actin 
cytoskeleton [Kanehisa et al, 2002; Kanehisa et al, 2004; Kanehisa et al 2006; 
Aoki- Kinoshita and Kanehisa, 2007; Kanehisa 2008]. 
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Regulation of nervous system development. Examining the 
mapping of the MAPK signaling transduction pathway (Figure 6.2) 
indicates the stress-induced materials, such as those downstream 
mitochondrial DNA damage signals, such as those downstream 
mitochondrial DNA damage signals, pro-caspase, FAS and TNFR, have 
activated neutrophil, JNK and P38 MAPK signaling pathways, 
respectively. The whole process involved the fate of neural precursor 
axon and dendrite growth patterns, the expression and activity of 
functionally important proteins through IC-induced bladder smooth 
muscle contraction status [Harper and LoGrasso, 2001]. 
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Figure 6.2 Reference KEGG pathway representing the regulation of MAPK 
signaling transduction (Kanehisa et al, 2002; Kanehisa et al, 2004 ; Kaneh1sa et al 
2006; Aoki-Kinoshita and Kanehisa, 2007; Kanehisa 2008]. 
Regulation of tissue homeostasis. Searching for the mechanisms 
of maintaining tissue homeostasis through IC status devoted in the 
discovery ofTGF-beta signaling transduction system (Figure 6.3). The 
bone marrow proteins and activins are found to be activated through 
plasma membrane serine-threonine kinase receptors and cytoplasmic 
effectors in response to IC stimulus. The SMAD and non-SMAD 
proteins engage in specifying the vertral mesoderm, induction of 
mesoderm and endoderm, regulation of cell proliferation, cell 
differentiation, cell cycle and apoptosis through IC status [Deryncl 
and Zhang, 2003]. 
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Figure 6.3 Reference KEGG pathway representing the regulatton of TGF- beta 
signaling transductton [Kanehtsa et al , 2002; Kanehtsa et al, 2004; Kanehi sa et al 
2006 ; Aoki-Kinoshita and Kanehisa, 2007; Kanehisa 2008]. 
--~-
Regulation of energy homeostasis. PPAR is a member of the 
nuclear receptor superfamily activated by various hydrophobic 
compounds [Takada and Kato, 2005]. According to the mapping 
representing the regulations of PPAR signaling transduction (Figure 
6.4 ), PPARalpha was found to be activated in response to IC stimulus. 
Through PPAR/RXR heterodimetric complex, PPARalpha promotes the 
transport of long-chain fatty acids and retinoids X acids into 
mitochondrial that in turn stimulates the beta-oxidative degradation 
of fatty acids by the carnitine 0-palmitoyltransferase I (CPTI) system 
[Takahashi et al., 2005]. While the mitochondria devote organelles in 
the cells and the sites of metabolic enzyme-specific reactions in the 
respiratory chains, it is also the site where oxygen acts as the final 
electron receptor in electron transport chain. In the presence of IC, 
mitochondrial oxidative stress could cause mitochondrial dysfunction, 
reduce production and triggering the apoptosis. 
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Figure 6.4 Reference KEGG pathway representing the regulation of PPAR 
signaling transduction [Kanehisa et al, 2002; Kanehisa et al, 2004; Kanehisa et al 
2006; Aoki-Kinoshita and Kanehisa , 2007; Kanehisa 2008). 
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Complement and coagulation cascades. According to the 
mapping on the pathway representing the regulation of complement 
and coagulation cascades (Figure 6.5), the classical and lectin 
pathways, respectively, are triggered to mediate complement 
activation through IC status. Complement activation products exert a 
number of effects on macrophage via specific surface receptors 
causing internalization of offending agents, microbes and immune 
complexes, promoting of intracellular killing, controlling migration 
behavior, inducing release of potent biological substances [Norris, 
2003; Ruf et al., 2003; Campbell, 2003]. Thus, complement is also 
implemented as a pathogeneses of I C. In addition, blood coagulations 
are found to arise through the tissue factor (FC) pathway. The TF 
pathway triggers the production of Thrombin in response to IC 
stimulus. 
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Figure 6.5 Reference KEGG pathway representing the regulation of complement 
and coagulation cascades [ Kanehisa et al, 2002 ; Kanehtsa et al, 2004 ; Kaneh tsa et 
al 2006 ; Aoki -Kinoshita and Kanehisa, 2007; Kanehisa 2008] . 
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Allergic inflammatory r esponse. Finally, there is an indication of 
the mast-cell activation mediated by the high-affinity IgE receptor of 
Fe episilon RI on the basis of the mapping onto the pathway of Fe 
episilon RI signaling transduction (Figure 6.6). To date, it is well 
known that Fe episilon RI is considered as a key event in the allergy 
inflammatory response [Siraganian, 2003; Gilf illan and Tkaczyk, 
2006] . Therefore, the activation of Fe episilon RI signaling 
transduction pathway has triggered allergic inflammation through IC 
status. 
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Figure 6.6 Reference KEGG pathway representing the regulation of Fe episilon 
RI signaling pathway [Kanehisa et al, 2002; Kaneh1sa et al, 2004; Kaneh1sa et al / 
2006; Aoki-Kinoshlta and Kanehisa, 2007; Kanehisa 2008]. 
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In conclusion, the pathogenic mechanisms of human IC can be 
summarised as follows: (1) complex metabolrc reactions, including 
carbohydrate, lipid, cofactors, vitamins, xenobiotics, nucleotide and 
amino acid metabolisms, are found to have a strong association with 
bladder smooth muscle contraction through IC status, (2) we have 
tound tne transcr\pt\ona\ regu\at\ons of lC-\nduced bladder smooth 
muscle contraction status, including the level of contractile force, 
tissue homeostasis, energy homeostasis and the development of 
nervous system, and (3) there is an indication of the mast cell 
activation mediated by the high-affinity IgE receptor of Fe episilon RI 
triggering allergic inflammation through IC status. Such genetic 
alteratrons, jointly termed "bladder remodeling" can constitute an 
important long-term consequence of IC. 
6.2.2 Asthma 
Patients with asthma suffer from repeated episodes of airway 
narrowing that can cause shortness of breath along with wheezing 
and/or coughing. Airway passages clench up and contract as if they 
have been clamped in a vice [Stephenson, 2006]. Watery mucus spil ls 
into the upper respiratory system [Stephenson, 2006]. The lung 
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struggle and have to force the next breath [Stephenson, 2006]. It is 
warning to both the sufferer and to the parent with a child who is 
choking for air because of it. 
Asthma is triggered by a respiratory track infection or allergic 
reaction-the body's immune response to a molecule or agent it seems 
an unwelcome or "foreign" [Stephenson, 2006]. Several molecules or 
agents can trigger an asthma attack. That which triggers an asthma 
attack in one patient, however, may not do so in anther. Dust mites, 
cockroach feces, mouse feces, cat or dog dander, pollen, wood smoke, 
smog, ozone, paint, exhaust, exercise, cold and heat can, in the 
susceptible person, precipitate an allergic reaction [Stephenson, 
2006]. Inhalation of an allergen such as a cat dander of fecal material 
from dust mites triggers the release into the bloodstream of a special 
kind of antibody called IgE, which subsequently attach to 
inflammatory cells of the immune system [Stephenson, 2006]. That is, 
in asthma and other allergic disorders, the binding of IgE to the 
high-affinity Fe episilon receptor (Fe episilon RI) on mast cells activate 
signaling transduction pathway resulting in the release of histamines 
and other allergic inflammation mediators. Several pathological 
abnormalities, including airway inflammation and airway remodeling 
(thickening of the smooth muscle !aye~ increased epithelial cell 
mucus content, and subepithelial fibrosis), are generally seen in 
asthma [Fahy et al., 2000]. Though the clinical disease spectrum has 
been well established, little is known about its molecular mechanisms. 
The advance of microarray technology and the completion of the 
human genome project offer a new opportunity to gain insight into 
global gene expression profiles in asthma, leading to the identification 
of mast cell products mediated via the high-affinity Fe episilon RI. 
Microarray analyses of the effects of targeted interventions, such as 
transgenic high expression of cytokines of gene targeting, could help 
to elucidate the contributions of specific molecules and pathways [Erie 
and Yang, 2003]. While Sayama et al [2002] reported that Illl was 
the mast cell product mediated via the Fe episilon RI, their attempts 
remained undetermined for three reasons: 
1. The results they presented were disconnected with the 
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acknowledged Fe episilon RI signaling pathway at the KEGG 
pathway [Kanehisa et al, 2002; Kanehisa et al, 2004; Kanehisa et 
al 2006; Aoki-Kinoshita and Kanehisa, 2007; Kanehisa 2008]. 
2. Sayama et al [2002] deposited their microarray data on the Gene 
Expression Omnibus under platform accession no GSE3271. We 
scrutinised the results they represented and did not find any clue 
providing evidence on the activation of Illl. 
3. We all know that asthma and other allergic disorders are complex 
diseases. An individual gene (e.g. Illl) for superior intelligence 
probably does not exist as it does for asthma and other allergic 
disorders. Instead, genes and gene products work together in 
complex and dependent ways to cause allergic inflammation and 
anaphylactic reactions. 
To actually identify new mast cell products, the Mahalanobis distance 
in the K-means clustering algorithm is used to group microarray gene 
expression profiling of the human umbilical cord blood-derived mast 
cells two hours post stimulation by the high-affinity IgE receptor of Fe 
episilon RI (Figure 6. 7). The data used here was available from the 
Gene Expression Omnibus under platform accession no GSE3281, and 
this microarray experiment was performed by Sayama et al [2002]. At 
the finest level, we find that there is a cluster of 48 features that 
reveal considerable fold increase in expressions over baseline "o" 
levels in two human umbilical cord blood-derived mast cell 
populations (Figure 6.8). Thus, genes within this cluster are highly 
differentially expressed in the human umbilical cord blood-derived 
mast cells mediated via the high-affinity Fe episilon RI. 
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Figure 6. 7 K-means clustering results of microarray gene expression profiles in 
the human umbilical cord blood-derived mast cells mediated by the high-affinity 
IgE receptor of Fe episilon RI (K= 15). 
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Figure 6.8 A cluster of 48 features that reveal considerable fold increase in 
expressions over baseline "0" levels in two human umbilical cord blood-derived 
mast cell populations. 
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Table 6.2 Highly differentially expressed genes in the human umbilical cord 
blood-derived mast cells stimulated via the high-affinity IgE receptor of Fe episilon 
RI. 
Gene Symbol 
IL3 
CSF2 
TNF 
ITGA2 
NR4A3 
NR4A2 
BTG2 
SMARCA2 
ZNF264 
MIRNlSS 
KPNAS 
CD69 
CCL4 
CXCL2 
CCL3 
CCL3Ll 
H62864 
ILl A 
ILS 
LIF 
JMJD3 
NFKBID 
GEM 
MMP25 
Gene Ontology 
immune response; promote eosinophil production and 
activation 
immune response; promote eosinophil production and 
activation 
inflammatory response; stimulates cytokines and 
chemokines; activates endothelium 
cell adhesion 
transcription 
transcription 
transcription 
transcription 
transcription 
transcription 
protein import into nucleus 
activate T lymphocyte 
immune and inflammatory response 
immune and inflammatory response 
immune and inflammatory response 
immune and inflammatory response 
immune and inflammatory response 
immune and inflammatory response 
immune and inflammatory response 
immune response 
inflammatory response 
inflammatory response 
immune response 
inflammatory response 
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To characterise their biological processes, we perform gene ontology 
on all features within this cluster with the help of Entrez Gene [Maglott 
et al., 2007]. This enables us to identify 24 distinct genes that are 
up-regulated in the human umbilical cord blood-derived mast cells 
mediated by the high-affinity IgE receptor of Fe episilon RI (Table 6.2). 
The nature of five cytokines (IL3, CSF2, TNF, ILlA and LIF) and six 
chemokines (CCL4, CXCL2, CCL3, CCL3Ll, H62864 and IL8) have 
been altered through these processes. Several genes involved in 
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transcriptional activities are also up-regulated (NR4A3, NR4A2, BTG2, 
SMARCA2, ZNF 264 and MIRN155). Anti-IgE activated human mast 
cells also change the expression of a cell adhesion molecule (ITGA2) 
and additional genes involved in inflammatory responses (JMJD3, 
NFKBID, GEM and MMP25). 
According to the mapping onto the Fe episilon RI signaling 
transduction pathway at the KEGG pathway [Kanehisa et al, 2002; 
Kanehisa et al, 2004; Kanehisa et al 2006; Aoki-Kinoshita and 
Kanehisa, 2007; Kanehisa 2008] (Figure 6.9), there is an indication 
that mast cell activation mediated via the Fe episilon RIcan secret TNF, 
IL3 and CSF. In addition, the production of TNF promotes 
inflammation, activates endothelium as well as stimulates cytokines 
and chemokines; whereas the production of IL3 and CSF2 activates 
eosinophils [Turner and Kinet, 1999; Nadler et al., 2000; Nadler and 
Kinet., 2002; Gu et al., 2001; Kawakami et al., 2002; Siraganian, 
2003; Gilfillan and Tkaczyk, 2006]. Such changes, jointly termed 
"airway remodeling," can constitute an important long-term 
consequence of asthma. 
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Figure 6.9 Reference KEGG pathway representing the regulation of Fe episilon 
RI signaling transduction [Kanehisa et al, 2002; Kanehisa et al, 2004; Kanehisa et 
al 2006; Aoki-Kinoshita and Kanehisa, 2007; Kanehisa 2008]. 
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6.2.3 Obesity and Type 2 Diabetes 
Suppose you bite off a piece of cake. As the cake is digested and its 
carbohydrate converted into the sugar glucose, the pancreas, a 
banana-shaped gland next to your stomach, squirts out a shot of 
insulin, helping to guide that sugar down the pathway that ends in its 
storage as fat or in its use as the gasoline for the engine that drives 
muscle movement [Stephenson, 2006]. 
As part of its function, insulin regulates glucose production and 
controls the movement of glucose into muscle cells through both 
direct and indirect effects on the liver [Edgerton et al, 2006]. If insulin 
fails to do its business, either because it is not made or because the 
body is unable to respond to it, glucose accumulates [Stephenson, 
2006]. Lifted blood sugar (glucose), a condition called hyperglycemia, 
can lead to the onset of diabetes. 
Generally speaking, diabetes comes in two versions, type 1 and type 
2. While they are both the same disease, they start off by different 
ways. Type 1 diabetes is genetic and affects the patient from birth, 
whereas type 2 diabetes afflicts those who are obese. 
Although obesity is a strong risk factor for the onset of type 2 diabetes, 
not all obese persons are diabetic. Actually, only around 10 percent of 
obese persons develop diabetes [Beck-Nielsen and Hother-Niesen, 
1996]. Up to the present time, it is still much a mystery on what 
decide which obese non-diabetic individuals will transfer to diabetes. 
To know what decide which obese non-diabetic individuals will 
transfer to diabetes, the Mahalanobis distance in Ward's linkage 
hierarchical clustering algorithm is used to group microarray gene 
expression profiling of adipose tissue from lean, obese and obese 
diabetic (hyperglycemia and severely diabetic) mice (Figure 6.10). 
The data used here was available from Gene Expression Omnibus 
under platform accession no GSE2952, and this microarray 
experiment was implemented by Nadler et al [2000]. At the finest 
level, we find that there is a cluster of 108 features that exhibit 
substantial fold increase in the adipose tissue from obese diabetic 
mice (Figure 6.11). Thus, genes within this cluster are highly 
differentially expressed in the adipose tissue from obese diabetic 
mice. 
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Figure 6.10 Clustering results of microarray gene expression profiling of adipose 
tissue from lean, obese and obese-diabetic (increasing hyperglycemia and severely 
diabetic) mice. 
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Figure 6.11 A cluster of 108 features that exhibit considerable fold increase in 
adipose tissue from obese diabetic (increasing hyperglycemia and severely diabetic) 
mice. 
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Table 6.3 Highly differentially expressed genes associated with the development 
of obese diabetes. 
Gene Symbol 
Fa bpS 
PkmZ 
HZ-Aa 
HZ-Ebl 
Ctsl 
Lgals3 
Fcerlg 
Igk-Vl 
Igh-lb 
Pik3c3 
Pik3ca 
Jakl 
Clqb 
Serpinfl 
Serpinhl 
Lilrb3 
MfgeB 
Ednl 
AtpZbl 
Rfc4 
Rbmsl 
TscZZd3 
Zfp503 
GtfZb 
Eif4al 
Eif4a3 
EifSa 
Wdr57 
Ankhdl 
Prpsl 
Tm4sf19 
SerfZ 
EG626841 
Gene ontology 
glucose metabolism; lipid metabolism 
glycolysis 
antigen processing and presentation (MHC class II) 
antigen processing and presentation (MHC class II) 
Proteolysis; antigen processing and representation (MHC class II) 
IgE binding 
Fe epision RI pathway; regulation of mast cell cytokine production; 
immunoglobulin mediated immune response 
IgE mediated immune response 
IgE mediated immune response 
phosphoinositide-mediated signaling 
phosphoinositide-mediated signaling 
cytokine and chemokine mediated signaling pathway 
complement activation; classical pathway 
serine protease inhibitor activity 
serine protease inhibitor activity 
B cell mediated immunity 
phagocytosis 
diuresis; natriuresis 
ion transport 
DNA replication 
DNA replication 
transcription 
transcription 
transcription; translational initiation 
translation 
RNA splicing, mRNA processing; rRNA processing 
translation 
RNA splicing, mRNA processing 
RNA binding; protein binding 
nucleotide biosynthesis 
unknown 
unknown 
predicted gene 
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5730403Ml6Rik hypothetical protein 
Cdr2 biological process 
Gorasp2 
Dnajb4 
Nedd41 
Ppp2r3a 
Ctsa 
Cstb 
Ctsd 
Ctsz 
Lgmn 
Ctsa 
Pcdh7 
S100a6 
App 
Actb 
Msn 
Mgp 
Npr3 
Cd97 
Rgsl 
Cdc42 
Iqgapl 
Rab28 
Gkapl 
Tubb2a 
Centbl 
Cryab 
Htral 
biological process 
protein folding 
ubiquitin ligase activity 
mitochondrial protein transporting ATP synthase complex 
proteolysis 
proteolysis 
proteolysis 
proteolysis 
proteolysis 
proteolysis 
cell adhesion 
cell cycle; cell proliferation 
Axonogenesis 
F-actin 
moesin; cytoskeleton protein binding 
cartilage development 
peptide receptor activity, G protein coupled 
G protein coupled receptor signaling pathway 
G protein coupled receptor signaling pathway 
Rho protein singal transduction; small GTPases mediated signaling 
transduction 
small GTPases mediated signaling transduction 
small GTPases mediated signaling transduction 
G protein signaling, coupled to cGMP nucleotide second messenger 
GTPase activity; microtubule based movement 
regulation of ARF GTPase activity 
transmembrane receptor protein tyrosine kinase signaling 
pathway 
regulation of transmembrane receptor protein tyrosine kinase 
signaling pathway 
To characterise their biological processes, we perform gene ontology 
on all features within this cluster with the help of Entrez Gene [Maglott 
et al., 2007]. This enables us to identify 62 distinct genes that are 
associated with the development of hyperglycemia (Table 6.3). 
Specifically, we observe changes in lipid and glucose metabolism 
IO:i 
(FabpS). These metabolisms require the release of energy, which is 
made available from mRNA encoding small GTPases domains, 
including Ras, CDC42 and Rho isoforms and ATP pmotor rotein 
[Kosztin et al., 2002]. The expressions of MHC class II molecules are 
up-regulated through these processes, suggesting that MHC class II 
expressions have a strong association with the progress of obese 
diabetes. We also observe the expression of Endothelin-1 (Edn1) is 
up-regulated through these processes. According to Hoffman et al 
[2000], the diuresis and natriuresis are caused the differential effect 
of Edn 1. 
It can be observed that obese diabetes initiate classical pathway of 
complement cascades promoting muscle contraction, phagocyte 
recruitment and B cell mediated immune responses [Kirschfink, 1997; 
Bhole D and Stahl, 2003]. Several genes involved in potential 
interactions with the binding of IgE to the high-affinity Fe episilon RI 
and the activation of mast cells are up-regulated through these 
processes, suggesting that obese diabetes trigger the binding of IgE 
to the high-affinity Fe episilon RI and the activation of mast cells 
causing allergic reactions [Gilfillan, A.M. and Tkaczyk, 2006; Zhang et 
al, 2007]. Changes in ubiquitin proteasome system are also observed. 
Furthermore, we observe changes in the regulation of Wnt receptor 
(Csnk2a2) and TGF-beta receptor signaling pathway (Cryab and 
Htra1), indicating the potential roles of Wnt receptor and Tgf-beta 
receptor signaling pathways are involved in the development of obese 
diabetes. 
In conclusion, the pathogenic mechanisms underlying the progress of 
obese diabetes include: (1) MHC class II expressions are strongly 
linked to the susceptibility of the obese diabetes, (2) the diuresis and 
natriuresis are caused by the differential effect of Edn1, (3) obese 
diabetes initiate classical pathway of complement cascades promoting 
muscle contraction, phagocyte recruitment and B cell mediated 
immune responses, ( 4) changes in ubiquitin proteasome system are 
observed, (5) obese diabetes promote the binding of IgE to the 
high-affinity Fe episilon RI and the activation of mast cells triggering 
allergic reactions, and (6) Wnt receptor and Tgf-beta receptor 
signaling pathway are involved in the onset of obese diabetes. 
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6.2.4 HIV /AIDS 
The human immunodeficiency virus (HIV) infection originated from a 
natural infection of chimpanzees [Barnes, 2005]. The virus evolved 
into a silent infection causing no harm within its natural host [Barnes, 
2005]. Chimpanzees that were hunted and slaughtered for food by 
rural people gave the virus the opportunity to jump species and 
infected humans during the butchering process [Barnes, 2005]. It 
would only take a kin scratch or nick in contract with infected blood or 
other body fluids of the animal to permit infection [Barnes, 2005]. 
Most likely the virus occasionally infected rural people in isolated area 
of the Conge with deadly results for many before its escape from total 
central Africa during the latter half of the twentieth century [Barnes, 
2005]. The virus quickly adapted to human beings to turn into a 
human disease transmitted through intravenous drug abuse, blood 
transfusions and sexual contact. 
But the world did not know what was taking place in Africa. People 
outside Africa mostly ignored reports of the mysterious of HIV 
infection and the disease it caused, acquired immune deficiency 
syndrome (AIDS), despite the fact that tens of thousands of people 
were killed in this part of the world [Barnes, 2005]. Many Africans 
blamed witchcraft for the carnage, and African government denied the 
seriousness of epidemic [Garrett, 1994]. At the same time, the global 
blood market and illicit heroin traffic greatly facilitated movement of 
this virus to different regions of the globe. 
Until the summer of 1981, the recognition of AIDS put the world on 
notice of the impending HIV pandemic [Quagliarell, 1982; Jaffe et al, 
1983; Mansell et al, 1984]. The symptom was first described as 
Kaposi's sarcoma, an unusual form of skin cancer, for which they were 
a symptom [Mansell et al, 1984; Longo et al, 1983]. Physicians also 
began to take note of an unusual clustering of cases of rare 
Pneumocystis carinii pneumonia [Pass et al, 1983; Wollschlager et al, 
1984]. Both Kaposi's sarcoma and the Pneumocystitis form of 
pneumonia were opportunistic diseases; they were usually seen only 
with patients whose immune systems have been compromised 
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[Stephenson, 2006]. The patients were all found to be suffering from 
a substantial reducing in the number of circulating T cells of a type 
known as CD4+ and their immune defense had collapsed 
[Stephenson 2006]. 
HIV coming from central Africa has been labeled HIV-1 to distinguish 
it from another HIV type from west Africa, HIV-1, first identified in 
1985 [Marlink, 2001]. The virus from west Africa bears a strong 
relationship with Mangabey monkeys, macaques, green monkeys and 
mandrills [Strauss and Strauss, 2002]. This indicates that humans 
picked up HIV-2 from monkeys in West Africa separately from 
transmission of HIV-1 in central Africa from chimpanzees to humans. 
Like HIV-1 viruses, HIV-2 viruses probably jumped species from 
monkeys to humans in isolated rural areas more than once over many 
years [Barnes, 2005]. But HIV-2 most remains confined to west Africa, 
and it follows a far less virulent path in humans than HIV-1. 
HIV-1 's target is a white blood cell called a T cell-one of the very 
defenders the immune system enlists to engage viruses when they 
appear [Stephenson, 2006]. On the surface of aT cell are receptors 
used to receive communication from other cells and to snag other 
proteins or molecules, very specifically, for transport across the cell 
membrane [Stephenson, 2006]. HIV-1 uses CD4 receptors and CCR5 
receptors to tightly dock with its victim T cell [Liu et al, 1996; Abbas 
et al, 1997]. With attachment, the outer coat of HIV fuses with the 
outer membrane of its host and the virus spills its contents into the 
cell [Liu et al, 1996; Abbas et al, 1997]. 
On average, it takes eight years from the time of initial HIV-1 infection 
to the onset of full-brown AIDS [Stephenson, 2006]. Without the 
protection ofT cells, all the other microbes, constantly at the gate, 
finally breach what is left of the body's defenses [Stephenson, 2006]. 
The AIDS patient finally succumbs to any number of other diseases 
such as pneumonia, tuberculosis or cancer against which the body can 
no longer mount resistance [Stephenson, 2006]. 
Although it is well known that changes in T cell function are a hall 
mark of HIV-1 infection, the pathogenic mechanisms leading to these 
lOR 
changes are still relatively unknown [Hyrcza et al, 2007]. To identify 
the pathogenic mechanisms leading to these changes, the 
Mahalanobis distance in Ward's linkage hierarchical clustering 
algorithm is used to group microarray gene expression profiling of ex 
vivo human CD4+ T cells from untreated HIV-1 patients at different 
disease stages and rates of disease progression (Figure 6.12). The 
data used here was available from Gene Expression Omnibus under 
platform accession no GSE6740, and this microarray experiment was 
performed previously by Hyrcza et al [2007]. At the finest level, we 
find there is a cluster of 328 features that exhibit considerable fold 
increase in the CD4+ T cells from early ( s 6 months) untreated HIV-1 
patients (Figure 6.13). Thus, genes within this cluster are highly 
differentially expressed in the CD4+ T cells from early untreated 
HIV-1 patients. 
Figure 6.12 Clustered display oftranscnptional responses in ex vtvo human CD4+ 
cell from untreated HIV-1 patients at dtfferent disease stages and rates of diseasej 
prog resston. 
-- -- - --- --- - - - · - --
' Figure 6 .13 A cluster of 293 features that exhibited considerable fold increases in ex vivo human CD4+ cell from patients infected with 
1 
I HIV-1 within 6 mon_t_h_s_o_f _s_tu_d_y_. _______________________________ ____ _____ _j. 
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Table 6.4 Highly differentially expressed genes in ex vivo human CD4+ T cell from 
patients infected with HIV-1 within 6 months of study. 
Gene symbol 
TOP2A 
ISGlS 
MXl 
PLSCRl 
RSAD2 
AURKA 
KIF2C 
NCAPH 
PBK 
TPX2 
MREllA 
RADSl 
MSHS 
ESPLl 
TTK 
ASPM 
AURKB 
BUBl 
BIRCS 
DCLRElA 
FANCI 
HELLS 
SMC4 
SPC25 
CCNA2 
CCNBl 
CCNB2 
CCNF 
CHEKl 
CENPE 
CKAP2 
CHAFlB 
CDC2 
CDC6 
CDC20 
Gene ontology 
retroviral genome replication 
response to virus 
response to virus 
response to virus 
defense response to virus 
mitosis 
mitosis 
mitosis 
mitosis 
mitosis 
meiosis 
meiosis 
meiosis 
spindle organization and biogenesis during meiosis 
spindle organization and biogenesis during meiosis 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
cell cycle 
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CDC25A cell cycle 
CDC45L cell cycle 
CDCA3 cell cycle 
CD CAS cell cycle 
CDKN3 cell cycle 
CDTl cell cycle 
CEP55 cell cycle 
DLGAPS cell cycle 
E2F8 cell cycle 
K!Fll cell cycle 
K!F23 cell cycle 
KIFCl cell cycle 
MCM2 cell cycle 
MCM4 cell cycle 
MCMS cell cycle 
MCM6 cell cycle 
MCMlO cell cycle 
NCAPG2 cell cycle 
NUSAPl cell cycle 
FBXOS cell cycle 
GMNN cell cycle 
MKI67 cell cycle 
NEK2 cell cycle 
NCAPG cell cycle 
NDCSO cell cycle 
NUSAPl cell cycle 
PTTGl cell cycle 
SMC2 cell cycle 
UBE2C cell cycle 
ZWINT cell cycle 
ZWILCH cell cycle 
MPHOSPH9 M phase of mitotic cell cycle 
GTSEl G2 phase of mitotic cell cycle 
CENPF G2 phase of mitotic cell cycle 
BARDl cell cycle arrest 
BUBlB cell cycle; cell cycle checkpoint 
BRCAl cell cycle checkpoint 
RBBP8 cell cycle checkpoint 
Ill 
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PSMA4 cell cycle checkpoint; signaling by WNT 
PML 
DNA damage response, signal transduction by P53 class 
mediator resulting in cell cycle arrest 
FANCL DNA repair 
DTL DNA replication 
GINSl DNA replication 
GINS2 DNA replication 
ORClL DNA replication 
POLE2 DNA replication 
RRM2 DNA replication 
TREXl DNA replication 
HISTlHlE nucleosome assembly 
ANXA4 anti-apoptosis; signal transduction 
XAFl apoptosis 
LAMP3 cell proliferation 
MYF6 cell proliferation 
LMNBl cell communication 
OIPS cell communication 
GEMIN6 metabolism of non-coding RNA 
CHI3L2 carbohydrate metabolism 
GK carbohydrate metabolism 
GALKl carbohydrate metabolism 
SUCLA2 carbohydrate metabolism 
EPRS amino acid metabolism 
HIBCH amino acid metabolism 
PCBDl amino acid metabolism 
PSMB2 amino acid metabolism 
PSMAS amino acid metabolism 
WARS amino acid metabolism 
TKl nucleotide metabolism 
OASl nucleotide metabolism 
TYMS nucleotide metabolism 
TYMP nucleotide metabolism 
OASl nucleotide metabolism 
OAS2 nucleotide metabolism 
DHFR metabolisms of vitamins and cofactors 
CD38 metabolisms of vitamins and cofactors 
ACOT7 lipid metabolism 
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A POLl lipid metabolism 
ETNKl lipid metabolism 
FAR2 lipid metabolism 
FDXR lipid metabolism 
SLC27A2 lipid metabolism 
MANEA glycoprotein glucosylmannohydrolase activity 
IVD metabolism 
KIAA0859 metabolism 
MTlE biological process 
SPTLC2 biosynthetic process 
DHRS7B oxidation reduction 
PRDX3 oxidative reduction 
ATP6VOE1 transport (ATP hydrolysis coupled proton) 
ATP6V1D transport (ion, proton) 
PCTP transport (lipid) 
TAPl transport ( oligopeptide) 
SLC1A4 transport (glutamate/neutral amino acid) 
SLC04Al transport (ion) 
SLC6A8 transport (neurotransmitter) 
SLC13Al transport (sodium ion, sulfate) 
HBB transport (oxygen) 
AP3Dl intracellular protein transport 
HSPAlA response to stress; ATP binding 
DDX60 ATP binding 
NVL ATP binding 
GIMAP4 GTP bindig 
ESPN actin binding 
NUDTl response to oxidative stress 
TRAFDl metal ion binding; zinc binding; protein binding 
NTN2L axon guidance 
KIF4A anterograde axon cargo transport 
TUBGl microtubule cytoskeleton organization and biogenesis 
KIF14 microtubule based movement 
KIF15 microtubule based movement 
KIF18A microtubule based movement 
KIF20A microtubule based movement 
MYL6B muscle filament sliding 
AHNAK nervous system development 
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SPAG6 
CELSR3 
PXN 
RARRESl 
GPR19 
GPR107 
GPR171 
GPSM2 
ARL4C 
HMMR 
LY6E 
CCRl 
CCRS 
MRl 
AIM2 
GBPl 
IFI6 
IFI16 
IFI35 
IFI44 
IFI44L 
IFIT3 
EDN3 
TNFSFlO 
TNFRSF17 
ECT2 
STATl 
LGALS9 
IGL@ 
IGLV@ 
IGLJ3 
IGHM 
IGHGl 
IGHG3 
IGKC 
IGKVlD-13 
cell projection organization 
cell adhesion 
cell adhesion 
cell proliferation 
G-protein coupled receptor signaling pathway 
G-protein coupled receptor signaling pathway 
G-protein coupled receptor signaling pathway 
G-protein coupled receptor signaling pathway 
small GTPases mediated signal transduction 
ECM-receptor interaction 
cell surface receptor linked signal transduction 
immune and inflammatory response 
immune and inflammatory response 
immune response 
immune response 
immune response 
immune response; anti-apoptosis 
DNA damage response, signal transduction by P53 class 
mediator resulting in cell cycle arrest 
immune response 
immune response 
immune response 
immune response 
regulation of MAP kinase 
immune response; NF-kappaB and MAPK8/JNK activation 
immune response; NF-kappaB and MAPK8/JNK activation 
regulation of NF-kappaB cascade 
regulation of NF-keppa B cascade 
regulation of NF-keppa B cascade 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
IGKVlORlS-118 immune response 
I I-I 
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IGKV10R2-108 immune response 
OASL immune response 
OAS3 immune response 
CSTS thiol protease inhibitor 
MELK protein amino acid phosphorylation 
PLK4 protein amino acid phosphorylation 
CPM Proteolysis 
LXN 
perception of pain, sensory transduction of temperature 
stimulus 
FBX038 ubiqintin mediated protein catabolism 
HERC6 ubiqintin mediated protein catabolism 
USP18 ubiqintin mediated protein catabolism 
CENPA nucleosome assembly 
HJURP DNA binding 
TIMM17A protein targeting to mitochondria 
PAQR4 progestin and adipoQ receptor 
APOBEC3B biological process 
IF!Tl biological process 
IFI27 biological process 
Clorf112 open reading frame 
C3orf14 open reading frame 
C5orf42 open reading frame 
C6orf142 open reading frame 
Cllorf75 open reading frame 
C12orf48 open reading frame 
ATXN7Ll unknown 
BTN2A2 unknown 
CENPM unknown 
CLDNDl unknown 
LRPSL unknown 
NTSDC2 unknown 
PC NAP unknown 
TMEM156 unknown 
KIAAOlOl hypothetical protein 
KIAA1751 hypothetical protein 
LOC284244 hypothetical protein 
MGC5370 hypothetical protein 
MGC29506 hypothetical protein 
115 
I I 6 
MIRN650 microRNA 
EXOSC4 RNA processing 
INTS7 snRNA processing 
ASFlB transcription 
BAZlB transcription 
CARHSPl transcription 
MED18 transcription 
EZH2 transcription 
FHL2 transcription 
EYA4 transcription 
FOXMl transcription 
HOXB7 transcription 
HIVEP3 transcription 
MED8 transcription 
MLFl!P transcription 
MYBL2 transcription 
PKNOXl transcription 
POU2AF1 transcription 
SATB2 transcription 
WDHDl transcription 
WHSCl transcription 
ZBTB32 transcription 
PALM2-AKAP2 co-transcription 
MRPL35 translation 
TSFM translation 
To characterise their biological processes, gene ontology within this 
cluster was performed on all features using Entrez Gene [Maglott et al., 
2007]. This enabled us to identify 247 distinct genes that are highly 
differentially expressed in the CD4+ cells through early HIV-1 
infectious status (Table 6.4). Particularly, changes in carbohydrate, 
lipid, cofactors, vitamins, nucleotide, amino acid and non-coding RNA 
metabolisms are observed. These metabolisms require the release of 
energy, which is made available for mRNA encoding small GTPases 
and ATP proteins [Kosztin et al., 2002]. The expressions of 
interferon-induced proteins (IFI6, IFI16, IFI35, IFI44, IFI44L and 
IFIT3) are up-regulated in the CD4+ T cells through early HIV-1 
infectious status. The expressions of IgH (IGHM, IGHG1 and IGHG3), 
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117 
IgK (IGKC, IGKVlD-13, IGKV10R15-118 and IGKV10R2-108) and 
IgL (IGL@ and IGLV@) molecules are up-regulated in the CD4+ T cells 
through early HIV-1 infectious status. 
It can be observed that several genes involved in potential 
interactions with NF-kappaB activation are up-regulated in the human 
CD4+ T cells through early HIV-1 infectious status. We also observe 
changes in potential interactions with cell cycle progression through 
early HIV-1 infectious status, suggesting that early HIV-1 infection 
changes cell cycle progression in vivo promoting virus production. It 
can be observed that HIV-1 genome replication is regulated by 
topoisomerase II, alpha isozyme (TOP2A) as well. In addition, several 
genes involved in the regulation of Netrin-2 like (NTN2L) mediated 
axon guidance are up-regulated in the CD4+ T cell through early 
HIV-1 infectious status [Dickson, 2002], indicating that Netrin-2 like 
mediated axon guidance promote T cell turnover through early HIV-1 
infectious status. 
In summary, gene expression profiling identified the pathogenic 
mechanisms underlying changes in T cell function through early HIV-1 
infectious status, which include: (1) carbohydrate, lipid, cofactors, 
vitamins, nucleotide, amino acid and non-coding RNA metabolisms 
have a direct association with changes in T cell function, (2) the 
expressions of interferon-induced protein, IgH, IgK and IgL genes are 
up-regulated in the human CD4+ T cells, (3) genes involved in 
NF-kappaB activation are up-regulated in the human CD4+ T cells ( 4) 
early HIV-1 infection changes cell cycle progression in vivo promoting 
virus production, (5) Netrin-2 like mediated axon guidance promote T 
cell turnover, and (6) the transcriptional evidence that CD4+ T cells in 
early untreated HIV-1 patients are activity responsible for viral control, 
whose genome replication are regulated by DNA topoisomerase II, 
alpha isozyme (TOP2A). 
6.2.5 Chlamydia Pneumoniae Infection 
C. pneumoniae, the obligate intracellular gram-negative bacterium, 
causes acute respiratory infections in humans and mice [Yang et al., 
1993]. The normal route of entry of this bacterium is oral and nasal 
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mucosa [Rodriguez et al., 2007]. Infection with C. pneumoniae has 
been related to asthma, chronic obstructive pulmonary disease and 
also to non-respiratory disease like atherosclerosis [Ciementsen et al., 
2002; Johnston, 2002; Belland et al., 2004; Grayston, 2005]. It is 
widely distributed in the population, and up to 50 percent of the 
people of the developed world are sero-positive by the age of 20 years 
[Rodriguez et al., 2007]. Nonetheless, the host immune defense 
mechanisms triggered by C. pneumoniae are still relatively unknown. 
Although Rodriguez et al. [2007] reported that myeloid differentiation 
factor-88 (MYD88) and toll-like receptors play a critical role in 
inducing immunity against C. pneumoniae, their attempts remained 
undetermined for two reasons: 
1. Rodriguez et al. [2007] deposited their microarray data on the 
Gene Expression Omnibus under platform accession no GSE6690. 
We inspected the resulted they represented and did not find any 
clue providing evidence on the activation of toll-like receptors and 
toll like receptor signaling transduction pathway. 
2. We all know that C. pneumoniae infection is a complex disease. An 
individual gene (e.g. MYD(9) for superior intelligence probably 
does not exist as it does for C. pneumoniae infection. Instead, 
genes and gene products work together in complex and dependent 
ways to cause pathogeneses underlying C. pneumoniae infection. 
To actually find the host immune defense mechanisms underlying C. 
pneumoniae infection, the Mahalanobis distance in K-means 
clustering is used to organise microarray gene expression profiling of 
the macrophages of C57BL/6 mice after infection with C. pneumoniae. 
The data used here was available from Gene Expression Omnibus 
under platform accession no GSE6690, and this microarray 
experiment was performed by Rodriguez et al. [2007]. We consider 
thirteen group arrangements corresponding to the measured 
fluorescence intensity of the macrophages after infection with C. 
pneumoniae versus uninfected controls (Figure 6.14 ). At the finest 
level, we find that there is a cluster of 60 features that reveal 
considerable fold increase in the macrophages after infection with C. 
pneumoniae (Figure 6.15). Thus, genes within this cluster are highly 
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differentially expressed in the macrophages after infection with C. 
pneumoniae. 
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Figure 6.14 K-means clustering results of transcriptional responses in the 
macrophage of 57BL/6 mice after infection with C. pneumoniae versus uninfected 
controls (K=13). 
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Figure 6.15 A cluster of 60 features that reveal substantial fold increase in the 
macrophages of 57BL/6 mice after infection with C. pneumoniae. 
Table 6.5 Highly differentially genes in the macrophages of 57BL/6 mice after 
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infection with C. pneumoniae. 
Gene symbol Gene ontology 
Fcgr2b IgE mediated immune response; IgE binding 
Pou2f2 IgE secretion during immune response 
Lcp2 mast cell activation; cytokine secretion 
Gp49a mast cell surface glycoprotein precursor 
Ccl2 immune and inflammatory response 
Ccl3 immune and inflammatory response 
Ccl4 immune and inflammatory response 
Cell immune and inflammatory response 
Bcl6 immune and inflammatory response 
Tnf immune and inflammatory response 
Dusp16 apoptosis 
Mapkapk2 protein serine-threonine kinase activity 
Plk2 protein serine-threonine kinase activity 
Slpi protein serine-threonine kinase activity 
Ikbke immune response 
Lilrb4 immune response 
Clec4e immune response 
Gchl regulation of lung blood pressure 
Cited2 blood vessel development 
Icaml leukocyte adhesion 
Marcksll cell proliferation 
Slfn2 cell proliferation 
Myold ATP binding 
Hck ATP binding 
Abr small GTPases mediated signaling transduction 
Ankrd57 unknown 
4933426M11Rik hypothetical protein 
Tnipl translation 
Atf3 transcription 
Cebpd transcription 
E\12 transcription 
Ets2 transcription 
Tes transcription 
Zc3h12c protein binding 
Cpd proteolysis 
Gsr amino acid metabolism 
120 
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Slc2al 
Slclla2 
Hp 
Sod2 
Nfkbia 
UsplS 
Herpudl 
Bcl2alb 
Bcl2ald 
Ier3 
Phldal 
Tnfrsflb 
transport (facilitated glucose) 
transport (cobalt ion, iron ion) 
response to reactive oxygen species 
mitochondrial organization and biogenesis 
respiratory electron transport chain 
ubiquitin-mediated proteolysis; 
ubiqintin-dependent protein catabolism 
protein modification process 
apoptosis 
apoptosis 
apoptosis 
apoptosis 
apoptosis 
121 
To characterise their biological processes, we perform gene ontology 
on all features within this cluster using Entrez Gene [Maglott et al., 
2007]. This enables us to identify 49 distinct genes that are highly 
differentially expressed in the macrophages after infection with C. 
pneumoniae (Table 6.5). In particular, we observe changes in a 
cytokine (Tnf) and four chemokines (Ccl2, Ccl3, Ccl4, and Ccl7) 
through these processes. We also observe changes in ubiquitin 
proteasome. Changes in electron transport chain, response to 
reactive oxygen species (ROS) and apoptosis are also observed, 
suggesting that C. pneumoniae infection lead to the deleterious 
effects of oxygen from the metabolic reduction of the highly active 
and toxic ROS and subsequently promote endothelial damage and 
atherosclerosis [MJ Nadler and JP Kinet, 2002]. 
C. pneumoniae infection also promotes IgE secretion (Pou2f2), the 
binding of IgE to the high-affinity Fe episilon RI (Fcgr2b), and the 
activation of mast cell (Lcp2), suggesting that the binding of IgE to the 
high-affinity Fe episilon RI and the activation of mast cell promote 
allergic inflammation in the macrophages of C57BL/6 mice triggered C. 
pneumoniae. The activation of mast cell mediated via the high-affinity 
Fe episilon RI trigger the secretion of Tnf. The production of Tnf 
promotes allergic inflammation, activates endothelium as well as 
stimulates cytokines and chemokines in response to C. pneumoniae 
infection [Vivier et al., 2004; Bonnema and Leibson, 1996]. 
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Furthermore, according to the mapping onto the KEGG reference 
pathway representing the regulation of natural killer cell mediated 
cytotoxicity [Perussia, 2000], it can be observed that natural killer 
cells are activated triggering cytotoxicity, secreting cytokines and 
chemokines in the macrophages of C57BL/6 mice triggered C. 
pneumoniae. As a result, C. pneumoniae infection initiates signaling 
transduction pathway regulation NK cell activation -induced host 
immunity against this microorganism. 
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Figure 6.16 Reference KEGG pathway representing the regulation of natural 
killer cell mediated cytotoxicity [Kanehisa et al, 2002; Kanehisa et al , 2004; 
[ Kaneh1sa et al 2006; Aoki - Kinoshita and Kanehisa, 2007; Kanehisa 2008]. 
To sum up, the host immune defense mechanisms in the macrophages 
of C57BL/6 mice after infection with C. pneumoniae can be 
summarised as follows: (1) C. pneumoniae infection lead to the 
deleterious effects of oxygen from the metabolic reduction of the 
highly active and toxic reactions oxygen species, which promote 
endothelial damage and atherosclerosis, (2) changes in ubiquitin 
proteasome are observed, (3) C. pneumoniae infection initiate natural 
killer cell mediated cytotoxicity, ( 4) C. pneumoniae infection cause the 
binding of IgE to the high-affinity Fe episilon RI and the activation of 
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mast cell promoting Tnf-mediated allergic inflammation; such 
changes termed "airway remodeling" can constitute an important 
consequence of C. pneumoniae -induced asthma. 
6.2.6 Cardiac Allograft Rejection 
1:?3 
Heart and lung transplants, introduced into clinical practice in 1981, 
have been performed in over 20,000 patients worldwide for whom 
other effective medical therapy was not available [Masters et al., 
1999]. Though the administration of immunosuppressive therapy has 
enabled the early survival of cardiac transplant recipients, patients 
still have a 30 percent risk of rejecting the grafts during the first two 
years following transplantation [Masters et al., 1999; Matsui et al., 
2003]. The administration of immunosuppressive therapy also 
suppresses the immune system of patients and entails many 
problems such as infection, spontaneous neoplasm, undesirable 
metabolic effects and drug toxicity [Matsui et al., 2003]. In addition, 
there have been well revealed cases of patients requiring multiple 
transplant surgeries as their bodies reject graft after graft. 
In order to identify the injurious metabolisms responsible for this 
rejection, the Mahala nobis distance in K-means clustering algorithm is 
used to group microarray gene expression profiling of cardiac 
allografts from BALB/c to CS?BL/6 mice (Figure 6.17). The data used 
here was available from Gene Expression Omnibus under platform 
accession no GSE437, and this microarray experiment was 
implemented previously by Matsui et al [2003]. We consider thirteen 
group arrangements given by K-means clustering corresponding to 
the measured fluorescence intensity of cardiac allografts. At the finest 
level, we find that there is a cluster of 194 features that exhibit 
substantial fold increase in cardiac rejection allografts (Figure 6.18). 
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Figure 6.17 K-means clustered displayed of transcnptional response 1n cardiac 
rejectmg allografts (K= 13). 
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Figure 6.18 A cluster of 194 features that exhibit substantial fold increase in 
cardiac rejection allografts. 
Table 6.6 Highly differentially expressed gene in cardiac rejecting allografts. 
Gene Symbol Gene Ontology 
Anxal arachidonic acid secretion 
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AtpScl ion transport 
P2rx4 transport (ion) 
Adfp transport (long-chain fatty acid) 
Slc3a2 transport (amino acid) 
Slcllal transport (iron ion) 
Slc31al copper ion transport 
LaptmS transport 
Msrl transport (phosphate, lipoprotein) 
Txnl transport 
YipfS transport 
Sec61al protein transport 
Sec61b protein transport 
Gltp glycolipid transport 
Npc2 intercellular cholesterol transport 
Nasp transport; histain exchange 
Cyba 
oxidation reduction; transpport (leukocyte 
transendothelial migration) 
Cd24a chemokine transport 
Ncaml cell adhesion 
Fermt3 cell adhesion 
Selplg cell adhesion 
Tgfbi cell adhesion 
Tnc cell adhesion 
Thbsl cell adhesion; inflammatory response 
Pscdbp regulation of cell adhesion 
Emp3 cell growth 
Uck2 metabolism 
Sdcbp metabolism 
Ltb4dh metabolism 
Gpd2 carbohydrate metabolism 
Man2al carbohydrate metabolism 
Pgaml carbohydrate metabolism 
Ugdh carbohydrate metabolism 
Pdk3 carbohydrate metabolism; glucose metabolism 
Ugtla6a carbohydrate; lipid; xenobiotics 
Car2 energy metabolism (nitrogen metabolism) 
Angptl4 lipid metabolism 
Apocl lipid metabolism 
1~6 
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Grn lipid catabolism 
Pla2g4a lipid metabolism 
Pla2g7 lipid metabolism 
Ptgsl lipid metabolism 
Sptlc2 lipid metabolism 
Scdl lipid metabolism 
Ugcg lipid metabolism 
Argl amino acid metabolism 
P4hal amino acid metabolism 
Gclm amino acid metabolism 
Satl amino acid metabolism 
Dck nucleotide metabolism 
Tyms nucleotide metabolism 
Rrm2 nucleotide metabolism; oxidation reduction 
Pnpl 
nucleotide metabolism; metabolism of cofactors and 
vitamins 
Bstl metabolisms of cofactors and vitamins 
Hmoxl metabolisms of cofactors and vitamins 
Ncf2 
superoxide metabolism; NADP catabolism (leukocyte 
endothelial migration) 
Mmp13 collageniscatabolism; proteoly 
Anxa2 collagen fibrinolysis; angiogenesis; fibrinolysis 
Lyz2 cell wall catabolism; cytolysis 
Histlh2ab nucleosome assembly 
Ctsz proteolysis 
Ctsc proteolysis 
Ctsh proteolysis 
Lgmn proteolysis 
Hck amino acid phosphorylation 
Lgals3 IgE binding 
Srgn mast cell secretory granule organization and biogenesis 
Klrcl antigen processing and representation 
Hl3 antigen processing and presentation 
Procr antigen processing and presentation 
Cdldl 
antigen processing and presentation (via MHC classs 
!b) 
Fcgrl antigen processing and presentation (via MHC classs I) 
Fcgr2b antigen processing and presentation (via MHC classs II) 
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Tapbp 
Hmhal 
Iqgapl 
BireS 
ShisaS 
Adam9 
McmS 
Atf3 
Bachl 
Cebpb 
Nfil3 
Fos 
Litaf 
Lrrfipl 
Gtf2e2 
Ostfl 
Sfpil 
Tgifl 
Baspl 
Nfkbiz 
PpplrlSb 
Glrx 
Rnu35a 
Pabpcl 
H2afz 
Ssr2 
Arl6ipl 
Tpd52 
Gp49a 
Id2 
Mkrnl 
Ctla2b 
Ctla2a 
Pira3 
Cstb 
antigen processing and presentation (MHC classs I) 
antigen processing and presentation (MHC classs I); 
signal transduction; intercellular signal cascade 
small GTPases mediated signal transduction 
apoptosis 
apoptosis 
proteolysis; integrin-mediated signaling pathway 
cell cycle; transcription 
transcription 
transcription 
transcription 
transcription 
transcription 
transcription; apoptosis 
transcription 
transcription 
transcription 
transcription 
transcription 
transcription 
transcription; inflammatory response 
translation; endoplasmic reticulum overload response 
transport; cell redox homeostasis 
RNA 
mRNA processing; mRNA splicing 
chromosome organization and biogenesis; nucleosome 
assembly 
cotranslational protein targeting to membrane 
cotranslational protein targeting to membrane 
protein heterodimerization activity; protein 
homodimerization activity 
unknown 
transcription 
biological process 
biological process 
biological process 
receptor activity 
adult locomotory behavior 
12R 
128 
129 
Apbblip signal transduction 
RassfS 
signal transduction (apoptosis; cell cycle) (leukocyte 
transendothelial migration) 
Ptk2b single complex assembly 
Wsbl intercellular signaling cascade 
Cxcr4 axon guidance 
Gnai3 axon guidance 
Sema4d axon guidance 
Btgl cell migration 
Capg cell projection biogenesis 
Arhgdib Gtpase activator activity 
Rasdl small GTPases mediated signal transduction 
Actnl cortical cytoskeleton organization and biogenesis 
Csrpl actin cytoskeleton organization and biogenesis 
TmsblO actin cytoskeleton organization and biogenesis 
Kif22 microtubule-based movement 
Tubb6 microtuble-based movement 
TubbS microtubule-based process 
Wipfl actin filament based movement 
Tpml actin binding; structural constituent of cytoskeleton 
Ccl9 immune response 
Mobkllb metal ion binding 
Rnf145 metal ion binding 
Rnfl49 metal ion binding 
SlOOa4 calcium ion binding 
S100a6 calcium ion binding 
SlOOaS calcium ion binding 
S100a9 actin cytoskeleton organization; leukocyte chemotaxis; 
SlOOalO calcium ion binding 
SlOOall calcium ion binding 
Diapl actin cytoskeleton organization and biogenesis 
Rgsl6 GPCR signaling pathway 
Timpl red blood cell maturation 
Ptpnl 
insulin receptor signaling pathway; amino acid 
dephosphorylation 
Igf2bp2 regulation of cytokine biosynthesis 
G6pdx cytokine production 
Clqc complement activation; immune response 
129 
~ 
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Hp blood coagulation 
Serpinel blood coagulation 
Serpinalb blood coagulation 
Igk-V20 immune response 
Ccr5 immune response 
Il4ra immune response 
Lilrb4 immune response 
Olrl immune response 
Saa3 immune response 
Clec4a2 immune response 
Clec4d immune response 
Cd14 immune rand inflammatory response 
Tnfrsflb inflammatory response 
Lilrb3 B cell mediated immunity 
Skap2 B cell activation 
Il7r T cell differentiation 
Cd68 macrophage activation 
Cdknla cell cycle 
Cd 1 d 1 cell cycle 
Prrl3 unknown 
Tmem49 unknown 
D17H6S56E-5 unknown 
Bxdcl unknown 
Slfn4 unknown 
Slfn2 regulation of cell proliferation 
Evi2a cell proliferation 
Mki67 cell proliferation 
To characterise their biological processes, we perform gene ontology 
on all features within this cluster with the help of Entrez Gene [Maglott 
et al., 2007]. This enables us to identify 127 distinct genes that are 
up-regulated in rejecting allografts of cardiac transplants (Table 6.6). 
Thus, these 127 genes are highly differentially expressed in rejecting 
allografts of cardiac transplants. Specifically, changes in some 
chemokines (Cxcr4, Ccl9, CcrS), cytokine-related molecules (II7r, 
Tnfrsf1b, Igf2bp2 and G6pdx), leukocyte immunoglobulin-like 
receptors ((Lilrb3 and Lilrb4), and cell adhesion-related molecules 
(Ncam1, Fermt3, Pscdbp, Selplg, Tgfbi, Tnc and Thbs1) are observed; 
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these molecules play essential roles in leukocyte migration. Changes 
in complex metabolisms are also observed, including carbohydrate, 
energy, lipid, cofactors, vitamins, nucleotide and amino acid 
metabolisms. Several genes involved in transport, transcription and 
translation are also up-regulated in cardiac rejection allografts. 
It can be observed that rejecting allografts initiate complement and 
coagulation cascades promoting muscle contraction, phagocyte 
recruitment, apoptosis, T cell and B cell mediated immune responses. 
Rejecting allografts also change the MHC class I and II molecules 
(Kircl, H13, Procr, Cdldl, Fcgrl, Fcgr2b, and Tapbp), in which the 
host T cell detects "foreign" antigens in rejecting allografts are derived 
from MHC class I and II molecules. Rejecting allografts also lead to gE 
production (II4ra), IgE binding (Lgals3), the high-affinity Fe episilon 
receptors (Fcgrl and Fcgr2b) and the mast cell secretory granule 
organisation and biogenesis (Srgn), suggesting that the binding of IgE 
to the Fe episilon RI promotes allergic reaction in this rejection. 
Several genes involved in Cxcr4 and Semaphorin 4D mediated axon 
guidance are up-regulated, indicating the potential roles of Cxcr4 and 
Semaphorin 4D mediated axon guidance promote immunological 
rejection of cardiac transplants. 
In conclusion, the injurious mechanisms underlying allograft rejection 
of cardiac transplant can be summarised as follows: (1) complex 
metabolisms are involved in, including carbohydrate, energy, lipid, 
cofactors, vitamins, nucleotide and amino acid metabolisms, (2) the 
presence of leukocyte migration is found in this rejection, (3) rejection 
allografts initiate complement and coagulation cascades promoting 
muscle contraction, phagocyte recruitment, apoptosis, T cell and B 
cell mediated immune responses, (4) the host T cell which detected 
"foreign" antigen in rejection allografts is derived from MHC class I 
and II molecules, and (5) rejection allografts lead to the binding of IgE 
to the high-affinity Fe episilon RI promoting allergic reaction, and (5) 
Cxcr4 and Sema6D mediated axon guidance promote immunological 
rejection of cardiac transplants. As a result, the blockade of individual 
pathways generally does not prevent allograft rejection and long-term 
survival is achieved only after the simultaneous blockade of all of 
them. 
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6.2.7 Kidney Allograft Rejection 
Kidney transplants, since the first successful transplant in 1954, have 
now extended and improved the quality of life for the majority of 
patients with end stage renal diseases [Andrew, 2002; Flechner et al., 
2004]. While the administration of immunosuppressive therapy has 
enabled the survival of kidney transplant recipients, these drugs 
suppress the immune system of patients and entail many problems 
such as infection, spontaneous neoplasm, undesirable metabolic 
effects and drug toxicity [Matsui et al., 2003]. 
To know the injurious mechanisms underlying kidney allograft 
rejection, the Mahalanobis distance in K-means clustering is used to 
arrange microarray gene expression profiling of kidney biopsies and 
peripheral blood lymphocytes in transplant patients including normal 
donor kidneys, well-functioning transplant without rejection, kidneys 
undergoing acute rejection and transplants with renal dysfunction 
without rejection (Figure 6.19). The data used here was available 
from Gene Expression Omnibus under platform accession no 
GSE1563, and this microarray experiment was implemented 
previously by Flecher et al [2005]. We consider fifteen group 
arrangements given by K-means clustering corresponding to the 
measured fluorescence intensity of kidney biopsies and peripheral 
blood lymphocytes. At the finest level, we find that there is a cluster of 
158 features that exhibit substantial fold increase in kidney biopsies 
undergoing acute rejection (Figure 6.20). 
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Figure 6.19 K-means clustering results of microarray gene expression profiling 
in kidney biopsies and peripheral blood lymphocytes from transplant patients 
including normal donor kidneys, well-functioning transplants without rejection, 
kidneys undergoing acute rejection, transplants with renal dysfunction without 
rejection. 
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Figure 6.20 A cluster of 158 features that exhibit substantial fold increase in 
kidney biopsies from transplant patients undergoing acute rejection. 
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Table 6.7 Highly differentially expressed genes in kidney biopsies from transplant 
patients undergoing acute rejection. 
Gene symbol Gene ontology 
AKR7 A2 carbohydrate metabolism 
FBPl carbohydrate metabolism 
FUCAl 
IMPA2 
IDHl 
IDH2 
MDHl 
SDHC 
UGDH 
ALDH2 
ALDH9Al 
GOTl 
QDPR 
GLUD2 
GLS 
GOT2 
OAT 
SEPHS2 
IARS 
CYBSA 
AKRlAl 
ACAAl 
ACAA2 
ACADSB 
ADHS 
ALDH3A2 
CLU 
GPX4 
HADH 
HADHB 
ANXA7 
PEX3 
ABCD3 
ATPSH 
ATPSJ 
carbohydrate metabolism 
carbohydrate metabolism 
carbohydrate metabolism 
carbohydrate metabolism 
carbohydrate metabolism 
carbohydrate metabolism 
carbohydrate metabolism 
carbohydrate metabolism; amino acid metabolism 
amino acid metabolism 
amino acid metabolism 
amino acid metabolism 
amino acid metabolism 
amino acid metabolism 
amino acid metabolism 
amino acid metabolism 
amino acid metabolism 
amino acid metabolism 
metabolisms of cofactors and vitamins 
lipid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism; amino acid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism 
calcium dependent phospholipid binding 
peroxisome organization and biogenesis 
peroxisome organization and biogenesis 
nucleotide metabolism 
nucleotide metabolism 
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ATPSO nucleotide metabolism 
ATP5Al nucleotide metabolism 
ATP5Cl nucleotide metabolism 
ATP5J2 nucleotide metabolism 
TXN nucleotide metabolism 
PON2 xenobiotics degradation 
PAM peptide metabolism 
NDUFA2 mitochondrial electron transport, NADH to ubiquinone 
NDUFAS mitochondrial electron transport, NADH to ubiquinone 
NDUFBS mitochondrial electron transport, NADH to ubiquinone 
NDUFS4 mitochondrial electron transport, NADH to ubiquinone 
NDUFAFl mitochondrial electron transport, NADH to ubiquinone 
PRDXl hydrogen peroxide catabolism 
PRDX2 response to oxidative stress 
PRDX3 hydrogen peroxide catabolism 
PRDX4 oxidation reduction 
HSP90AB1 regulation of nitric oxide biosynthesis process 
SURFl aerobic respiratory 
BNIP3 oxygen and reactive oxygen species metabolism 
NDUFSl oxygen and reactive oxygen species metabolism 
HSPDl protein transport into mitochondrial matrix 
SKPl ubiquitin mediated proteolysis 
UBAl ubiquitin mediated proteolysis 
UQCRQ ubiquitin mediated proteolysis 
CTSLl proteolysis 
CTSH proteolysis 
COX SA electron transport chain 
COX6Al electron transport chain 
COX6C electron transport chain 
COX7B electron transport chain 
ATP5G3 ATP synthesis coupled proton transport 
ATP6V1A ATP biosynthesis process 
VT!lB vehicle mediated transport 
GM2A transport (lipid) 
SLC25A4 transport (ATP) 
ATP6VOE1 transport (ion, protein) 
PKD2 transport (calcium ion) 
LAPTM4A transport 
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LAPTM4B transport 
DDBl DNA repair 
MSH3 base-excision repair; mismatch repair 
MRPS18B translation 
EARS2 translation 
CANX protein folding 
CTAGES protein folding 
FKBP2 protein folding 
HSPEl protein folding 
ST13 protein folding 
TN POl protein import into nucleus 
SARS tRNA processing 
SNRPN RNA splicing 
!Dl transcription 
ZNF117 transcription 
ZBTB20 transcription 
MORF4L2 transcription 
HOXD4 transcription 
ESD biological process 
REEPS biological process 
CFDPl biological process 
TRIM2 biological process 
MTlB biological process 
MTlE biological process 
MTlF biological process 
MTlH biological process 
FAM171Al unknown 
MXRA7 unknown 
TMEM59 unknown 
C5orf13 open reading frame 
C6orf108 open reading frame 
PGRMCl axon guidance 
DSTN actin filament severing 
PFN2 actin cytoskeleton organization and biosynthesis 
DYNLLl actin cytoskeleton organization and biosynthesis 
PRKCI 
actin cytoskeleton organization and biosynthesis; 
signaling by NGF 
RTN4 regulation of axon extension; signaling by NGF 
ll? 
RTN4 
DUSP3 
PALLD 
CAPRINl 
CTNNAl 
GDI2 
KRITl 
RIN2 
FGF9 
ANXA4 
PRKARlA 
FCGRT 
SODl 
CD9 
CD63 
AQP3 
CD46 
SERPINGl 
TNFSFlO 
AIFMl 
ACTAl 
SERPINE2 
APP 
APLP2 
ITIHSL 
PEBPl 
Regulation of axon guidance; signaling by NGF 
signaling by NGF 
cytoskeleton organization and biosynthesis 
cell projection 
establishment of cell polarity 
regulation of GTPases activity 
small GTPases mediated signaling transduction 
small GTPases mediated signaling transduction 
signal transduction 
signal transduction 
signal transduction 
lgE binding; antigen processing and presentation 
hemostasis 
hemostasis 
hemostasis 
regulation of immune system process 
complement activation, classical pathway 
complement activation, classical pathway 
immune response; apoptosis 
apoptosis 
muscle contraction 
serine proteinase inhibitor activity 
serine proteinase inhibitor activity 
serine proteinase inhibitor activity 
serine proteinase inhibitor activity 
serine proteinase inhibitor activity 
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To characterise their biological processes, we perform gene ontology 
on all features within this cluster with the help of Entrez Gene [Maglott 
et al., 2007]. This enables us to identify 135 distinct genes that are 
up-regulated in kidney biopsies from transplant patients undergoing 
acute rejection (Table 6. 7). Thus, those 135 genes are highly 
differentially expressed in kidneys from transplant patients 
undergoing acute rejection. In particular, changes in complex 
metabolisms are observed, including carbohydrate, lipid, cofactors, 
vitamins, xenobiotics, nucleotide and amino acid metabolisms. These 
metabolisms require the release of energy, which is made available 
from mRNA encoding small GTPases and ATP protein [Kosztin et al., 
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2002). Changes in oxygen and reactive oxygen species metabolisms 
are also observed. Several genes involved in potential interactions 
with electron transport chain and ubiquitin proteasome are 
up-regulated, suggesting rejecting allografts cause the deleterious 
effects of oxygen from the metabolic reduction of the highly active 
and toxic reactive oxygen species promoting endothelial damage and 
atherosclerosis. Several genes involved in transport, transcription and 
translation are up-regulated in rejection allografts as well. 
It can be observed that rejecting allografts initiate classical pathways 
of complement cascades promoting muscle contraction, hemostasis, 
immune and inflammatory responses [Bhold and Stahl, 2003; 
Turn berg and Motto, 2003]. Rejecting allografts also promote the 
binding of IgE to the high-affintiy Fe episilon RI promoting allergic 
reactions in this rejection [Draft and Novak, 2006]. Furthermore, 
rejecting allografts lead to progesterone receptor membrane protein 
(PGRMC1), a putative steroid membrane receptor expressed in the 
liver and kidney, mediated axon guidance promoting immunological 
rejection of kidney transplants. 
In conclusion, the injurious metabolisms underlying allograft rejection 
of kidney transplants can be summarised as follows: (1) complex 
carbohydrate, lipid, cofactors, vitamins, xenobiotics, nucleotide and 
amino acid metabolisms are involved in, (2) rejection allografts cause 
the deleterious effect of oxygen from the metabolic reduction of the 
reactive oxygen species promoting endothelial damage and 
atherosclerosis, (3) rejecting allografts initiate classical pathway of 
complement cascades promoting muscle contraction, hemostasis, 
immune and inflammatory responses, ( 4) rejecting allografts lead to 
the binding of IgE to the high-affinity Fe episilon RI promoting allergic 
reactions, and (5) rejecting allografts lead to progesterone receptor 
membrane protein (PGRMC1) mediated axon guidance promoting 
immunological rejection of kidney transplants. 
6.2.8 Human Endometrial Receptivity throughout the 
Menstrual Cycle 
The human endometrium, the anatomic prerequisite for establishing 
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and sustaining pregnancy, undergoes remarkable histological 
changes throughout the menstrual cycle, in preparation for embryonic 
implantation and subsequent shedding and regeneration in 
non-conception cycle [Taibi et al., 2006]. The differential histological 
appearance of this tissue was first described by Hitschmann and Adler 
[1908], and since the publication of the paper by Noyes eta!. [1950], 
it has been understood that endometrial histology correlates with the 
changes in the circulating of estradiol and progesterone. Based on an 
ideal 28-day cycle, Noyes et al. [1950] described distinct histological 
phases, which are known as proliferative, early-secretory, 
mid-secretory and late-secretory phases of the menstrual cycle. 
While histological criteria described by Noyes et a!. [ 1950] has 
r-emained the gold standard for more than 50 years in clinical 
diagnosis and management of women with endometrial disorders, 
substantial evidence has claimed the accuracy of such criteria [Taibi et 
al., 2006]. Recently, the usefulness of histological dating of the 
endometrium for couples with infertility has been addressed since 
histological delay in endometrial maturation fails to discriminate 
between fertile and infertile couples [Giudice and Feerenczy, 1996; 
Taibi et al., 2006]. In another recent study, histological features fail to 
reliably distinguish between specific menstrual cycle days and narrow 
intervals of days, leading to the conclusion that histological dating has 
neither the accuracy nor the precision to the useful in clinical practice 
[Taibi et al., 2006]. 
To search for biochemical signatures for the endometrium that may 
prove to be more useful, the Mahalanobis distance in Ward's linkage 
hierarchical clustering algorithm is used to group microarray gene 
expression profiling of the human endometrium at early-secretory, 
mid-secretory and late-secretory phases during the menstrual cycle 
(Figure 6.21). The data used here was available at Gene Expression 
Omnibus under platform accession no GSE4888 and this microarray 
experiment was implemented previously by Taibi et al [2006]. At the 
finest level, we find that there is a cluster of 209 features that are 
up-regulated in the endometrium at mid-secretory phase, moderately 
expressed for those at late-secretory phase, and down-regulated for 
those at early-secretory phase (Figure 6.22). 
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Figure 6.21 Clustering results of microarray gene expression profiles in the 
human endometriosis at early-secretory, mid-secretory, and late-secretory 
phases throughout the menstrual cycle. 
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Figure 6.22 A cluster of 209 features that are up-regulated in the endometrium at mid-secretory phase, moderately expressed for 
those at late-secretory phase, and down-regulated for those at early-secretory phase. 
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TABLE 6.8 Diagnostic discriminating genes whose expressions are up-regulated 
in the endometrium at mid-secretory phase, moderately expressed for those at 
late-secretory phase, and down-regulated for those at early-secretory phase. 
Gene symbol Gene ontology 
ANG ovarian follicle development 
ANXA4 
IER3 
SGKl 
AMIG02 
MUC16 
CLDN4 
COMP 
HABP2 
LAMB3 
SPPl 
CATSPERB 
RARRESl 
GADD45A 
LEFTYl 
EFNAl 
MET 
DNER 
EDNRB 
SlOOP 
SYNE2 
KRT7 
CRYAB 
GABARAPLl 
GABARAPL3 
DPP4 
PTPRR 
TSPANS 
MUC20 
C3 
C4BPA 
SERPINGl 
THBD 
CDSS 
apoptosis 
apoptosis 
apoptosis 
cell adhesion 
cell adhesion 
cell adhesion 
cell adhesion 
cell adhesion 
cell adhesion 
cell adhesion 
cell differentiation 
cell differentiation 
cell cycle 
cell growth 
axon guidance 
axon guidance 
neuron migration 
neural crest cell migration 
endothelial cell migration 
actin binding 
cytoskeleton reorganization and biogenesis 
muscle contraction 
autophagy 
autophagy 
proteolysis 
amino acid phosphorylation 
amino acid glycosylation 
protein homooligomer assembly 
immune response; blood coagulation 
immune response; blood coagulation 
immune response; blood coagulation 
immune response; blood coagulation 
immune response; complement activation 
143 
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CFD immune response; complement activation 
GBP2 immune response 
CXCL14 immune response 
ILlS immune response 
CRISP3 immune response 
DEFBl immune response 
CLEC4E immune response 
BCL6 immune response 
PAPLN serine-type endopeptidase inhibitor activity 
SLPI serine-type endopeptidase inhibitor activity 
GDF15 signal transduction 
GPRllO signal transduction 
RHPN2 signal transduction 
DEPDC6 intercellular signaling cascade 
MAP3K5 MAPKKK cascade 
DKKl down regulation of frizzled signaling pathway 
ARIDSB transcription 
ELL2 transcription 
FOXOl transcription 
CITED2 transcription 
CEBPD transcription 
KLF6 transcription 
NFIL3 transcription 
PAX8 transcription 
FOSL2 transcription 
NFKBIZ transcription 
IRX3 transcription 
MYOCD transcription 
FAM3C biological process 
SCGB2A2 biological process 
HRASLS3 biological process 
GRAMDlC unknown 
MUMlll unknown 
PHYHIPL unknown 
SESTDl unknown 
RAD21Ll unknown 
ClOorflO open reading frame 
C21org63 open reading frame 
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RNASE4 mRNA cleavage 
FAM84B hypothetical protein 
FAM134B hypothetical protein 
FAM149A hypothetical protein 
TC2N calcium binding 
STCl calcium ion homeostasis 
NDRGl response to metal ion 
LIM 53 metal ion binding 
MT2A metal ion binding 
MTlE metal ion binding 
MTlF metal ion binding 
MTlM metal ion binding 
MTlG metal ion binding 
MTlH metal ion binding 
MTlX metal ion binding 
GCNT3 carbohydrate metabolism 
IRS2 glucose metabolism 
ALDH1A3 lipid metabolism 
APOD lipid metabolism 
SOD2 lipid metabolism 
SRD5A3 lipid metabolism 
CP cofactors and vitamins metabolism 
INDO cofactors and vitamins metabolism 
NNMT cofactors and vitamins metabolism 
VNNl cofactors and vitamins metabolism 
AOXl amino acid metabolism 
ARG2 amino acid metabolism 
GPX3 amino acid metabolism 
MGSTl amino acid metabolism 
MAOA amino acid metabolism 
HAL amino acid metabolism 
GNLY xenobiotics metabolism 
RDHlO oxidation reduction 
IN DOLl oxidation reduction 
ABCC3 transport 
PAEP transport 
MFSD4 transport 
RBP4 transport 
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TRPMS 
SCARAS 
SLC15Al 
SLC15A4 
SLC16A3 
SLC18A2 
SLC44A4 
SLClAl 
SLC3Al 
SLC4Al 
SLC7A2 
SLC30A2 
SLC38Al 
TMEM37 
GABRE 
TCNl 
transport (ion) 
transport (phosphate) 
transport ( oligopeptide) 
transport ( oligopeptide) 
transport (monocarboxylic acid) 
transport (monoamine) 
transport (choline) 
transport (L-glutamate, dicarboxylic acid) 
transport (amino acid) 
transport (anion) 
transport (L-amino acid) 
transport (cation, zinc ion) 
transport (neutral amino acid) 
transport (calcium ion) 
transport (ion) 
transport (cobalt ion, cobalamin) 
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To identify their biological processes, gene ontology within this cluster 
is perform on all features with the help of Entrez Gene [Maglott et al., 
2007]. This enables us to identify 127 distinct genes that are 
up-regulated in the endometrium at mid-secretory phase, moderately 
expressed for those at late-secretory phase, and down-regulated for 
those at early-secretory phase. Thus, those 127 genes naturally 
classify tissues into three distinct phases, those at early-secretory, 
mid-secretory and late-secretory phases (Table 6.8). In particular, the 
nature of genes involved in ovarian follicle development (ANG), 
apoptosis (ANXA4, IER3 and SGK1), cell adhesion (AMIG02, CLDN4, 
COMP, HABP2, LAMB3, MUC16 and SPP1), cell differentiation and 
growth (CATSPERB, RARRES1 and GADD45A) are altered throughout 
the menstrual cycle. Changes involved in complex metabolisms are 
observed, including carbohydrate, glucose, lipid, cofactors, vitamins, 
xenobiotics and amino acid metabolisms, at mid-secretory phase, 
suggesting the presence of extracellular remodeling at mid-secretory 
phases. These metabolisms require the release of energy, which was 
made available for mRNA encoding small GTPases and ATP protein 
[Kosztin et al., 2002]. Two genes involved in vehicle explanation and 
completion intended for autophagy (GABARAPLl, GABARAPL3) are 
up-regulated in the endometrium at mid-secretory phase, moderately 
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expressed for those at late-secretory phase and down-regulated for 
those at early-secretory phase [Kiionsky and Emr, 2000; Bechet et al., 
2005], suggesting that autophagic degradation is the mechanism 
responsible for new blood vessel formation in the human 
endometrium throughout the menstrual cycle. 
It can be observed that several genes involved in potential 
interactions with complement and coagulation cascades are 
up-regulated in the endometrium at mid-secretory phase, moderately 
expressed for those at late-secretory phase and down-regulated for 
those at early-secretory phase, which subsequently promoted muscle 
contraction, chemotaxis, phagocyte recruitment and peritoneal 
inflammation [Bhold and Stahl, 2003; Turn berg and Botto, 2003]. 
Several genes involved in potential interactions with Ephrin A 
mediated axon guidance are up-regulated in the endometrium at 
mid-secretory phase, moderately expressed for those at 
late-secretory phase and down-regulated for those at late-secretory 
phase, indicating that Ephrin A mediated axon reflexes promoting 
retrograde menstruation at mid-secretory phase. In addition, DKKl, a 
gene involved in the regulation of the WNT receptor signaling pathway, 
is up-regulated in the endometrium at mid-secretory phase, 
moderately expressed for those at late-secretory phase and 
down-regulated for those at late-secretory phase, suggesting that 
WNT receptor signaling pathway may play a role in the progress of 
endometrial disorders. 
In conclusion, the biological mechanisms implicated in the human 
endometrium at mid-secretory phase can be summarised as follows: 
( 1) complex metabolisms, including carbohydrate, glucose, lipid, 
cofactors, vitamins, xenobiotics and amino acid metabolisms, are 
involved in, (2) the initiation of complement and coagulation cascades 
promote muscle contraction, chemotaxis, phagocyte recruitment and 
peritoneal inflammation, (3) the occurrence of Ephrin A mediated 
axon guidance promote retrograde menstruation, ( 4) autophagy is 
the mechanism responsible for the new blood vessel formation, and (5) 
WNT receptor signaling pathway may contribute to the development 
of endometrial disorders. 
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6.2.9 Ovarian Endometriosis 
Endometriosis, adenomysis and uterine fibroids represent the most 
widespread benign gynecological diseases in reproductive age and are 
collectively responsible for significant morbidity [Hever et al., 2007]. 
Endometriosis is associated with pain and other discomfort and plays 
a role in infertility [Berkeley et al., 2005]. Despite its high prevalence, 
the pathogenic mechanisms underlying endometriosis is relatively 
unknown. Diagnosis of endometriosis is also difficult, relying on 
symptoms, and laparoscopy examination being the only definitive 
confirmation [Hever et al., 2007]. Since the latter one is a surgical 
procedure, the diagnosis and subsequent treatment of endometriosis 
are usually delayed [Brosens et al., 2003]. Treatment options for 
endometriosis include surgery and/or suppression of ovarian steroids 
[Hever et al., 2007]. However, these strategies offer only temporary 
relief since the disease usually recurs [Hever et al., 2007]. 
To recognise the pathogenic mechanisms of ovarian endometriosis, 
the Mahalanobis disease in Ward's linkage hierarchical clustering is 
used to organise microarray gene expression profiling of ovarian 
endometriosis lesions corresponding to normal endometrial tissues 
obtained from the same patient at the same time (Figure 6.23). The 
data used here was available from Gene Expression Omnibus under 
platform accession no GSE7305, and this microarray experiment was 
performed by Hever et al [2007]. At the finest level, we find that there 
is a cluster of 293 features that reveal substantial fold increase in 
endometriosis lesions (Figure 6.24 ). Thus, genes within this cluster 
are highly differentially expressed in endometriosis lesions. 
r-
Figure 6.23 Clustering results of mrcroarray gene expression profiles in ovarian 
endometriosis lesions corresponding to normal endometrial tissues obtained from 
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Figure 6.24 A cluster of 293 features that reveal substantial fold increase in ovarian endometriosis lesions corresponding to normal 
endometrial tissues obtained from the same patient at the same time. 
150 
Table 6.9 Highly differentially expressed genes associated with ovarian 
endometriosis lesions. 
Gene symbol 
FOXCl 
OSAP 
GNG4 
GPC3 
LXN 
FRZB 
FZD7 
WISP2 
SFRP2 
TGFBR3 
FST 
ABL!Ml 
ARX 
CHLl 
NRP2 
NTN2L 
SEMA6D 
CLDNll 
SYNPO 
NEXN 
PROKl 
SCG2 
NTRK2 
ITPRl 
LMODl 
CALDl 
MYHll 
DMD 
TAGLN 
PRELP 
MEG3 
PEGlO 
PEG3 
Gene ontology 
ovarian follicle development 
ovary-specific protein 
hormone mediated signaling 
embryogenesis and morphogenesis 
perception of pain 
Wnt receptor signaling pathway 
Wnt receptor signaling pathway 
Wnt receptor signaling pathway 
Wnt receptor signaling pathway 
TGF-beta receptor signaling pathway 
TGF-beta receptor signaling pathway 
axon guidance 
axon guidance 
axon guidance 
axon guidance 
axon guidance 
axon guidance 
axon ensheathment 
cell projection 
regulation of cell migration; regulation of cytoskeleton 
reorganization and biogenesis 
activation of MAPK 
MAPKKK cascade 
signaling by NGF 
signaling by NGF 
tropomyosin binding 
cell motility 
muscle contraction 
muscle development 
muscle development 
skeletal development 
apoptosis 
apoptosis 
apoptosis 
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PRKAR2B apoptosis 
ITPRl apoptosis 
COON cell adhesion 
ITGBLl cell adhesion 
NCAMl cell adhesion 
NEGRl cell adhesion 
VCAMl cell adhesion 
COH3 cell adhesion 
CPXM2 cell adhesion 
NCAMl cell adhesion 
NFASC cell adhesion 
PPFIBPl cell adhesion 
SIGLECll cell adhesion 
THBS2 cell adhesion 
FLRT3 cell adhesion 
ECM2 cell-matrix adhesion 
SGCE cell-matrix adhesion 
ANGPTl cell differentiation 
TMEM176B cell differentiation 
POGFD cell proliferation 
RARRESl cell proliferation 
GPNMB cell proliferation 
TIMPl cell proliferation 
GASl cell cycle 
RGS2 cell cycle 
NOEl cell cycle 
AEBPl transcription 
BNC2 transcription 
ZFPM2 transcription 
NR4A3 transcription 
HOXC6 transcription 
LHX9 transcription 
MYOCO transcription 
MKX transcription 
FHL2 transcription 
KLF2 transcription 
PBX3 transcription 
TCF21 transcription 
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GATA4 
GATA6 
PDLIM3 
NRK 
ZNF521 
RNASE4 
RBMS3 
FAM129A 
MATN2 
SH3D19 
M85256 
Cl0orf116 
ClOorflO 
ITM2A 
GPM6A 
FAM70A 
KLHDC8A 
CCDC3 
CCDC80 
ABI3BP 
MEG3 
CLIP4 
FIB IN 
PLCXD3 
ST7L 
ANG 
DLKl 
PLSCR4 
PR0 51 
SERPINE2 
SERPINGl 
ClR 
C3 
C4A 
C4B 
C7 
CFH 
CFHRl 
transcription 
transcription 
transcription 
transcription 
transcription 
mRNA cleavage 
RNA binding; nucleotide binding 
biological process 
biological process 
biological process 
hypothetical protein 
open reading frame 
open reading frame 
unknown 
unknown 
unknown 
unknown 
unknown 
unknown 
unknown 
unknown 
unknown 
unknown 
unknown 
unknown 
multicellular organismal development 
multicellular organismal development 
blood coagulation 
blood coagulation 
blood coagulation; complement activation (classical pathway) 
blood coagulation; complement activation (classical pathway) 
complement activation; immune response 
complement activation; immune response 
complement activation; immune response 
complement activation; immune response 
complement activation; immune response 
complement activation; immune response 
complement activation 
1.":1 
153 
CLU 
LY96 
IGL@ 
IGLVl-44 
IGLV@ 
IGHG3 
IGKC 
IGLJ3 
IGHGl 
IGKC 
IGHM 
CCL2 
FAM19A2 
CD163 
TNFSF13B 
BST2 
SERPINA3 
PGMS 
PDK4 
CHI3Ll 
FABP4 
PLA2G2A 
PLA2G2F 
STAR 
HSDllBl 
PTGIS 
ENPP6 
ADHlB 
GPX3 
AOC3 
AOXl 
GATM 
INMT 
ST6GALNAC5 
NNMT 
DPYSL3 
complement activation; classical pathway 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response; activation of MAPK; B-cell receptor 
signaling pathway 
immune and inflammatory response 
immune and inflammatory response 
inflammatory response 
B cell costimulation T cell costimulation 
immune response; B-cell activation 
inflammatory response 
carbohydrate metabolism; glucose metabolism 
carbohydrate metabolism; glucose metabolism 
carbohydrate metabolism 
lipid metabolism; cholesterol homeostasis 
lipid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism 
lipid metabolism; amino acid metabolism; ethanol oxidation; 
oxidative reduction 
amino acid metabolism 
amino acid metabolism 
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amino acid metabolism; metabolisms of cofactors and vitamins 
amino acid metabolism 
amino acid metabolism 
amino acid glycosylation 
metabooisms of cofactors and vitamins 
nucleotide metabolism 
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DHRS2 
CSGALNACTl 
HS3ST1 
DSE 
HS6ST2 
PTPRZl 
FM02 
FMOl 
MSRB3 
TSPANS 
LRRC2 
SDPR 
CPVL 
PRSS35 
MRCl 
LTBP2 
DIRAS3 
CYBRDl 
ABCAS 
ABCA6 
COLECll 
COL10Al 
SCN7A 
SLC16A4 
ABCA9 
ACTG2 
PDLIM3 
EFEMPl 
PLN 
RCAN2 
RERGL 
SYTL2 
AKAP12 
ANGPTLl 
RERG 
FGF7 
PNOC 
xenobiotics metabolism 
glycan biosynthesis and metabolism 
glycan biosynthesis and metabolism 
glycan biosynsis 
transferace activity 
one-carbon compound metabolism 
reactive oxidative species metabolism; oxidative reduction 
oxidation reduction 
oxidation reduction 
amino acid glycosylation 
protein binding 
protein binding 
proteolysis 
proteolysis 
receptor-mediated endocytosis 
protein secretion; protein targeting 
genetic imprinting; regulation of cyclin-dependent protein 
kinase activity 
transport; electron transport chain 
transport 
transport (ABC) 
transport (phosphate) 
transport (phosphate) 
transport (sodium ion) 
transport (monocarboxylic acid) 
transport 
ATP binding; protein binding 
metal ion binding; zinc binding; protein binding 
calcium ion binding; protein binding 
cellular calcium ion homeostasis 
calcium-mediated signaling transduction 
small GTPases mediated signaling transduction 
Rab GTPase binding 
signal transduction 
signal transduction 
signal transduction 
signal transduction 
signal transduction 
I .5:' 
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TGFBR3 
MS4A4A 
MS4A7 
CHN2 
signal transduction 
signal transduction 
signal transduction 
intercellular signaling cascade 
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To characterise their biological processes, gene ontology within this 
cluster is perform on all features using Entrez Gene [Maglott et al., 
2007]. This enables us to identify 185 distinct genes that are highly 
differentially expressed in ovarian endometriosis lesions (Table 6.9). 
In particular, the nature of genes involved in ovarian follicle 
development (FOXCl), apoptosis (MEG3, PEG3, PEG10, PRKAR2B and 
ITPRl), cell adhesion (CDON, ITGBLl, NCAMl, NEGRl, VCAMl, CDH3, 
CPXM2, NCAMl, NFASC, PPFIBPl, SIGLEC11, THBS2 and FLRT3), 
cell-matrix adhesion (ECM2 and ECM2), cell differentiation (ANGPTl 
and TMEM176B), cell proliferation (GPNMB, PDGFD, RARRESl and 
TIMPl) and cell cycle (GAS1JNDE1 and RGS2) have been altered 
through these processes. The expressions of IgH (IGHG3, IGHGl and 
IGHM), IgK (IGKC and IGKC) and Igl (IGL@, IGLVl-44, IGLV@ and 
IGLJ3) molecules are also up-regulated in ovarian endometriosis 
lesions. Changes in complex metabolisms are also observed, including 
carbohydrate, glucose, lipid, cofactors, vitamins, xenobiotics and 
amino acid metabolisms. These metabolisms require the release of 
energy, which is made available from mRNA encoding small GTPases 
and ATP motor proteins [Kosztin et al., 2002]. 
It can be observed that several genes involved in potential 
interactions with complement and coagulation cascades are activated 
in ovarian endometriosis lesions promoting muscle contraction, 
phagocyte recruitment, T cell and B cell mediated immune responses 
[Holers, 2008; Klaska and Nowak, 2007]. Several genes involved in 
WNT receptor signaling pathway (FRZB, FZD7, WISP2 and SFRP2) 
and TGF-beta receptor signaling pathway (FST and TGFBR3) are 
up-regulated in ovarian endometriosis lesions, suggesting the 
potential roles of WNT and TGF-beta receptor signaling pathways 
involved in the development of endometriosis. In addition, several 
genes involved in potential interactions with Netrin2 like (NTN2L) and 
Semaphorin 6D (SEMA6D) mediated axon guidance are up-regulated 
[Dickson, 2002], suggesting that Netrin2 like and Semaphorin 6D 
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mediated axon guidance promoting retrograde menstruation in 
endometriosis. 
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In summary, the pathogenic mechanisms of ovarian endometriosis 
can be summarised as follows: (1) complex metabolic reactions, 
including carbohydrate, glucose, lipid, cofactors, vitamins, 
xenobiotics, nucleotide and amino acid metabolisms are involved, (2) 
complement and coagulation cascades are activated in ovarian 
endometriosis lesions promoting muscle contraction, phagocyte 
recruitment, T cell and B cell mediated immune responses, (3) WNT 
and TGF-bet receptor signaling pathways are participated in the 
development of ovarian endometriosis, and ( 4) Netrin-2 like and 
Semaphorin 6D mediated axon guidance promoting retrograde 
menstruation in ovarian endometriosis. 
6.2.10 Inflammatory Acne 
Acne is the most widespread skin condition affecting millions of people 
worldwide [Trivedi et al., 2006]. The pathogenesis of acne vulgaris is 
complex and incompletely understood [Trivedi et al., 2006]. 
Inflammation is a key component of the pathogenesis of acne [Trivedi 
et al., 2006]. An immunological reaction to the Gram-positive microbe 
Propionibacterium acnes may play a major role in the initiation of the 
inflammatory reaction [De Young et al., 1984; Jappe, et al, 2002]. 
Furthermore, viable P.acnes and not heat-killed organisms can 
stimulate the release of cytokines [Schroder, 2004]. While the 
initiating events causing acne still remain a mystery, there exists a 
debate as to whether hyperkeratinisation of the follicular duct 
precedes the influx of inflammatory cells or vice versa [Trivedi et al., 
2006]. 
To know the pathogenic mechanisms underlying inflammatory acnes, 
the Mahalanobis distance in the K-means clustering algorithm is used 
to group microarray gene expression profiling of inflammatory 
papules corresponding to normal skin biopsies. The data used here 
was available from Gene Expression Omnibus under platform 
accession no GSE6475, and this microarray experiment was 
implemented by Trivedi et al [2006]. We consider nine group 
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arrangements given by K-means clustering corresponding to the 
measured fluorescence intensity of inflammatory acnes versus 
normal skin biopsies (Figure 6.25). At the finest level, we find that 
there is a cluster of 60 features that reveal considerable fold increase 
in inflammatory papules (Figure 6.26). 
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Figure 6.25 K-means clustered display of microarray gene expression profiles in 
inflammatory papules corresponding to normal skin biopsies (K=9). 
Figure 6.26 A cluster of 60 features that reveal considerable fold increase in 
inflammatory papules from acne patients corresponding to normal skin biopsies. 
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TABLE 6.10 Highly differentially expressed genes in inflammatory acne. 
Gene symbol Gene Ontology 
IFI30 antigen process and representation (MHC class II) 
SRGN 
FCGR3B 
PLA2G2A 
PI3 
DDX3Y 
ElF lAY 
RPS4Yl 
BCL2Al 
GZMB 
FCNl 
TCNl 
APOBEC3A 
AKRlBlO 
NNMT 
MMP3 
MMPl 
MMPlO 
MMP12 
SPRR2D 
KRT16 
ADAMDECl 
SELL 
SPPl 
SELE 
SERPINAl 
SERPINB3 
SERPINB4 
ILS 
CXCLl 
CCL3 
CXCL13 
CXCL2 
LILRB2 
S100A7 
SlOOA9 
T-cell secretory granule organization and biogenesis 
IgE binding; 
Fe episilon RI signaling transduction pathway 
copulation 
DNA binding 
translation 
translation 
apoptosis 
apoptosis 
transport (phosphate) 
transport (colbalamin ; cobalt ion) 
xenobiotics biodegradation 
amino acid metabolism 
metabolisms of cofactors and vitamins 
metabolism 
metabolism 
metabolism 
metabolism 
epidermis development 
epidermis development 
integrin-mediated mediated pathway 
cell adhesion 
cell adhesion 
cell adhesion 
blood coagulation 
blood coagulation 
blood coagulation 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
inflammatory response 
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S100A12 
FPR2 
PTX3 
TNFAIP6 
inflammatory response 
inflammatory response 
inflammatory response 
inflammatory response 
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To characterise their biological processes, we perform gene ontology 
on all features within this cluster using Entrez Gene [Maglott et al., 
2007]. This enables us to identify 41 distinct genes that are highly 
differentially expressed in inflammatory papules (Table 6.10). In 
particular, we observe changes in five chemokines (ILS, CXCLl, CCL3, 
CXCL13 and CXCL2), a leukocyte immunoglobulin-like receptor 
(LILRB2), three cell adhesion molecules (SELL, SPP1 and SELE) and a 
gene involved in integrin-mediated signaling pathway (ADAMDEC1) 
through these processes; these molecules play essential roles in 
leukocyte migration. We also observe two genes involved in epidermis 
development (SPRR2D, KRT16) are up-regulated. Changes in 
metabolisms are also observed, including cofactors, vitamins, 
xenobiotics and amino acid metabolisms, in inflammatory papules. 
It can be observed that inflammatory acne activates intrinsic pathway 
of blood coagulations promoting hemostasis or the stoppage of 
bleeding [Kaufmann and Schaible, 2005]. A MHC class II molecule 
(IFI30) and a gene involved in T cell ecretory granule organisation and 
biogenesis (SRGN) are up-regulated, suggesting that inflammatory 
acne activates MHC class II expression triggering T cell mediated 
immune response in response to bacteria infection. Furthermore, 
there is an indication of the binding of IgE to the high-affinity Fe 
episilon RI promoting allergic inflammation in inflammatory papules. 
In conclusion, the pathogenic mechanisms underlying inflammatory 
acne can be summarised as follows: (1) the presence of leukocyte 
migration, (2) the activation of intrinsic pathway of blood coagulations 
promoting hemostasis or the stoppage of bleeding, (3) the activation 
of MHC class II expression triggering T cell mediated immune 
response in response to bacteria infection, and (4) the binding of IgE 
to the high-affinity Fe episilon RI promoting allergic inflammation. 
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6.3 Conclusion 
A natural way of viewing a complex data set is first to scan and survey 
the large-scale features and then to address the details of interest 
[Eisen et al., 1998]. In this chapter, we first find variant genes 
associated with the disease under investigation where the correlation 
between genes is taken into account. Next, we identify gene-specific 
information using Entrez Gene or map variant genes onto KEGG 
pathways to obtain a linkage between key molecules and biochemical 
pathways associated with the disease under investigation in a 
cause-effect format. The approaches are generalised ones, with no 
inherent specificity to the particular method used to acquire 
microarray gene expression data. Therefore, these approaches may 
be used to develop genome-based diagnostic tests and therapeutic 
targets in many other types of diseases. 
Finally, we have seen the possibility that medicine of the future could 
include a scan of a patient's entire genome, looking for all variant 
genes that predispose toward disease, and this work has made 
possible a useful data analysis tool in the outlook of modern medicine. 
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Chapter 7 
Conclusion 
7.1 Summary of Research Contributions 
In this thesis, a choice of bioinformatics techniques used in the 
analysis of disease-related microarray gene expression data is 
developed. They examined variant genes associated with the study 
disease and subsequently derived insight into the molecular aetiology 
of disease using: (1) the linear logistic regression model, (2) the 
conditional or fixed effect logistic regression model, and (3) the 
Mahalanobis distance in the K-means or hierarchical clustering 
algorithms. For an unmatched study, the variant genes can be 
assessed using the linear logistic regression model. For a matched 
study, the variant genes can be assessed using the conditional logistic 
regression model. Alternatively, one can employ the Mahalanobis 
distance in K-means or hierarchical clustering algorithms for data 
mining and pattern recognition in gene expression analysis. In these 
analytical procedures, strong emphasis is placed on the interpretation 
of disease-related microarray gene expression data in terms of 
biological processes that contribute to the disease under investigation. 
This requires the consideration of biological interdependencies and 
potential confounding, as well as the identification of gene-specific 
information using Entrez Gene [Maglott et al., 2007]. In other words, 
fundamental to this thesis is that the mass of numbers produced by 
gene chips are primarily driven by their genetic roots in the human 
genome. 
A central step in implementing K-means or hierarchical clustering 
algorithms is to select a distance measure, which will calculate the 
similarity between genes on the basis of their expression profiles. 
Given that all clustering procedures are based on some form of 
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disease measure, the method of calculating distance matrix can have 
an important effect on the clustering results [Mimmack et al., 2001]. 
This will influence the shape of the clusters, as some genes may be 
close to one another according to one distance measure, and farther 
away according to another. 
We can demonstrate the important influence on the choice of distance 
measure by the example with which we dealt in Section 6.2.10. In this 
example, the applicability of the Mahalanobis distance and of the 
frequently used Pearson correlation coefficient are examined in the 
context of clustering gene expression profiles in inflammatory papules 
corresponding to normal skin biopsies using K-means clustering 
algorithm. 
Figure 7.1 The Pearson correlation coefficient in K-means clustered display of 
microarray gene expression profiles in inflammatory papules corresponding to 
normal skin biopsies (K=9). 
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Figure 7.2 The Mahalanobis distance inK-means clustered display of microarray 
gene expression profiles in mflammatory papules corresponding to normal skin 
biopsies (K= 9) . 
Geometrically, the Pearson correlation coefficient between two genes 
X and \' can be viewed as the cosine of the angle between X and 
Y on the basis of their expression profiles. Therefore, the Pearson 
correlation coefficient varies from -1 to + 1 wheres the eosin varis 
from 0 to 1 in a single quadrant. A positive value for the coefficient 
implies a positive linear relationship between two genes, whereas a 
negative value for the coefficient implies a negative linear relationship 
between two genes. The closer the coefficient is to -1 or + 1, the 
stronger the linear correlation between two genes. Moreover, the 
Pearson correlation coefficient depends upon the assumption of 
normality, lienarly and homoscedasity. These assumptions mandate 
that the distributions of both genes related by the coefficient should 
be normal and that the scatter-plots should be linear and 
homoscedatic. In genomics, on the other hand, the distributions of 
two genes may not satisfy the assumption of linearly, normality and 
homoscedasity. Therefore, the clustering result with the Pearson 
correltion coefficient as a distance measure in K-means clustering 
algorithm, as shown in Figure 7 .1, are disturbed as a result of omitting 
the assumption of linearly, normality and homoscedasity. 
A better distance measure that incorporates the differences in 
variance as well as the covariance between genes is the Mahalanobis 
distnce [Tseng et al., 2009]. The Mahala nobis distance gives less 
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weight to genes with high variance and to high correlated genes so 
that all characteristics are treated as equally important. Apart from 
accounting for covariances between genes and for differences in 
vairances, the Mahalanobis distance has other attractive properties, 
such as being related to the log-likeliood of multivariate normal 
distributions, and to multidimensional scaling [Greenacre and 
Underhill, 1982; Stephenson and Doblas-Reyes, 2000; Mimmack et 
al., 2001]. The clustering result with the Mahalanobis distance as a 
distance measure in K-means clsutering algorithm, as shown in Figure 
7.2, efficiently revealed a cluster of 60 features that exhibit 
substantial fold increase in inflammatory papules corresponding to 
normal controls. The variant gene clusters can be revealed for a 
further explanation of molecular biological mechanisms [as presented 
in Section 6.2.10]. 
7. 2 Perspectives 
In discussing the role of gene chips in clinical practice, the 
bioinformatics techniques in the analysis of disease-related 
microarray gene expression data presented here have contributed to 
the exploitation of genome-based expression profiling as a single 
standardised microarray platform for minimally invasive diagnostic 
tests and therapeutic interventions in the study disease. 
Presently, most microarray-based diagnostic tests are still in the 
development stage since many challenges remain in adopting DNA 
microarrays as a commonplace platform for diagnostic testing 
[Aitman 2001; Pollack, 2007]. For instance, the existing procedure 
used to classify prognostic subtypes of childhood ALL using DNA 
microarrays is the selection of a number of discriminating genes for 
the various ALL subtypes using Chi-square statistic, and there are 
marked differences in the number of diagnostic discriminating genes 
for the various ALL subtypes [Ross et al., 2003; Ross et al., 2004]. 
This simple technique, however, does not support the use of 
genome-based expression profiling as a single standardised 
microarray platform for diagnosis of the known prognostic subgroups 
of pediatric ALL in clinical practice, since it can be extremely laborious, 
time-consuming and expensive. Furthermore, such procedures do not 
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address the full potential of genome-based experiments to alter our 
understanding of cellular biology by offering, through an inclusive 
analysis of the entire repertoire of transcripts, a continuing 
comprehensive window into the biology underlying the clinical 
difference among these leukaemia subtypes. 
In order to support the use of genome-based expression profiling as a 
single standardised microarray platform for minimally invasive 
diagnostic tests and therapeutic targets in childhood ALL, the 
Mahalanobis distance in the K-means clustering algorithm has been 
has been used to analyse and make sense of microarray gene 
expression profiling of bone marrow samples from pediatric patients 
with various prognostic subtypes of childhood ALL (as presented in 
Section 5.1). The results show that the expressions of seven MHC 
class II molecules (HLA-DQBl, HLA-DPAl, CD74, HLA-DRBl, HLA-G, 
HLA-B and HLA-DRA) are a unique gene set in classifying childhood 
acute lymphoblastic leukaemia, and the application of DNA 
dementhylating agent to induce MHC class II expressions will be 
beneficial in the prevention of pediatric acute lymphoblastic 
leukaemia relapse [Holling et al., 2004]. As a result, a commonplace 
diagnostic array platform consisting of these seven MHC class II 
molecules can be developed for classifying childhood ALL in clinical 
practice. According to the digitized intensity output patterns from 
DNA microarrays, clinicians can provide promise of a more accurate 
diagnostic tests and tailored treatments to each pediatric patient with 
ALL in clinical practice in a straightforward manner. 
7.3 Conclusion Remarks 
The main theme of this thesis is to provide better fundamental 
bioinformatics techniques in the analysis of disease-related 
microarray gene expression data. This work resolved the challenges 
in adopting DNA microarrays as a commonplace platform for 
diagnostic testing and therapeutic targets in clinical practice. In the 
next three to five years, the development of diagnostic microarray 
platform is likely to offer promise of more accurate diagnostic tests 
and tailored treatments to each patient in clinical practice. 
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Furthermore, the identification of biological mechanisms, new 
indicators of disease prognosis, and new therapeutic targets are likely 
to be understood in almost any kind of diseases, and will start to enter 
clinical practice with new treatment strategies within this time frame. 
The success of these computational approaches has given us 
confidence to "see" the information in disease-related gene 
expression data based on biological necessities. 
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Genome-based expression profiles as a single standardised 
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Abstract 
Introduction and hypothesis To investigate the molecular 
signature underlying experimental interstitial cystitis (IC) 
using eDNA microarray. 
Methods Microarray gene expression profiles are studied in 
bladder epithelium of C57BL/6 mice with ovalbumin or 
substance P-induccd experimental IC versus Escherichia 
coli lipopolysaccharide-induced bacterial cystitis. 
Results Main findings are summarized as follows: firstly, a 
"75-genc" model was discovered to contain high expressions 
of bladder epithelium which feature in experimental IC. 
Secondly, glucose, lipid, nucleotide, xenobiotics, and amino 
acid metabolisms arc involved in. Thirdly, T-cell-mediated 
immune and inflammatory responses arc observed. Fourthly, 
Wnt, Tgf-beta, Mapk, and insulin growth factor receptor 
signaling pathways are also involved in. In addition, 
experimental IC leads to Ephrin- and Semaphorin-mediated 
Ling-llong Tseng and Ilene Chen contributed equally to this paper. 
L.-11. Tseng (Bi) · C.-L. Lee· T.-S. Lo 
Depanment of Obstetrics and Gynecology, 
Chang Gung Memorial llospital and University of Chang Gung 
School of Medicine, 
Tao-Yuan. Taiwan 
e-mail: 3g7330@'yahoo.com.lw 
I. Chen 
School of Electncal and Information Engineering, 
University of Sydney, 
Sydney, Australia 
M.-Y Chen 
Depanment of Electncal Engmccring, Stanford Umvers1ty. 
Stanford, CA. USA 
L. K. Lloyd 
Division of Urology, Univer~1ty of Alabama School of Medicme, 
Birmingham, AL, USA 
Published online: 20 January 2009 
axon guidance promoting parasympathetic inflammatory 
reflexes. 
Conclusions Further characterization of human TC-induced 
gene expression profiles would enable the usc of genome-
based expression profiling for the therapeutic targets and 
diagnosis of IC. 
Keywords Bladder pain syndrome/interstitial cystitis (BPS/ 
IC) · C57BU6 mice· Gene expression · eDNA microarray 
Introduction 
Research into bladder pain syndrome/interstitial cystitts 
(BPS/TC) has a very long history. It was first documented 
by Mercier in 1937, and characterized by Skene in 1887, as 
the presence of an inflammation that destroys the urinary 
bladder mucous membrane, partly or wholly, and extends to 
muscular parities [1]. In 1914, Hun ncr popularized IC with 
the description of a characteristic bladder wall ulcer [I]. In 
I 947, Hand made the first epidemiological description oflC 
as the widespread, small, submucosa bladder hemorrhage 
and substantial shrinkage in the bladder capacity [I]. In 
1987, Messing and Stamey recognized glomerulation as an 
indicator of TC [1]. Up to the present time, the etiology of 
BPS/TC is still relatively unknown and has been acknowl-
edged by the American Urological Association, as a most 
challenging disease. 
The urothclium plays a pivotal role as a barrier between 
urine and its solutes and the underlying bladder. Bladder 
surface mucus is a critical component of this function. 
Currently, the most accepted hypothesis is glycosamino-
glycans (GAG) deficiency [2]. The GAG layer is extremely 
hydrophilic and traps water which forms a barrier at the 
critical interface between urine and the bladder. The result 
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is a highly impermeable urothelium that serves as a key 
protective barrier for the bladder interstitium [2]. 
One of the most difficult aspects in the treatment ofBPS/IC 
is its diagnosis. Presently, the requirements for diagnosis 
involve excluding all other causes, such as urinary tract 
infection, bladder cancer and sexually transmitted disease. 
Also, a cystoscopy is optional in which the bladder is 
distended and hemorrhage are identified, however, the 
cystoscopy with hydrodistention is only used to rule-out other 
disorders but not used to rule in the diagnosis of BPSIIC. 
Although several potential candidate BPSIIC markers were 
isolated from the urine of patients with BPSIIC, they were a 
few molecules surrounded by the networks of molecular 
interaction and biological coordination. We all know that 
BPSIIC is a complex disease [3]. An individual gene for 
superior intelligence probably nor does it exist for BPS/IC. 
Instead, genes and gene products work together in complex 
and mysterious ways to cause the symptoms ofBPSIIC [4]. 
The completion of the human genome project and the 
advance ofmicroarray technology, which amounts to hundreds 
of data points for thousands or tens of thousands of genes, have 
enabled the use of gene chips in the diagnosis ofBPSIIC. DNA 
molecules can be attached to small squares of glass that by 
analogy with computer circuits are called microarray. Micro-
array platfonns can be designed so that they will detect altered 
genes associated with BPSIIC. These advances promise to 
revolutionize medicine as they are expected to reveal the 
mechanisms underlying BPS/IC as well as to pinpoint potential 
targets for drug discovery and diagnostics. 
To support the use of genome-based expression profiling 
as a single standardized microarray platform for the 
diagnosis of BPS/IC, we wish to put forward a compre-
hensive analysis of bladder epithelium of C57BL/6 mice 
with ovalbumin (OVA) or substance P (SP)-induced 
experimental IC versus Escherichia coli lipopolysaccharide 
(LPS)-induced bacterial cystitis. 
Materials and methods 
Source of data 
We studied the gene expression based DNA/eDNA array in 
bladder epithelium of C57BL/6 mice with OVA, SP-induced 
cystitis corresponding to LPS-induced bacterial cystitis. Bladder 
epitheliums were examined at I and 4 h after OVA, SP, or LPS 
challenge. The data used here was available from gene 
expression omnibus under platform accession non GSE597. 
Experimental procedures 
Bladder epithelium samples from C57BL/6 mice with OVA, 
SP, or LPS-induced cystitis were obtained as described in 
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Int Urogynecol J 
Saban et al. [5]. Three bladders from each group were 
homogenized together in Ultraspec RNA solution (Biotecx, 
Houston, TX, USA) for isolation and purification of total 
RNA [5]. RNA was DNase-treated according to manufac-
turer's instructions (Clontech Laboratories, Palo Alto, CA, 
USA), and 10 ~g of RNA was evaluated by denaturing 
forrnaldehyde/agarose gel electrophoresis [5]. This proce-
dure was repeated using an additional three bladders in each 
experimental group [5]. Therefore, two pools of RNA were 
generated per experimental group for a total of six mice and 
two separate hybridizations per group [4]. Then, eDNA 
probes prepared from DNase-treated RNAs obtained from 
each of the experimental groups were hybridized simulta-
neously to membranes containing Atlas Mouse 1.2 Arrays 
(Clontech, Cat. #7853-1) [5]. The radioactively labeled 
complex eDNA probes were hybridized overnight to mouse 
eDNA expression arrays (Clontech) using ExpressHyb 
hybridization solution with continuous agitation at 68°C 
[5]. After high- and low-stringency washes, the hybridized 
membranes were exposed overnight at room temperature to 
a ST Cyclone phosphor screen (Packard BioScience 
Company, Downers Grove, IL, USA) [5]. 
Cluster analysis 
Cluster analysis is a generic term that attempts to determine 
whether or not a given dataset contains distinct groups, and, 
if so, to find the groups. In this analysis, a hierarchical 
clustering algorithm is used, which leads to a series of 
hierarchical groups, reported by tree-like dendrograms. This 
method starts from a similarity matrix calculation between 
the genes to be clustered on the basis of their expression 
profiles. The similarity metric used here is the Mahalanobis 
distance, defined as follows: 
d = .I :t (x"- AJk)' 
k=J crt 
where X;k and X;k are the measured fluorescence ratio of test 
samples i and j and a; is the standard deviation of the X;k 
over the sample set. The similarity between two clusters is 
based on Ward's linkage, where the inter-cluster distance is 
computed as the increase in the "error sum of squares" 
(ESS) after fusing two clusters into a single cluster. 
Results 
We have used Ward's linkage hierarchical clustering to 
cluster the global gene expression profiles in OVA or SP-
induced experimental IC versus LPS-induced bacterial 
cystitis (Fig. 1 ). Heap maps are used to represent the 
measured fluorescence ratio of bladder epithelium in the 2-
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Fig. I Clustered display of gene expression profiles in bladder epithelium of C57BU6 mice with experimental cystitis (OVA or SP-induccd 
cystitis) corresponding to LPS-induced cystitis 
dimensional grids and the rank-by-feature color scale 
scheme is used to represent the magnitude of the data on 
the basis of their expression patterns [6 8]. Medium data 
points are colored black, data points with increas ing ranks 
are colored with reds of increasing intensity, and decreasing 
ranks are colored with greens of increasing intens ity [6 8]. 
At the finest level, we have found that there is a c luster of 
75 features that exhibit considerable fold increases in 
experimental TC (Fig. 2). 
To characterize their molecular functions and processes, we 
perform gene ontolo1.,ry on all features within this cluster. This 
enables us to identify 75 distinct genes that are up-regulated in 
bladder epithelium from C57BU6 mice with experimental TC 
(Table I). Therefore, these 75 genes naturally distinguish 
those mice with cystitis into two kinds of cystiti s, those with 
experimental IC and LPS-induced bacterial cystitis. In 
particular, we observe changes in cytokine production, 
cytokine- and chemokine-mediated s ignaling pathway, 
hematopoietin/interferon-class (0200-domain) cytokine re-
ceptor activity, T cell activation as well as T cell antigen 
processing and presentation through these processes. Several 
genes involved in cell adhesion, transcription factors, DNA 
damage and repair, mRNA cleavage, apoptosis, cell cycle, 
and cell proliferation are up-regulated. Changes in complex 
metabolic reactions are also observed, including glucose. 
lipid, nucleotide, xenobiotics, and amino acid metabolisms. 
It can be observed that several genes involved in the 
regulation of Wnt, Tgf-bet and Mapk, and insulin growth 
factor signaling pathways are up-regulated. Therefore, the 
Wnt, Tgf-beta, and insulin growth factor receptor s igna ling 
pathways participate the pathophysiological development 
process through experimental IC process. C hanges in 
Ephrin- and Semaphorin-mediated axon guidance are also 
observed [9 II]. T herefore, experimenta l IC leads to 
Ephrin- and Semaphorin-mediated axon guidance promoting 
parasympathetic inflammatory reflexes [ 12]. In addi tion, a 
gene involved in urogenita l system development (Pax2) and 
a gene involved in ovulation from ovarian follicle (Nos3) 
a re up-regulated. Therefore, experimenta l IC also activated 
genes involved in urogenita l system development and 
ovulation from ovarian follic le. 
Discussion 
Microarray-based genomic surveys and other high-throughput 
approaches (ranging from genomics to combinational chem-
istry) are becoming increasingly important in clinical research 
[6]. Therefore, we need to enable ourselves to "see" the 
information in the massive tables of quantitative measures 
that these techniques produce (6). Our approaches to this 
problem can be generalized as follows: firstly, we use Ward's 
linkage hierarchical clustering to arrange genes, based on the 
order inherent in the genes. Secondly, a "75-gene" model is 
developed as a single standardized m icroarray platform for 
the diagnosis of experimental IC. Thirdly, the results we 
represent gain insight into the mechanisms underlying 
experimental IC. 
Considerable evidence suggests that bladder pain syndrome/ 
interstitial cystitis (BPS/IC) involves urogenital permeability 
defect that a llows urinary potassium to penetrate tissue and 
promote symptoms (2). Studies show that this defect is present 
in most patients with BPS!IC who have been tested for it. as 
well as in many patients with symptoms of BPSITC who have 
received a variety of other diagnoses. 
Consequently, if we can scan a BPSIJC patient's entire 
genome on urinary epithelium searching for all a ltered 
genes that predispose toward symptoms of BPS/IC, we can 
use genome-based minimally invasive test and therapeutic 
targets for BPSIJC. In future studies. we would like to 
Fig. 2 A cluster with 75 features that were up-regulated 111 bladder epitheli um of C57BU6 mice with expenrnental IC (OVA or SP-mduccd 
cystitis) corresponding to LPS-induced cystitis 
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Table 1 Representation of diagnostic discriminating genes in bladder 
epitheliums from mice with OVA, SP, and LPS-induced cystitis 
Gene 
symbol 
Plat 
Ipfl 
LOCI4433 
Poldl 
Gstm2 
Fzd4 
Dkkl 
Erbb2 
Tgtbrl 
Tgfb2 
Ksr 
Map2k4 
lgfbp! 
Igfbp4 
Igfbp5 
Pax2 
Nos3 
Efna3 
Gnai2 
Sema3d 
Kif5c 
Kitl 
Tbx! 
Nkx6-2 
Grin2a 
Phox2a 
Fmnl 
Cnrt 
Mc4r 
Rlnl 
Cttn 
Mdfi 
Stap2 
Apafl 
Dad! 
Ei24 
Nb\J 
Cks2 
Ccnf 
Pml 
Brcal 
Dbp5 
HoxctO 
Candl 
Ebf2 
Pax2 
Pou6fl 
Nrli2 
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Gene ontology 
Lipid catabolism 
Glucose metabolism 
Glucose metabolism 
Nucleotide metabolism 
Amino acid metabolism; xenobiotics metabolism 
Wnt receptor signaling pathway 
Wnt receptor signaling pathway 
TGF-beta receptor signaling pathway 
TGF-beta receptor signaling pathway 
TGF-beta receptor signaling pathway 
TGF-beta receptor signaling pathway; regulation of 
MAPK 
MAPKKK cascade 
Insulin-like growth factor binding; regulation of cell 
growth 
Insulin-like growth factor binding; regulation of cell 
growth 
Insulin-like growth factor binding; regulation of cell 
growth 
Urogenital system development 
Ovulation from ovarian follicle 
Axon guidance 
Axon guidance 
Axon guidance 
Axon guidance 
Neural crest cell migration 
Neural crest cell migration 
Regulation of spinal cord motor neuron fate 
Synaptic transmission 
Somatic neuron differentiation; sympathetic nervous 
system development; parasympathetic nervous system 
development 
Actin cytoskeleton organization and biogenesis 
G protein coupled receptor signaling pathway 
G protein coupled receptor signaling pathway 
Signal transduction 
Protein binding 
Protein binding 
Protein binding 
Apoptosis 
Apoptosis 
Apoptosis 
Cell cycle 
Cell cycle 
Cell cycle 
DNA damage response; DNA repair 
DNA damage response; DNA repair 
Transcription 
Transcription 
Transcription 
Transcription 
Transcription 
Transcription 
Transcription 
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Table 1 (continued) 
Gene 
symbol 
Dbp 
Dlx3 
Tcf21 
Cutll 
E2f3 
Perl 
Cited 
Bapxl 
Rara 
Dmtfl 
Zic3 
Eed 
Mafb 
Thra 
Skit 
Pop4 
Hsp!JO 
learnt 
Csk 
Cntnl 
Cd44 
Col6a1 
lfuar2 
Lta 
Rei 
Mp! 
II t rt 
Gene ontology 
Transcription 
Transcription 
Transcription 
Transcription 
Transcription 
Transcription 
Transcription 
Transcription 
Transcription 
Transcription 
Transcription 
Transcription 
Transcription 
Transcription (thyroid hormone receptor alpha) 
Transcription 
mRNA cleavage 
Response to stress 
T cell antigen processing and presentation 
Regulation ofT cell activation 
Cell adhesion 
Cell adhesion 
Cell adhesion 
Cell proliferation 
Immune and inflammatory response 
Cytokine production 
Hematopoietin/interferon-class (D200-domain) 
cytokine receptor activity 
Cytokine and chemokine-mediated signaling pathway; 
immune response 
define the programs of gene expression in human BPSIIC 
bladder epithelium. Such analysis would enable the classi-
fication of samples of unknown, equivocal or ambiguous 
histoty, thus supporting the use of genome-based expression 
profiling as a single standardized microarray platform for the 
diagnosis ofBPS/IC in clinical practice. 
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Appendix B 
Genome-based expression profiling study following spinal cord injury 
in the rat: an array of 48-gene model 
Neurourology and Urodynamics lJ 
L1 Genome-Based Expression Profiling Study Following Spinal Cord Injury in the Rat: An Array of 48-Gene Model 
Ling-Hong Tseng, Ilene Chen, Yi-Hao Lin, Ching Chung Liang,' and L. Keith lloyd 
Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital and University of Chang Gung 
Memorial Hospital, Linkou Medical Center, Tao-Yuan, Taiwan 
Aim: To explore the potential molecular mechanisms underlying experimental neurogenic bladder dysfunction. 
Methods: With the aid of Affymetrix GeneChip Rat Genome U34A arrays, we examined microarray gene 
expression profiles in bladder wall tissue from female Sprague-Dawley rats within the first 3 weeks following 
spinal cord injury. Gene transcripts expressed in rat bladder wall tissue at 3 days, 7 days, and 3 weeks following 
spinal cord injury were compared to normal rat bladder wall tissue. Results: The Mahalanobis distance in 
hierarchical cluster analysis revealed a 48-gene model, which contained high expressions in rat bladder wall tissue 
at 3 days, 7 days, and 3 weeks following spinal cord injury. According to gene ontology, plausible molecular 
alterations in rat bladder wall tissue following spinal cord injury include: (1) the release of nerve growth factor 
(NGF) and transforming growth factor beta 1 (Tgfbl) (2) the secretion of histamine from mast cells, (3) the 
occurrence of blood coagulation, (4) the occurrence of N-terminal protein myristoylation, and (5) Axon guidance 
mediated by EnaNasodilator-stimulated phosphoprotein (EnaNASP) promotes reestablishment of the bladder reflex 
following spinal cord injury. Such changes, jointly termed "bladder remodeling," can constitute an important long-
term consequence of neurogenic bladder dysfunction. Conclusion: The success of this innovation has supported the 
use of microarray-based expression profiling as a commonplace platform for the pathogenesis and therapeutic 
interventions of experimental neurogenic bladder dysfunction. Neurourol. Urodynam. 
© 2009 Wiley-Lias, Inc. 
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INTRODUCTION 
The bladder is a unique organ which needs the central 
nervous system and peripheral nerves to synchronize the 
urine storage and emptying. Neurogenic bladder (NGB) refers 
to dysfunction of the bladder due to neurogenic dysfunction or 
insult emanating from internal or external trauma, disease, or 
injury. Symptoms of NGB range from neurogenic detrusor 
overactivity to detrusor sphincter dyssynergia, depending 
upon the site of neurogenic insult. 1 The urethra also may be 
affected, resulting in sphincter underactivity or overactivity 
and loss of coordination with bladder function.1 In addition, 
NGB can cause urine leakage-a major quality of life issue- and 
can lead to severe complications, such as recurrent urinary 
tract infection, vesicoureteral reflux, autonomic dysreflexia, 
renal failure, and urosepsis. 
One of the most difficult aspects in the treatment of NGB 
is its management. In addition to a complete medical 
and voiding history, the requirements for management 
rely primarily upon accurate diagnosis with a variety of 
clinical examination, including videourodynamics and selec-
tive radiographic imaging studies.1 One difficulty in the 
management of NGB is the establishment of low-pressure 
urinary drainage without the use of an indwelling urethral or 
suprapubic catheter.2 An indwelling urethral or suprapubic 
catheter presents its own problem, which include increased 
risk of urinary tract infection and formation of bladder stones. 
When bladder compliance falls to a dangerous level despite 
the catheterization, enterocystoplasty has been the gold-
standard therapy? Although this procedure increases bladder 
capacity and compliance, it has been plagued by complica-
tions, such as metabolic disorders, perforations, excessive 
© 2009 Wiley-Liss, Inc. 
mucous productions, and stones. 3 We need to find some better 
fundamental methods for the management of NGB. 
The completion of the human genome project and the 
advance of microarray technology offer a new opportunity to 
gain insight into global gene expression profiles in NGB. Several 
clinical researchers have started to examine transcriptional 
changes in the central nervous system or peripheral nerves 
following spinal cord injury (SCI).4 - 9 Based on our prior works 
which have shown this concept is acceptable,10'11 we focus on 
examining transcriptional changes in rat bladder wall tissue 
following SCI. These advances help to revolutionize medicine 
as they are expected to reveal the potential pathogenic 
mechanisms of NGB as well as to pinpoint potential targets 
for therapeutic interventions and diagnostics. 
To explore the potential pathogenic mechanisms under-
lying NGB, we wish to put forward a better fundamental 
analysis for transcriptional responses in rat bladder wall 
tissue following experimental SCI. The results contain novel 
features which are of considerable biologist interest. Funda-
mental to this study is that the mass of numbers produced by 
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DNA microarrays relating to experimental NGB are primarily 
driven by their genetic roots in the genome. It enables the 
genome to become a unifying explanation for the patho-
geneses of NGB. 
MATERIALS AND METHODS 
SoUice of Data 
The data used in this analysis was collected from Gene 
Expression Omnibus under platform accession no. GSE14096. 
Female Sprague-Dawley rats (170 g) were anesthetized with 
halothane and a complete laminectomy at the T9- T10 spinal 
level was performed according to the established protocols.12 
Bladder were harvested from normal and spinal cord injury 
(SCI) rats (3 days, 7 days, or 3 weeks post-surgery) under 
halothane anesthesia, snap-frozen in liquid nitrogen, and 
stored until further processing? Institutional Review Board 
approval was obtained for the study. 
RNA Processing 
Total RNA was isolated using Trizol reagent and following 
the manufacturer's instructions (Invitrogen, Carlsbad, CA). 
Total soluble proteins were collected by homogenizing the 
tissue samples in Tissue Protein Extraction Reagent (Pierce 
Biotechnology. Rockford, IL) supplemented with 0.5 mM 
PMSF and by subjecting the homogenates to three freeze-
thaw cycles. The tissue lysates were centrifuged and protein 
concentrations of the supernatant samples were measured 
spectrophotometrically using the Bradford method. 
Microarray Hybridization 
Gene transcripts expressed by rat bladder wall tissue in 
normal, 3 days, 7 days, and 3 weeks following SCI (1 rat from 
each group) were evaluated using oligonucleotide arrays. 
Briefly, 20 1-1g t of biotin-labeled cRNA was fragmented following 
the manufacture's instruction (Affymetrix, Santa Clara, CA). All 
labeled samples were hybridization to Affymetrix GeneChip Rat 
Genome U34A Array Set RG-U34A (Affymetrix). 
Cluster Analysis 
Data derived from GeneChips have two potential sources of 
error: experimental and analytical. While experimental error 
can be limited by higher quality samples and standardized 
hybridization procedures, analytical error is difficult to 
control. The standard goal of minimizing both false positives 
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and false negatives is compromised by the assumption-laden 
tools used for analysis.s Cluster analysis is a commonly used 
method in the analysis of microarray gene expression data. 
This method starts from a similarity matrix calculation 
between the genes to be clustered on the basis of their 
expression profiles. At present, cluster analysis with the 
Pearson correlation coefficient, Spearman correlation coeffi-
cient or standard correlation coefficient as a distance measure 
has been frequently used in the analysis of microarray gene 
expression data. Although the Pearson correlation coefficient, 
Spearman correlation coefficient or standard correlation 
coefficient are scale invariant, they do not take the covariance 
between genes into consideration. However, changes in 
expression levels of genes do not occur as individual events, 
but participate in a complex and interdependent manner due 
to gene co-expression and co-regulation, giving to the working 
of lively organisms and their parts. Unless the distance 
measure properly takes the covariance between genes into 
account, the organized profiling can be disturbed as a result of 
ignoring interdependencies. 
To account for the covariance between genes, a proper 
distance measure can be used in the Mahalanobis distance 
defined as follows : 
~~ = (xi - xi )'S- 1(xi - xi) 
where Xi and xJ are two data points, S is the p x p covariance 
matrix of X, and X is assumed to be of full rank so that s-1 
exists.10·11·13 The Mahalanobis distance incorporates covariance 
between gene expression levels as well as differences in 
variances.10·11·13 It gives less weight to genes with high variance 
and to high covariated genes, so that all characteristics are 
treated as equally important by considering the covariance 
between genes and the results can be derived insight into the 
molecular biology of the disease or condition under investiga-
tion. 
RESULTS 
With the aid of Affymetrix GeneChip Rat Genome U34A 
Arrays, we examined microarray gene expression profiling of 
8,799 distinct features in bladder wall tissue from female 
Sprague-Dawley rats within the first 3 weeks following 
spinal cord injury (SCI). Gene transcripts expressed by rat 
bladder wall tissue in 3 days, 7 days, and 3 weeks following 
SCI were compared to normal rat bladder wall tissue. To 
account for the biological interdependencies,10•11 the Mahala-
nobis distance in Ward's linkage hierarchical clustering 
was used to cluster gene expression profiles in the rat bladder 
wall tissues within the first 3 weeks following SCI (Fig. 1). 
Fig. 1. Clustering results of gene transcripts expressed by rat bladder wall tissue in 3 days, 7 days, and 3 weeks 
following spinal cord injury were compared to normal rat bladder wall tissue. 
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Fig. 2. A duster of 48 genes that revealed considerable fold mcrease m rat bladder wall tissues m 3 days, 7 days, 
and 3 weeks following sptnal cord mjury 
Here we used heat maps to represent the measured 
fluorescence intensities of the bladder wall tissues in the 
two-dimensional grids. Cells with intensities of zero are 
colored black, increasing positive intensities with reds 
of increasing intensity, and increasing negative intensities 
with greens of increasing intensity.14 This visual representa-
tion preserves all the quantitative information, but trans-
mits it to our brain by ways of a much higher-bandwidth 
channel than the "number-reading" channel14 At the finest 
level, we found that there was a cluster of 48 genes 
that revealed considerable fold increase in rat bladder 
wall tissue at 3 days, 7 days, and 3 weeks following SCI 
(Fig. 2). Thus, these 49 genes contained high expressions of rat 
bladder wall tissue in 3 days, 7 days, and 3 weeks following 
SCI. 
To characterize their biological processes, we performed 
gene ontolof¥ on those 48 genes with the aid of Entrez Gene 
(Table 1).15- Specifically, changes in complex metabolisms 
were observed in rat bladder wall tissue following SCI, 
including carbohydrate, lipid, histamine, amino acid, xeno-
biotics, androgen. and estrogen metabolisms. We observed the 
gene expression for proprotein convertase subtilisin/kexin 
type 6 (Pcsk6) was up-regulated, which produced nerve 
growth factor (NGF) in rat bladder wall tissue following SCI. 
We also observed the gene expression for transforming 
growth factor beta 1 (Tgfbl) was up-regulated, which 
caused epithelial-mesenchymal transition in rat bladder 
wall tissue following SCI. The gene expression of tyrosine 
3-monooxygenase/tryptophan 5-monooxygenase activation 
protein zeta polypeptide (Ywhaz) was also up-regulated,18 
which caused histamine secretion from mast cells in rat 
bladder wall tissues flowing SCI. 
Two genes contributed to blood coagulation (Thbd and 
Gzmg) were up-regulated in rat bladder wall tissues 
flowing SCI. Two genes contributed to N-terminal protein 
myristoylation (Ptpnl8 and Tnk2) were up-regulated as 
well. Furthermore, several genes involved in potential 
interactions with Ena-vasodilator stimulated phosphoprotein 
(Evl) mediated axon guidance triggered by ubiquitin-
mediated degradation were up-regulated in rat bladder wall 
tissues flowing SCI, suggesting the incidence and recurrence 
of bladder reflex following SCI. Lastly, we confirmed the 
changed gene expressions of four genes (Pcsk6, Tgfbl, Ywhaz, 
and Evl) by semiquantitative reverse transcription-PeR and 
observed quantitative agreement between the methods for 
all four genes. Semiquantitative reverse transcription-PeR 
revealed the elevated steady-state mRNA levels for these four 
genes. 
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DISCUSSION 
Comprehensive assessment of changes in gene expression 
that contribute to experimental NGB has resulted in the 
identification of potential pathogenic mechanisms and novel 
therapeutic interventions. To that end, we have undertaken a 
comprehensive analysis to assess changes in gene expression 
in rat bladder wall tissue following spinal cord injury (SCI) 
with the aid of high-density oligonucleotide microarrays. 
In the present study, we sought to recognize pathogenic 
mechanisms underlying experimental neurogenic bladder 
(NGB). For this purpose, we investigated the time course of 
genomic up-regulations in rat bladder wall tissue following 
SCI. We selected genes that were up-regulated in rat bladder 
wall tissue following SCI and therefore, represent a relative 
universal bladder responses to SCI. The array analysis 
exhibited that of the over 8,000 distinct features examined, 
the 48 genes summarized in Table I were up-regulated. 
According to gene ontology,11·13·14 potential molecular 
mechanisms in rat bladder wall tissue following SCI include: 
the release of nerve growth factor (NGF) and transforming 
growth factor beta 1 (Tgfbl), (2) the secretion of histamine 
from mast cells, (3) the occurrence of blood coagulation, (4) the 
occurrence of N-terminal protein myristoylation, and (5) Axon 
guidance mediated by Ena/Vasodilator-stimulated phospho-
protein (Ena/V ASP) promotes re-establishment of the bladder 
reflex following spinal cord injury. Furthermore, several genes 
contributed to complex metabolisms were up-regulated in rat 
bladder wall tissue following SCI, including carbohydrate, 
lipid, histamine, amino add, xenobiotics, androgen and 
estrogen metabolisms. Taken these results strongly suggest 
the existence of "bladder remodeling" promoting NGB 
formation. 
This is the most important set of the transcriptional 
program induced in the pathogenesis of NGB, and identified 
48 up-regulated genes. It is the first report in the microarray 
literature to employ a novel bioinformatics technique, cluster 
analysis with the Mahalanobis distance as a similarity 
measure, for identifying gene with over-expressed patterns 
in two populations. A major endeavor in functional genomics, 
in addition to revealing genome-wide changes in gene 
expression under defined conditions, is the "reverse engineer-
ing of signaling networks within cells" such that arral data 
are used to inter potential upstream regulatory events. 9 This 
concept is based on the premise that co-expressed genes are 
likely to share common transcriptional regulators.20 To 
address this problem, we used the Mahalanobis distance in 
agglomerative hierarchical clustering algorithm in order that 
4 Tseng et aL 
TABLE I. Representation of Highly Differential Expressed Genes in Bladder Wall Tissues From Female Sprague-Dawley Rats Within the First 2 Weeks 
Following Spinal Cord Injuzy 
Gene symbol 
---
Pcsk6 
Tgfbl 
Full name 
Proprotein convertase subtilisin/kexin type 6 
Transforming growth factor, beta 1 
Gene ontology 
Ywhaz Tyiosine 3-monooxygenase/tiyptophan 5-monooxygenase 
Nerve growth factor production 
Epithelial-mesenchymal transition 
Histamine secretion by mast cells 
Evl 
Cntf 
Gm 
Arpcib 
Prph1 
Grid2 
Tctex1 
Corolb " 
Olr1191 
Gnbl 
Ralgds 
Nras 
Rab2 
RabllA 
Ube2a 
Ripk3 
Csnk2b 
Nup62 
Timp 
Col12a1 
Rgd1563250 
Cstb 
Meor 
Fmod 
Hmgcsl 
Tpil 
Ugtlaal 
Hdlbp 
Pcyt2 
Sult2al 
Offit 
Hal 
Sirt2 
Ftl1 
Adfp 
Ppib 
Basp1 
LrrcB 
Pdlim1 
Thbd 
Gzmg 
Ptpn18 
Tnk2 
Nmtl 
Mgat2 
activation protein zeta polypeptide 
Ena-vasodilator stimulated phosphoprotein 
Ciliary neurotrophic factor 
Granulin 
Actin related protein 2/3 complex, subunit 1B 
Peripherin 
Glutamate receptor ionotropic delta 2 
Dynein light chain Tctex-type 1 
Coronin, actin binding protein, 1B 
Olfactory receptor 1191 
Guanine nucleotide binding protein beta 1 
Ral guanine nucleotide dissociation stimulator 
Neuroblastoma ras oncogene 
RAB2A, member RAS oncogene family 
RABllA, member RAS oncogene family 
Ubiquitin-conjugating enzyme E2A 
Receptor-interacting serine-threonine kinase 3 
Casein kinase 2, beta polypeptide 
Nucleoporin 62 kDa 
Metallopeptidase inhibitor 1 
Collagen, type XII, alpha 1 
RGD1563250 
Cystatin B 
Mitochondrial trans-2-enoyl-CoA reductase 
Fibromodulin 
3-Hydroxy-3-methylglutaryl-Coenzyme A synthase 1 
Triosephosphate isomerase 1 
UDP glucuronosyltransferase 1 family polypeptide A1 
High density lipoprotein binding protein 
Phosphate cytidylyltransferase 2 ethanolamine 
Sulfotransferase family, cytosolic, 2A, 
dehydroepiandrosterone-preferring, member 1 
Dihydrolipoamide S-succinyltransferase 
Histidine arrunonia-lyase 
Sirtuin 2 
Ferritin light chain 1 
Adipose differentiation related protein 
Peptidylprolyl isomerase B 
Brain abundant, membrane attached signal protein 1 
Leucine rich repeat containing 8 family member A 
PDZ and llM domain 1 
Thrombomodulin 
Granzyme G 
Protein tyrosine phosphatase, non-receptor type 18 
Tyrosine kinase non-receptor 2 
N-Myristoyltransferase 1 
Mannoside acetylglucosaminyltransferase 2 
the correlation between genes and the differences in variances 
were taken into consideration.21- 24 We were able to identify 
48 genes whose expression levels in rat bladder positively 
associated with the pathogenic mechanisms underlying 
experimental NGB. This technique helps us for data mining 
and pattern recognition in gene expression analysis. The up-
regulated gene clusters can be exhibited for further explan-
ation of pathogenic mechanisms. 
The present study differs from most previous approaches 
whose findings were obtained by gene isolating (i.e., observing 
the activities of one gene at any one time).17- 19·22- 24 Seki 
et al.22•23 checked NGF levels using enzyme-linked immuno-
sorbent assay in chronic spinalized rats. Kikuno et al.24 studied 
Neurourology and Urodynamics DOl 10.1002/nau 
Axon guidance 
Regulation of axon regeneration 
Regulation of epithelial cell differentiation 
Regulation of actin polymerization 
Intermediate filament cytoskeleton organization 
Synaptic transmission by the neurotransmitter glutamate 
Microtubule-based process 
Actin binding 
G-Protein-coupled receptors signaling pathway 
G-Protein-coupled receptors signaling pathway 
Ras protein signaling transduction 
Small GTPases mediated signaling transduction 
Small GTPases mediated signaling transduction 
Small GTPases mediated signaling transduction 
Ubiquitin-mediated protein catabolism 
NIK-1-kappaB/NF-kappaB cascade 
NIK-1-kappaB/NF-kappaB cascade 
Upregulation of 1-kappaB kinase/NF-kappaB cascade 
Cartilage biogenesis 
Collagen fibril organization 
Transmembrane protein 
Adult locomotory behavior 
Fatty acid elongation in mitochondria 
Extracellular small interstitial proteoglycans 
Carbohydrate metabolism: amino acid metabolism 
Carbohydrate metabolism; lipid metabolism 
Carbohydrate metabolism; xenobiotics metabolism: androgen 
and estrogen metabolism 
Lipid metabolism 
Lipid metabolism 
Lipid metabolism 
Amino acid metabolism 
Histidine metabolism 
Histone deacetylation 
Transport (iron ion) 
Transport Oong-chain fatty acid) 
Protein folding 
Unknown 
Biological process 
Regulation of transcription 
Blood coagulation 
Blood coagulation 
Protein amino acid dephosphorylation 
Protein amino acid dephosphorylation 
N-Terminal protein myristoylation 
N-Terminal protein myristoylation 
the combined effects of NGF and vascular endothelial growth 
factor on regeneration of the bladder acellular matrix graft in 
rats following SCI by assessing smooth muscle induction, 
collagen and nerve fiber regeneration. Instead of observing the 
activities of one gene at any one time, we performed an 
explanatory study, colloquially called a "fishing expedition," 
which is one in which multiple hypotheses were proposed for 
scientific investigation with the aid of microarray gene 
expression profiles in rat bladder wall tissue following SCI 
versus normal controls? 5 The primary theme of such study is 
to learn enough about possible causes of experimental NGB so 
that one or more specific hypotheses may be proposed and be 
sufficiently supported to justify a detailed investigation?5 
Furthermore, our explanatory results consistent with ana· 
lytical findings from other groups 21- 24 in which experimental 
neurological bladder dysfunction resulted in the up-regulation 
of transcripts from Tgfbl and genes with roles in production 
of NGF, metabolisms, protein synthesis and the axonal 
cytoskeleton. Our analysis presented here indicated that 
genes with roles in transports, histamine secretion by mast 
cells and blood coagulation were up-regulated, whereas 
changes in genes involved in oxidative stress, apoptosis, cell 
adhesion, cell growth/differentiation, and proteolysis were 
less common. As a result, the blockade of individual 
pathway generally des not fully eliminate the symptoms of 
NGB and optimal management is achieved only after the 
simultaneous blockade of multiple pathways contributing to 
the pathogenesis of NGB. 
In summary, the present study constitutes the most 
definitive assessment of the functional genomics of bladder 
wall tissue following SCI to date. However, these results 
are very preliminary and further studies are needed to 
substantiate the clinical utility of these methods. Continued 
efforts of large-scale genomic data should contribute to our 
knowledge of NGB and hopefully will ultimately lead to 
improvements in treatment and recovery. In future studies, 
we would like to define the programs of gene expression in the 
human bladder in response to NGB formation. These advances 
promise to revolutionize medicine as they are expected to 
reveal the mechanisms underlying NGB as well as to pinpoint 
potential targets for drug discovery. 
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Objective: To assess the molecular signatures underlying endometrial disorder u~ing eDNA microarray. 
Design: Gene expressiOn-based oligonucleotide array of the normal endometrium. 
SeUing: University hospital. 
Patient(s): Humans. 
lntervention(s): Endometrial tissues were obtained from 28 normal cycling women undergoing endometrial bi-
opsy. RNA was extracted from each tissue and all labeled samples were hybridized to Affymetrix Human U 133 
plus 2.0 array. 
Main Outcome Measure(s): Transcriptional response. 
Result(s): Hierarchical cluster analysis with the Mahalanobis distance revealed a "126-gene" model, which are 
up-regulated at mid-secretory phase, moderately expressed at late-secretary phase, and down-regulated at late-se-
cretory phase. Furthermore, the mechanisms underlying the receptivity of human endometrium at mid-secretary 
phase can be summariled: first, complex metabolic reactions are involved. Second, the activation of complement 
and coagulation cascades promotes muscle contraction, chemotaxis, phagocyte recruitment, and peritoneal inHam-
mation. Third, Ephrin A-mediated axon guidance promotes retrograde menstruation. Fourth, autophagic degrada-
tion is suggested to be responsible for the new blood vessel formation. In addition, DKK I is up-regulated, 
indicating that WNT signaling pathway may contribute to the development of endometrial disorders. 
Conclusion(s): The success of this innovation has supported the use of microarray-based genome expression pro-
filing as a single standardized platfonn for diagnosis of endometrial disorders. (Fertil SteriJ(JJ 2009; • : • - • . 
©2009 by American Society for Reproductive Medicine.) 
Key Words: Human endometrium. menstrual cycle, endometrial disorder, eDNA microarray 
The human endometrium, the anatomic prerequisite for es-
tablishing and sustaining pregnancy, undergoes remarkable 
histologic changes throughout the menstrual cycle, in prepa-
ration for embryonic implantation and subsequent shedding 
and regeneration in nonconception cycle (I). The differential 
histologic appearance of this tissue was first described by 
Hitschmann and Adler (2), and since the publication of the 
article by Noyes et al. (3), it has been understood that endo-
metrial histology correlates with the changes in the circulat-
ing of estradiol and progesterone. Based on an ideal 28-day 
cycle, Noyes et al. (3) described distinct histologic phases, 
which are known as proliferative (PE), early-secretory 
(ESE), mid-secretory (MSE), and late-secretory (LSE) phases 
of the menstrual cycle. 
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Although histologic criteria described by Noyes et al. (3) 
has remained the gold standard for more than 50 years in clin-
ical diagnosis and management of women with endometrial 
disorder, substantial evidence has claimed the accuracy of 
such criteria ( I). Recently, the usefu !ness of histologic dating 
of the endometrium for couples with inferti lity has been ad-
dressed, because histologic delay in endometrial maturation 
fails to discriminate between fertile and infertile couples (I, 
4). In another recent study, histologic features fail to reliably 
distinguish between specific menstrual cycle days and narrow 
intervals of days, leading to the conclusion that histologic 
dating has neither the accuracy nor the precision to the useful 
in clinical practice ( I). 
The completion of the human genome project and the ad-
vance of microarray technology, which amounts to hundreds 
of data po ints for thousands or tens of thousands of genes, 
offer a new opportunity to gain insight into global gene 
expression profiles in the human endometrium throughout 
the menstrual cycle. DNA molecules can be attached to 
small squares of glass so called microarray by analogy with 
computer circuits. Microarray platforms can be designed so 
that they will detect altered genes within the human endome-
trium throughout the menstrual cycle and thus diagnose 
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a patient's vulnerability to endometrial disorder. Our study 
is to show how such methods can used to disclose the undiag-
nosed endometrial disorder based on all altered genes .These 
advances promise to revolutionize medicine, as they are 
expected to reveal the mechanisms responsible for endome-
trial disorder as well as to pinpoint potential targets for 
drug discovery and diagnostics. 
To support the use of genome-based expression profiling as 
a single standardized microarray platform for the diagnosis of 
endometrial disorder, we wish to put forward a comprehen-
sive analysis to study the gene expression model-based 
RNA/spotted DNA/eDNA array on the human endometrium 
at distinct phases of the menstrual cycle. 
MATERIALS AND METHODS 
Source of Data 
The data used here were available at Gene Expression Omni-
bus under platform accession no. GDS4888. Endometrial 
samples (n = 28) were obtained from normally cycling un-
dergoing endometrial biopsy. All subjects of the well-charac-
terized samples were normoovulatory, with regular cycles 
(24-35 days), had not been on steroid hormone medications 
within 3 months of endometrial sampling, and were between 
the ages of 23 and 50 years old. Indications for the endome-
trial sampling (uterine leiomyoma, n = 14; endometrial biop-
sies, n = 8; uterine prolapse, n - 4; pelvic pain, n I; and 
ovarian cyst, n - I). In this analysis, we study the gene ex-
pression-based oligonucleotide array of the normal endome-
trium at disti net phases of the menstrual cycle. The menstrual 
cycle was categorized into seven stages based on histopatho-
logic criteria (3): early, mid, late-PE phases; ESE, MSE, LSE, 
and menstrual. Endometrial tissues were then snap frozen on 
dry ice immediately after collection and stored at - 80°C until 
RNA extraction. Institut ional review board approval was 
obtained for the study. 
RNA Extraction 
Total RNA was extracted using Trizol reagent (Invitrogen, 
Tokyo, Japan) according to the manufacture's instruction. 
Curetting was homogenized ( I mL Trizol/100 mg tissue) 
and incubated at room temperature for 5 minutes. After the 
addition of chloroform (0.2 volume of Trizol), samples 
were nurtured for another 3 minutes at room temperature, 
centrifuged for 15 minutes at 12,000 g (4°C), and the aqueous 
phase RNA was precipi tated with an equal volume of 100% 
ethanol. Total RNA was further purified using the RNeasy 
Mini Kit (Qiagcn, Tokyo, Japan) according to the manufac-
ture's instruction. Some samples with a lower RNA yield 
were concentrated by adding I 0% sodium acetate, I% glyco-
gen, and 2.5 vol 100% cold ethanol. They were then incu-
bated overnight at -20 C, centrifuged at 4°C for 30 
minutes at 20,000 g, and washed once with cold 80% ethanol, 
with air drying of the RNA pellet. Samples were stored in 
RNase-frce H20, and the purity was analyzed by both the 
2601280 absorbance ratio as well as gel e lectrophoresis. 
-
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Microarray Hybridization 
All microarray procedures followed Affymetrix protocols. 
Concisely. biotinylatcd cRNA was then prepared using the 
Enzo BioArray high-yield T7 transcript labeling kits (Enzo, 
Farmingdale, NY.) cRNA was subsequently purified using 
the clean-up module and fragmented using 5 x fragmentation 
buffer (200 mM Tris [pH 8. 1], 500 mM KOAc, ISO mM 
MgOAc). All labeled samples were hybridized to GeneChip 
Human U 133 plus 2.0 array (Affymetrix, Emeryvi lle, CA). 
Cluster Analysis 
Cluster analysis is a commonly used method in the analysis of 
microarray gene expression profiles. This method starts from 
a simi larity matrix calculation between the genes to be clus-
tered on the basis of their expression profiles. The simi larity 
measure can be used is the Mahalanobis distance defined as 
follows: 
d~ = (x, - x1)'s 1 (x, - x1) 
where x, and Xj are two data points, S is the p x p covari-
ance matrix of X, and X is assumed to be of fu ll rank so that 
S 1 exists (5). In this note, a hierarchical clustering algorithm 
is used, which leads to a series of hierarchical grouping, re-
ported by tree-like dendrograms. The similarity between 
two clusters is based on the Ward's linkage, where the inter-
cluster distance is computed as the increase in the "error sum 
of squares" after fusing two clusters into a single cluster. 
RESULTS 
The Ward's linkage hierarchical clustering is used to arrange 
the global gene expression profiles in the human endome-
trium at ESE, MSE, and LSE phases throughout the men-
strual cycle (Fig. I). Here we usc heat maps to represent 
the measured fluorescence ratio of the endometrium on the 
two-dimensional grids. Cells with log ratios of zero arc col-
ored black, increasing positive log ratios with reds of increas-
ing intensity, and increasing negative log ratios with greens of 
increasing intensity (6). This visual representation preserves 
a ll the quantitative information, but transmits it to our brain 
by means of a much higher bandwidth channel than the 
"number-reading" channel (6). At the finest level, we have 
found that there is a cluster of 209 features that were up-reg-
ulated in the endometrium at the MSE phase, moderately ex-
pressed for those at LSE phase, and down-regulated for those 
at LSE phase (Fig. 2). 
To characterize their molecu lar functions, gene ontology 
within this c luster is performed on a ll features using Entrez 
Gene Database (7). This enables us to identify 126 distinct 
genes that were up-regulated in the endometrium at mid-
secretory phase, moderately expressed for those at LSE 
phase, and down-regulated for those at LSE phase. As a result, 
those 126 genes naturally classify tissues into three distinct 
phases, those at ESE, MSE, and LSE (Table I). ln particular, 
the nature of genes involved in ovarian follicle development 
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FIGURE 1 
I Cluster an~lysis displayed the global gene expression profiles in the human endometrium at ESE, mid-secretory, 
and LSE phases throughout the menstrual cycle. 
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(ANG), apoptosis (ANXA4, IER3, and SGKI ), cell adhesion 
(AM1G02, CLDN4, COMP, HABP2, LAMB3, MUCI6, 
and SPP I), cell differentiation and growth (CATSPERB, 
RARRES I, and GADD45A) are altered throughout the cycle. 
Changes invo lved in complex metabolism are observed, in-
cluding carbohydrate, glucose, lipid, cofactors, vitamins, xe-
nobiotics, and amino acid, a t mid-secretory phase, suggesting 
the presence of extracellular remodeling at the MSE phase. 
These metabolisms require the release of energy, which is 
made avai lable for mRNA encoding small GTPases and 
ATP motor proteins. 
Two genes involved in vehicle explanation and completion 
intended for autophagy (GABARAPLI , GABARAPL3) are 
up-regulated in the endometrium at the MSE phase. moder-
ately expressed for those at the LSE phase, and down-regu-
lated for those at LSE phase (8, 9}, suggesting that 
autophagic degradation is the mechanism responsible for 
new blood vessel formation in the endometrium throughout 
the menstrual cycle. It can be observed that several genes in-
volve in potential interactions with complement and coagula-
tion cascades are up-regulated in the endometrium at the 
MSE phase, moderately expressed for those at the LSE phase, 
and down-regulated for those at the LSE phase, which subse-
quently promote muscle contraction , chemotaxis, phagocyte 
recruitment, and peritoneal inflammation (I 0, II ). Several 
genes involved in potential interaction with Ephrin A-medi-
ated axon guidance and up-regulated in the endometrium at 
MSE phase, moderately expressed for those at the LSE phase 
and down-regulated for those at LSE phase, indicating that 
Ephri n A-mediated axon reflexes trigger retrograde menstru-
ation at the MSE phase. In addition, DKK I, a gene involved 
FIGURE 2 
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in the regulation of the WNT signaling pathway, is up-regu-
lated in the endometrium at the MSE phase, moderately ex-
pressed for those at the LSE phase, and down-regulated for 
those at LSE phase, suggesting that Wnt signaling pathway 
may play a role in the progress of endometrial disorders. 
In summary, the mechanisms implicated in the human en-
dometrium at the MSE and LSH phases can be summarized 
as follows: first, complex metabolic reactions, including car-
bohydrate, g lucose, lipid, cofactors, vitamins, xenobiotics, 
and amino acid, are involved. Next, the activation of comple-
ment and coagulation cascades promotes muscle contraction, 
chemotaxis, phagocyte recrui tment, and peritoneal inflam-
mation. Third, Ephrin A-mediated axon guidance promotes 
retrograde menstruation. Fourth, there is an indication of 
vehicle explanation and completion intended to autophagy, 
suggesting that autophagic degradation is the mechanism 
responsible for the new blood vessel formation in the human 
endometrium during the menstrual cycle. In addition, WNT 
signaling pathway may contribute to the development of 
endometrial disorders. 
DISCUSSION 
This is the most significant set of the transcriptional program 
on human endometrium to date, and identified a total of 126 
genes that arc up-regulated in the human endometrium at the 
MSE phase, moderately expressed for those at the LSE phase, 
and down-regulated for those at the LSE phase. It is the first 
report in the microarray literature to employ a novel bio infor-
matics technique, cluster analysis with the Mahalanobis dis-
tance as a similarity for identifying genes that naturally 
A cluster of 209 features that was up-regulated in the endometrium at MSE phase, moderately expressed at late-
secretary phase, and down-regulated at LSE phase. 
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r TABLE 1 
Representation of gene in the human 
endometrium, which were up-regulated in the 
endometrium at mid-secretory phase, 
moderately expressed for those at late-
secretary phase, and down-regulated for 
those at late-secretory phase. 
Gene symbol Gene ontology 
ANG ovarian follicle development 
ANXA4 apoptosis 
IEA3 apoptosis 
SGK1 apoptosis 
AMIG02 cell adhesion 
MUC16 cell adhesion 
CLDN4 cell adhesion 
COMP cell adhesion 
HABP2 cell adhesion 
LAMB3 cell adhesion 
SPP1 cell adhesion 
CATSPEAB cell differentiation 
AAAAES1 cell differentiation 
GADD45A cell cycle 
LEFTY1 cell growth 
EFNA1 axon guidance 
MET axon guidance 
DNEA neuron migration 
EDNAB neural crest cell migration 
S100P endothelial cell migration 
SYNE2 actin binding 
KAT? cytoskeleton reorganization and 
biogenesis 
CAYAB muscle contraction 
GABAAAPL1 autophagy 
(ATP8) 
GABARAPL3 autophagy 
DPP4 proteolysis 
PTPAA amino acid phosphorylation 
TSPAN8 amino acid glycosylation 
MUC20 protein homooligomer assembly 
C3 immune response; blood 
coagulation 
C4BPA immune response; blood 
coagulation 
SEAPING1 immune response; blood 
coagulation 
THBD immune response; blood 
coagulation 
CD55 immune response; complement 
activation 
CFD immune response; complement 
activation 
GBP2 immune response 
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TABLE 1 
Continued. 
----
Gene symbol Gene ontology 
CXCL14 
IL15 
CAISP3 
DEFB1 
CLEC4E 
BCL6 
PAPLN 
immune response 
immune response 
immune response 
immune response 
immune response 
immune response 
serine-type endopeptidase 
SLPI 
inhibitor activity 
serine-type endopeptidase 
inhibitor activity 
GDF15 
GPA110 
AHPN2 
DEPDC6 
MAP3K5 
DKK1 
signal transduction 
signal transduction 
signal transduction 
intercellular signaling cascade 
MAPKKK cascade 
down-regulation of frizzled 
signaling pathway 
AAID5B transcription 
ELL2 transcription 
FOX01 transcription 
CITED2 transcription 
CEBPD transcription 
KLF6 transcription 
NFIL3 transcription 
PAX8 transcription 
FOSL2 transcription 
NFKBIZ transcription 
IAX3 transcription 
MYOCD transcription 
FAM3C biological process 
SCGB2A2 biological process 
HAASLS3 biological process 
GAAMD1 C unknown 
MUM1 L 1 unknown 
PHYHIPL unknown 
SESTD1 unknown 
AAD21 L 1 unknown 
C1 Oorf1 0 open reading frame 
C21 org63 open reading frame 
ANASE4 mANA cleavage 
FAM84B hypothetical protein 
FAM134B hypothetic protein 
FAM149A hypothetic protein 
TC2N calcium binding 
STC1 calcium ion homeostasis 
NDAG1 response to metal ion 
LIMS3 metal ion binding 
MT2A metal ion binding 
MT1 E metal ion binding 
I Tseng. E.'nd,~ernal disorder: a 126-gme model. Fut-11 s- ,,-,;-1 2-0IJ9. 
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Continued. 
Gene symbol Gene ontology 
MT1F metal ion binding 
MT1M metal ion binding 
MT1G metal ion binding 
MT1H metal ion binding 
MT1 X metal ion binding 
GCNT3 carbohydrate metabolism 
IRS2 glucose metabolism 
ALDH1A3 lip id metabolism 
APOD lipid metabolism 
SOD2 lipid metabolism 
SRD5A3 lipid metabolism 
CP cofactors and vitamins 
metabolism 
INDO cofactors and vitamins 
metabolism 
NNMT cofactors and vitamins 
metabolism 
VNN1 cofactors and vitamins 
metabolism 
AOX1 amino acid metabolism 
ARG2 amino acid metabolism 
GPX3 amino acid metabolism 
MGST1 amino acid metabolism 
MAOA amino acid metabolism 
HAL amino acid metabolism 
GNLY xenobiotics metabolism 
RDH10 oxidation reduction 
INDOL1 oxidation reduction 
ABCC3 transport 
PAEP transport 
MFSD4 transport 
RBP4 transport 
TRPM8 transport (ion) 
SCAR AS transport (phosphate) 
SLC15A1 transport (oligopeptide) 
SLC15A4 transport (oligopeptide) 
SLC16A3 transport (monocarboxylic acid) 
SLC18A2 transport (monoamine) 
SLC44A4 transport (choline) 
SLC1A1 transport (L-glutamate, 
dicarboxylic acid) 
SLC3A1 transport (amino acid) 
SLC4A1 transport (anion) 
SLC7A2 transport (L-amino acid) 
SLC30A2 transport (cation, zinc ion) 
SLC38A1 transport (neutral amino acid) 
TMEM37 transport (calcium ion) 
GABRE transport (ion) 
TCN1 1ransport (cobal1 ion, cobalamin) I 
TSeti!I-.:::::Ometnal disorrfer· a 126-11cn~ model. Fertll Srerll 2()()9. 
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discriminate endometrial tissues into ESE, MSE, and LSE 
phases. 
In microarray-based studies of gene expression, a con-
founder or confounding gene can be defined as an extraneous 
gene that satisfies both ofrwo conditions: r ll it is a differential 
expressed gene for the study disease or physiologic condition, 
and [2] it is associated with other d ifferential expressed gene 
that is not a direct consequence of that differentia l expressed 
gene. In planning microarray data analysis of gene expression, 
one should always regard any known differential expressed 
gene for the study disease or condit ion as a potential con-
founder. The bioinformat ics algorithm should be developed 
to e ither assess or e liminate the effects of confounder. As 
a rule. a differential expressed gene that is confounder in the 
sample may be dealt with by adjusting procedures that reply 
on linear logistic regression model ( 12) and cluster analysis 
wi th the Mahalanobis distance as a similarity measure (5), 
which gives straightforward ways to account for the con-
founding. The consequence of ignoring the confounding is 
that incorrect differential expressed genes underlying the 
study disease or physiologic condition can be obtained. 
Our approach is a generali7Cd one, compatible with all 
known longitudinal or matched case-<:ontrol data analysis, 
and free of arbitrary effects because of the role of shifts in 
gene expression ( 13). Therefore, this approach may be used to 
develop genome-based diagnosis for many other kinds of dis-
eases or conditions (14. 15). Our original idea is to sec if there 
is a unique pattern for each individualized endometrial disor-
der and if we had tissue with an unknown entity we can com-
pare with what we had known, then offer proper treatment. In 
th is present study, we have used this approach to search for 
the roots of endometrial disorder based on all a ltered genes 
that predispose toward this. This example expresses a feature 
of gene expression that makes conditional regression model-
ing particularly worthwhile, namely, the tendency of gene 
expression data to derive insight into the pathogeneses of en-
dometrial disorder. It is, of course, not very surprising that 
this approach as presented has resolved problems caused by 
the role of shifts in the expression of genes, and that is has 
made possible a solid philosophy of space, time, and gene 
expression data. The success of th is computational approach 
has given us confidence to "see" the information in gene 
expression based on biologic necessities. 
In conclusion, these advances promise to revolutionize 
medicine, as they are expected to reveal the mechanisms un-
derlying endometrial disorder as well as to pinpoint potential 
targets for drug discovery and diagnostics. However, these re-
sults arc very preliminary, and further studies are needed to 
substantiate the clinical utility of these methods. 
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Abstract 
Introduction and hypothesis To explore the potential 
molecular mechanisms contributing to the pathogenesis of 
pelvic organ prolapse (POP) with the aid of high-density 
oligonucleotide microarrays. 
Methods We compared microarray gene expression profiles 
in pelvic connective tissue from women with POP and 
nonprolapsc controls. The round ligament and uterosacral 
ligament tissues were removed from each subject at the 
time of laparoscopic hysterectomy. RNA was then 
extracted, and all labeled samples were hybridized to ABI 
Human Genome Survey Microarray version 2.0 (Applied 
Biosystems, CA, USA). 
Results The Mahalanobis distance in hierarchical cluster 
analysis revealed a model of 33 genes, which contained 
high expressions of round and uterosacral ligaments from 
women with POP. According to gene ontology, the 
expressions of mitochondrial genes encoding ribosomal 
protein were upregulatcd. Genes involved in potential 
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interactions with mitochondrial electron transport, nucleosomc 
assembly, cell cycle, and apoptosis were also upregulated. 
As a result, defective mitochondrial translation caused by 
ribosomal protein contributes to the potential molecular 
etiology of POP. Such changes, jointly termed "remodeling 
of pelvic connective tissue", can constitute an important 
long-term consequence of POP. 
Conclusions Our results support the use of genome-based 
expression profiling as a commonplace platform for 
diagnostic tests of POP. 
Keywords Pelvic organ prolapse (POP) · Gene expression · 
DNA microarray · Cluster analysis 
Introduction 
Pelvic organ prolapse (POP) is a widespread problem that 
affects quality of life of countless millions of women [1). 
Although POP is rarely life-threatening and is not as 
dramatic as cancer, it has been shown that self-perception 
of the body is significantly affected in those with symptoms 
[1). Data from 1997 revealed approximately 350,000 POP 
operations performed in the United States alone (2]. Also, it 
is estimated that 11% of women over the age of 80 will 
undergo surgety for such conditions, with an additional 
30% who will require a repeat surgery [3]. Possible risk 
factors for POP include genetic predisposition, parity 
(particularly vaginal birth), connective tissue disorders, 
and factors associated with elevated intra-abdominal pres-
sure (e.g., obesity, chronic constipation) [4-6). However, 
the underlying mechanisms remain undetermined and 
irrespective of the inciting factor; the potential molecular 
mechanisms contributing to the pathogenesis of POP arc 
still unclear. 
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One of the most difficult aspects in the treatment of POP 
is its assessment and diagnosis. Currently, POP is measured 
with the POP quantification (POPQ) system [7]. This exam 
measures nine points in and around the vaginal canal using 
centimeters to give an outline of the POP [7]. Though 
POPQ system has an excellent inter- and intraobserver 
correlation and allows comparison within and between 
patients [8], it is not easy to be used for two reasons: First, 
it has been shown that POPQ staging of the anterior and 
apical compartments suggested a greater stage than clini-
cally suggested [9]. Next, during any assessment of pelvic 
organ support, the clinician should confirm the results of 
examinations of patients complaining of symptoms sugges-
tive of prolapse [7]. 
The advance of microarray technology and the draft 
sequence of the human genome offer a new opportunity to 
gain insight into global gene expression profiles in pelvic 
connective tissue from women with POP. Prior studies 
[10--16] offered some clues for the molecular etiology of 
POP. In addition, our prior works [17, 18] have supported the 
use of genome-based expression profiling as a commonplace 
microarray platform for the study of clinical disease. 
Therefore, we wish to put forward a better fundamental 
analysis for transcriptional responses in pelvic connective 
tissue from women with POP corresponding to nonprolapse 
controls. The results might contain novel features which are 
of considerable biological interest. Fundamental to this study 
is that the mass of numbers produced by DNA microarrays 
relating to POP are primarily driven by their genetic roots in 
the human genome. It enables the genome to become a 
unifying explanation for the pathogenesis of POP. 
Material and methods 
Study subjects 
The data used here was available at Gene Expression 
Omnibus under platform accession number GSE 12852. 
This is a case-control study of seven premenopausal women 
with POP corresponding to nine premenopausal non-
prolapse controls. Women with a history of endometriosis, 
adenomyosis, uterine fibroids, connective tissue disorders, 
and pelvic inflanunatory conditions were excluded. Two 
separate pelvic support tissues were collected from each 
subject. The round and uterosacral ligaments were obtained 
at the time of laparoscopic hysterectomy. Institutional 
Review Board approval was obtained for the study. 
RNA isolation and microarray hybridization 
RNA from each tissue was extracted with the Trizol reagent 
according to the manufacturer's instruction (Gibco BRL 
fl Springer 
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Life Technologies, NY, USA). At least 30 ~g total RNA 
was extracted from each tissue. 1 ~g RNA was subjected to 
gel analysis to verity the integrity of the RNA. 
Microarray hybridization 
All microarray procedures followed Applied BioSystems 
protocols. Briefly, 20 ~g of biotin-labeled cRNA was 
fragmented following the manufacture's instruction (Ap-
plied Biosystems, CA, USA). All labeled samples were 
then hybridized to ABI Human Genome Survey Microarray 
version 2 (Applied Biosystems, CA, USA) 
Cluster analysis 
Cluster analysis is a commonly used method in the analysis 
of microarray gene expression profiles. This method starts 
from a similarity matrix calculation between the genes to be 
clustered on the basis of their expression profiles. At 
present, cluster analysis with the correlation coefficient 
(e.g., Pearson correlation coefficient, Spearman correlation 
coefficient, and standard correlation coefficient) as a distance 
measure has been commonly used in the analysis of 
microarray gene expression data. Although the correlation 
coefficient is scale invariant, it does not take the covariance 
between genes into consideration. However, changes in 
expression levels of genes do not occur as individual events, 
but participate in a complex and interdependent manner due 
to gene coexpression and coregulation, giving rise to the 
working of lively organisms and their parts. Unless the 
distance measure properly takes the covariance between 
genes into account, the organized profiling can be disturbed 
as a result of iguoring interdependencies. 
To account for the correlation between genes, a proper 
distance measure can be used is the Mahalanobis distance 
defined as follows: 
d~ = (x;- xj)' S~I (x;- Xj) 
where xi and x1 are two data points, Sis the p xp covariance 
matrix of X, and X is assumed to be of full rank so that s-' 
exists [17-19]. The Mahalanobis distance is a distance 
measure introduced by P. C. Mahalanobis in 1936 [20]. It is 
based on correlations between variables by which different 
patterns can be identified and analyzed. The Mahalanobis 
distance incorporates covariance between gene expression 
levels as well as differences in variances [17-19]. It gives 
less weight to genes with high variance and to high 
correlated genes, so that all characteristics are treated as 
equally important [ 17-19]. Thus far, the Mahalanobis 
distance has not explicitly been commonly used in the 
organization of microarray gene expression data. 
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Fig. I Clustered d1splay of gene expression profiles m round and uterosacral ligaments from women with pelvic organ prolapse corresponding to 
nonprolapse controls 
Results 
With the aid of high-density oligonucleotide microarrays, we 
examined microarray gene expression profi ling of 32,878 
distinct features in round and uterosacral ligaments from 
women with POP corresponding to nonprolapse controls. 
Gene transcripts expressed by round and uterosacral ligaments 
from women with POP were compared to those without 
history of POP. To take the interdependencies between genes 
into account [ 17, I R], the Mahalanobis distance in Ward's 
linkage hierarchical clustering was used to cluster the global 
gene expression profiles in round and uterosacral ligaments 
from women with POP corresponding to nonprolapse 
controls (Fig. I). Here, we used heat maps to represent the 
measured intensity of the round and uterosacral ligaments in 
the two-dimenstonal grids. Cells with intensities of zero are 
colored black, increasing positive intens ities with reds of 
increasing intensity and increasing negative intensities with 
greens of increasing intensity [21]. This visua l representation 
preserves all the quantitative information, but transmits it to 
our brain by ways of a much higher bandwidth channel than 
the "number-reading" channel [22]. At the finest level, we 
found that there was a c luster of 33 genes that revealed 
Fig. 2 A cluster with 33 
genes those were uprcgu lated 
in round and uterosacral 
ligaments from women w1th 
pelvic organ prolapse 
substantial fold increase in round and uterosacral ligaments 
from women with POP (Fig. 2). 
To characterize their biological processes, we performed 
gene ontology on those 33 genes with the aid of Entrez Gene 
(Table I) [23 25]. Specifically, we observed a gene 
contributing to 0-glycan biosynthesis (CIGALT ICI) was 
upregulated. Several genes contributing to transport, 
transcription, and translation were also upregulated. The 
expressions of genes encoding ribosomal protein (RPLI4, 
RPLI4A, RPLI5, RPLI5A, RPLI6, RPL22. RPL24, and 
RPSA) were upregulated in round ligament and uterosacral 
ligaments from women with POP. Genes involved in 
potential interactions with mitochondrial electron transport 
(PSMA3, NDUFB5, SDHB, COX7A2L, and CIGALTIC I), 
nucleosome assemb ly (H2BFS, TII ST I H2Bll, and 
HIST I H2BE), cell cycle (CKS I B and CCDC5), and 
apoptosis (POCO I 0) were upregulated in round and utero-
sacral ligaments from women with POP as well. Lastly, we 
confirmed the changed gene expressions of 20 genes 
(CIGALTIC.I, RPL14, RPLI4A, RPL15, RPLI5A, 
RPLI6, RPL22, RPL24, RPSA, PSMA3, NDUFB5, SOHB, 
COX7A2 L, C IGALTI C I , H2BFS, HI STI H2BH, 
HfSTIH2BE, CKS IB, CCDC5, and PDCOI) by semiquan-
uterosacralligMlent 
round bgament 
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Table 1 Representation of highly differential expressed genes in 
round ligament and uterosacral ligaments from female patients with 
pelvic organ prolapse 
Gene symbol 
CRSP9 
MCTSI 
TCEAL8 
C2lorf51 
SCNMI 
PAIP2 
RPL14 
RPL14A 
RPLIS 
RPLISA 
RPL16 
RPL24 
RPL22 
RPSA 
NACA 
ANAC 
BC-2 
ATP6VICI 
SCP2 
CKSIB 
CCDCS 
PDCDIO 
PSMA3 
NDUFBS 
SDHB 
COX7A2L 
CIGALTICI 
CGI-121 
RAP IA 
GNGS 
H2BFS 
HISTIH2BH 
HISTIH2BE 
Gene ontology 
Transcription 
Transcription 
Transcription 
Open reading frame 
mRNA processing 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Protein transport 
Protein transport 
Protein transport 
Proton transport 
Lipid transport 
Cell cycle 
Cell cycle 
Apoptosis 
Regulation of ubiquitin ligase 
activity during mitotic cell cycle 
Mitochondrial electron transport, 
NADH to ubiquinone 
Electron transport chain 
Electron transport chain 
0-glycan biosynthesis 
Protein catabolism 
Small GTPases-mediated signal transduction 
G protein-coupled receptor signaling pathway 
Nucleosome assembly 
Nucleosome assembly 
Nucleosome assembly 
titative reverse transcription-polymerase chain reaction 
(PCR) and observed quantitative agreement between the 
methods for all 20 genes. Semiquantitative reserve 
transcription-PeR revealed the elevated steady-state messenger 
RNA (mRNA) levels for these 20 genes. 
Discussion 
In the present study, we hypothesized that, in addition to the 
mechanical stresses on the pelvic floor, some women have 
~Springer 
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genetic differences that predispose them to POP. To that 
end, we have undertaken a comprehensive analysis to 
assess upregulated patterns of gene expression in pelvic 
connective tissue from women with POP. We sought to 
recognize the potential molecular mechanisms contributing 
to the pathogenesis of POP. We selected genes that were 
upregulated in round and uterosacral ligaments from 
women with POP that represent relative universal tran-
scriptional responses in POP. The array analysis revealed 
that of over 30,000 distinct features examined, the 33 genes 
summarized in Table I were upregulated. According to 
gene ontology, our analysis of transcriptional responses in 
pelvic connective tissue has suggested the potential 
molecular alterations underlying POP. First, the expressions 
of mitochondrial genes encoding ribosomal protein were 
upregulated. Second, several genes involved in potential 
interactions with mitochondrial electron transport, nucleosome 
assembly, cell cycle, and apoptosis were also upregulated. 
Such changes, jointly termed "remodeling of pelvic connective 
tissue", can constitute an important long-term consequence of 
POP. Taken these results entail defective mitochondrial 
translation caused by ribosomal protein contributes to the 
potential molecular etiology of POP. As a result, the therapies 
designed to prevent or inhibit defective mitochondrial transla-
tion caused by ribosomal protein would be beneficial in 
preventing or ameliorating the clinical manifestations of this 
disease. 
A major endeavor in functional genomics, in addition to 
revealing genome-wide changes in gene expression under 
defined conditions, is the reverse engineering of signaling 
networks within cells such that array data are used to 
explain potential upstream regulatory events [26]. This 
concept is based on the premise that coexpressed genes are 
likely to share common transcriptional regulators [27]. To 
address this problem, we used the Mahalanobis distance in 
agglomerative hierarchical clustering algorithm in order 
that the correlation between genes and the differences in 
variances were taken into account [ 17, 18]. We were able to 
identify 33 genes whose expression levels in pelvic 
connective tissue positively associated with the molecular 
mechanisms contributing to the pathogenesis of POP. POP 
comes later as a consequence of the activation of those risk 
genes associated POP probably with some commonly 
known epigenetic risk factors. 
The present study differed from most previous 
approaches whose analysis of microarray gene expression 
data were assessed by some statistical tests on an individual 
basis, essentially resulting in long lists of genes that are 
thought to have significantly changed transcriptional levels. 
Visco et al. [I 0] reported differential gene expression in 
pubococcygeus muscle from patients with POP, and these 
findings were subsequently confirmed by Hundley et al. 
[11]. In another study, Chen et al. [12] reported that elastin 
Tnt Urogynecol J 
remodeling is the molecular etiology of POP resulting in 
stress urinary incontinence, and they later claimed the 
differences in mRNA and protein expression in vaginal 
wall tissue from women with and without stress urinary 
incontinence [13, 14]. Recently, Hundley et al. [15] 
indicated differential messenger ribonucleic acid levels of 
actin- and myosin-related genes in women with POP. On 
the other hand, the results they presented remained 
uncertain for two reasons: First, they only investigated 
transcriptional responses of vaginal tissues or pelvic muscle 
ftom women with POP, without investigating their pelvic 
organ supportive tissue (e.g., round and uterosacral 
ligaments) which plays the most important role in uterine 
suspension [16]. Next, they hypothesized that elastin 
metabolism is the mechanism of POP and chose to examine 
genes involved in extracellular matrix metabolism only. 
Such analysis failed to address the full potential of genome-
based experiments to alter our understanding of cellular 
biology and to reveal the potential molecular mechanisms 
contributing to the pathogenesis of POP. However, in 
biology, these changes do not occur as independent events 
as the lists suggest, but in a complex and interdependent 
manner due to gene coregulation and coexpression. To 
support the human genome becoming a unifYing explana-
tion for all of human biology and medicine, we need to take 
the interdependencies between genes into consideration. We 
performed an explanatory study, colloquially called a 
"fishing expedition", which was one in which multiple 
hypotheses were proposed for scientific investigation with 
the aid of microarray gene expression profiles in pelvic 
connective tissue ftom women with POP. The primary 
theme of such study was to learn enough about possible 
causes of POP so that one or more specific hypotheses may 
be proposed and be sufficiently supported to justifY a 
detailed investigation in the future. 
Although the round and uterosacral ligaments used in 
this study were removed from each subject at the time of 
laparoscopic hysterectomy, the biopsy can be done using 
less invasive laser capture microdissection [28]. Combining 
laser capture microdissection, RNA amplification protocols, 
and microarray technologies, it is possible to develop a 
commonplace microarray platform for diagnostic tests and 
therapeutic interventions of POP in clinical practice in a 
straightforward manner. For example, a 20-gene min-
microarray platform for gene expression profiling of 
ClGALTlCl, RPL14, RPL14A, RPL15, RPL15A, 
RPL16, RPL22, RPL24, RPSA, PSMA3, NDUFB5, 
SDHB, COX7A2L, ClGALTlCl, H2BFS, HIST1H2BH, 
HIST1H2BE, CKSlB, CCDC5, and PDCDl can be 
developed for the classification of samples of unknown, 
equivocal, or ambiguous history, thus, offering the basis for 
a genetic screening tool for women at risk of developing 
POP, as well as future treatments for prevention of POP. 
In summary, the present study constitutes the most 
definitive assessment of the functional genomics of POP 
to date. However, these results are very preliminary, and 
further studies are needed to substantiate the clinical utility 
of these methods. Continued effects of large-scale genomic 
data should contribute to our knowledge of POP and 
hopefully, will lead to the improvement in treatment. 
Moreover, since POP contributes to causing stress urinary 
incontinence (SUI), we would like to define the programs 
of gene expression in SUI in the future. It will be of great 
interest to know the interrelationship between POP and 
SUI. Such analyses would give additional insights into 
what "works" are needed in sustaining a relationship 
between POP and SUI in present. 
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